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Summary 
 
The organs and tissues of the human body comprise of an astonishing variety of cells as different in 
morphology and function as muscle cells and neurons. Amazingly, despite their different protein contents, 
they largely contain the identical genomic information. In order to understand the processes that enable 
this differentiation, we need to determine the underlying regulatory mechanisms. A very recent discovery 
in this context was the posttranscriptional regulation of gene expression by microRNAs (miRNAs).  miRNAs 
are small RNA molecules that mediate translational repression and degradation of mRNA transcripts 
through partial complementarity to their 3’ untranslated region (UTR) . Among the first miRNAs to be 
identified, let-7 stands out for its high conservation in sequence and developmental functions in 
development throughout the animal kingdom. During my PhD, I studied the role of let-7 in Caenorhabditis 
elegans in the context of two distinct processes of tissue development, namely differentiation of the 
epidermis (called hypodermis), and morphogenesis of the vulva. The functions of the let-7 miRNA in 
formation of the adult cuticle have been extensively studied and are well understood. let-7 controls 
differentiation of specific, mitotically active epidermal cells by inducing cell cycle exit, fusion, and switch 
to an adult specific transcriptional program upon repression of targets such as lin-41, daf-12, hbl-1 and 
let-60/ras. I set out to identify novel interactors of let-7 in a genome-wide RNAi screen for suppression of 
the lethal let-7 bursting phenotype. Candidates were then verified using fluorescence-based reporter 
systems for onset of hypodermis differentiation and intensity of repression of a known target. Thereby, I 
was able to validate a whole set of novel members of the let-7 network, comprising genes downstream in 
the pathway as well as potential regulators of let-7 activity. Notably, both groups of repressors contain 
factors required for cell cycle progression and mitosis, which indicates an active crosstalk between let-7 
and the cell-cycle machinery. In a second project, I explored the molecular basis for the prominent let-7 
vulval bursting phenotype. Despite the absence of overproliferation or any other obvious phenotype in 
vulval morphogenesis, I was able to show that let-7 activity is required in the vulva, and that its major 
function in this context is repression of a single target, namely lin-41. Disruption of let-7 binding to lin-41 
through modification of the let-7 complementary sites by CRISPR/Cas9 mediated genome editing suffices 
to trigger the bursting phenotype, proving that repression of a single target is the key function of the 
miRNA in this context. In summary, my work shows that while both differentiation of hypodermis as well 
as vulval integrity are mediated through repression of lin-41, the downstream effect of this regulation 
seem to differ, suggesting that let-7 can be wired to control distinct processes depending on the cellular 
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context. With respect to the latest findings both in C. elegans as well as in mammals, it will be interesting 
to determine if this depends on differential molecular functions of LIN-41 in the two tissues. 
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Introduction 
 
C. elegans as a classical model organism for development 
 
All multicellular organisms develop different tissues and organs from a single fertilized oocyte. During this 
process, pluripotent precursor cells have to differentiate into highly specialized cells as different as muscle 
cells, neuronal cells or germ cells. While these distinct cell types all share the same genomic information, 
they still differ in cell morphology and function due to individual, cell type-specific gene expression 
profiles. Numerous studies over the last decades have elucidated that the resulting distinct protein 
outputs are generated by a delicate interplay of regulatory modules. As a first level, transcription can be 
regulated by sets of cell type specific transcription factors. The earliest fate choice in mammalian 
development, the decision between placental trophectoderm and embryonic tissue, is regulated through 
reciprocal activity of the transcription factors Cdx2 and Oct3/4. Overexpression of Cdx2 can induce 
trophectoderm formation, while activity of Oct3/4 is required to establish the pluripotent state of the 
inner cell mass (Niwa et al. 2005). Such transcriptional states can then be enforced by epigenetic 
modifications of chromatin such as DNA methylation and histone modifications, resulting in closure of 
genomic regions specific for other downstream cell lineages. An elegant proof of this paradigm was the 
finding that reprogramming of mouse embryonic fibroblasts (MEFs) into pluripotent stem cells involved a 
reduction of the repressive histone modification H3K9me2 at the locus of the pluripotency factors Oct3/4 
and Nanog (Takahashi and Yamanaka 2006). Differential gene expression can also be established on the 
level of mRNA. Probably the most drastic developmental decision based on alternative mRNA splicing is 
the sex determination of Drosophila melanogaster (Hodgkin 1989). More recently, it became apparent 
that specialized small RNAs themselves can act as regulators of gene expression at the mRNA level. The 
discovery of posttranscriptional gene repression by microRNAs (miRNAs) and short interfering RNAs 
(siRNAs) has transformed our view of both RNA biology and gene regulation.  
Our understanding of developmental processes in animals has been substantially shaped by countless 
discoveries made in the nematode Caenorhabditis elegans. This roundworm of roughly one millimeter in 
length can be found in the soil of temperate zones all over the world, where it feeds on microorganisms 
such as bacteria that decompose organic materials. Adult hermaphrodites lay around 200 eggs from which 
the larvae hatch after approximately 10 hours of embryonic development at 25°C. Subsequently, the 
worms go through four larval stages (L1-L4) that each end with a molting event during which the worms 
6 
 
shed off their cuticle. With the fourth and final molt, they reach the sexually mature adult stage and start 
to produce oocytes, which can be fertilized by sperm from the hermaphrodite’s own spermatheca or after 
mating with rarely occurring male animals. Due to its size and short life cycle, C. elegans can be easily 
cultured in large amounts in the lab using agar plates covered with E. coli, and the hermaphrodite’s self-
fertilization combined with the possibility to use males to cross different mutations facilitates genetics 
tremendously (Brenner 1974). Moreover, both its small size and the fact that the embryo as well as the 
worm are transparent facilitate visualization of cell divisions using light microscopy. C. elegans has been 
traditionally used as a model system for forward genetic screens because of its large brood size. Worms 
can be mutagenized using EMS (ethyl methane sulfonate), and progeny can be screened for obvious 
phenotypes such as abnormal body morphology (e.g. dumpy, “dpy”) or locomotion (uncoordinated, 
“unc”). These phenotypes can then be mapped to mutations in single genes and gene functions can be 
determined. Today, researchers have access to a variety of techniques adapted for C. elegans that allow 
to address almost any scientific question possible. One of the most important achievements was the 
discovery that injection of plasmid DNA into the hermaphrodite gonad results in the establishment of 
large extrachromosomal DNA arrays (Mello et al. 1991). These arrays can be replicated and propagated 
during mitosis and inherited to progeny by a mechanism similar to endogenous chromosomes. 
Furthermore, arrays can be stably integrated into the genome of the worm at a random position by 
irradiation (Mitani et al. 1993). This means that by using appropriate promoters, C. elegans can be 
engineered to express any transgene of interest, either ubiquitously or in specific tissues or cell types. 
When this technique was combined with the discovery of GFP (green fluorescent protein) it became 
possible to visualize the intracellular localization of proteins as well as the expression profiles of gene-
specific promoters by fusing the mRNA sequence of gfp to the coding sequence or the promoter of any 
gene of interest (Chalfie et al. 1994). Since the early nineties, these techniques have evolved to a point 
where researchers can now integrate a single copy of a transgene at a defined genomic locus using a 
recombination technique based on Mos1 transposon mobilization, ensuring defined expression levels of 
the transgene even in the germ line (Frokjaer-Jensen et al. 2008). Major technical advances were also 
made in the context of gene manipulation. The observation of efficient gene knockdown upon injection 
of complementary double-stranded RNA molecules into the germ line greatly improved functional gene 
analysis for the C. elegans community (Fire et al. 1998). Moreover, this study on RNA interference (RNAi) 
thereby lead to the discovery of RNA mediated posttranscriptional gene silencing, which has changed our 
understanding of gene regulation dramatically. In addition to posttranscriptional knockdown of any gene 
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of interest, the discovery of the CRISPR/Cas9 system of bacteria and its application for targeted genome 
editing now allow deletion or modification of genomic loci (Frokjaer-Jensen 2013). 
Because of the numerous advantages in handling and the technical tools available C. elegans has become 
essential in various fields of biological research such as cell biology, neuroscience or aging. However, the 
worm originally began its career as a model organism for development.  The simple anatomy and total life 
cycle of only about 50 hours at 25°C make it an ideal system to follow development over the course of 
time. In a laborious study John E. Sulston and coworkers were able to map the cell divisions of each single 
cell from the oocyte to its final position in the adult worm. This pioneering work resulted in a complete 
cell lineage of the developing animal which revealed that the tiny worm shows a strikingly invariant 
pattern of cell division, apoptosis and tissue specification events during development (Sulston and Horvitz 
1977, Kimble and Hirsh 1979, Sulston et al. 1983, Hedgecock et al. 1983). This always gives rise to a final 
959 nuclei in wild-type hermaphrodites and 1031 nuclei in male animals. Subsequent to this finding, 
mutants were identified that show abnormalities in the cell division pattern, leading to cell fate 
specification or tissue differentiation defects (Horvitz and Sulston 1980, Sulston and Horvitz 1981, Chalfie 
et al. 1981). Looking at the cell lineage of C. elegans, a hallmark of development becomes apparent: 
Developmental control has to be exerted on two different, interconnected levels. Pathways must exist to 
ensure that a cell division gives rise to a pair of daughter cells with defined properties. But in order to 
result in a functional organ, cell divisions of a given type have to occur at a precisely controlled time point. 
The invariant cell lineage of C. elegans has allowed researchers to ask fundamental questions regarding 
the genetic and molecular regulation of development in time and space. One important contribution to 
our understanding of developmental control was made by the discovery of the heterochronic pathway in 
Caenorhabditis elegans. 
 
The heterochronic pathway of C. elegans controls developmental timing 
 
At the beginning of the first larval stage a hermaphrodite C. elegans larva consists of 558 cells. The division 
events of the remaining profiferative blast cells that allow growth and result in the final 959 somatic cells 
of the adult have been carefully mapped and are relatively easy to follow over larval development (Sulston 
and Horvitz 1977, Kimble and Hirsh 1979, Sulston et al. 1983). Soon after the initial mapping of 
postembryonic cell divisions, mutants were identified that showed alterations in the normally invariant 
pattern (Horvitz and Sulston 1980). It became apparent that some of these mutations lead to reiteration 
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of parental or even grandparental division patterns (Chalfie et al. 1981). This observation prompted Victor 
Ambros and Robert Horvitz to adapt the concept of heterochrony for C. elegans development (Ambros 
and Horvitz 1984). They defined heterochronic defects as cell division or differentiation events occurring 
in the correct cell lineage but at the wrong time point. As a consequence, mutant animals would display 
altered developmental timing in one cell type or tissue relative to the rest of the animal. Indeed, they 
were able to identify both precocious mutants expressing a given fate too early due to skipping of a 
developmental event, as well as retarded mutants that reiterated the previous fate. These findings proved 
that C. elegans could be used to study the timing mechanisms that underlie development and ultimately 
lead to the discovery of the heterochronic pathway as a consecutive cascade of gene products regulating 
developmental decisions from the L1 larva to the adult worm (Rougvie 2001). 
 
The heterochronic pathway controls timing of vulva development 
 
One of the first major developmental processes found to be affected by the heterochronic pathway is the 
development of the hermaphrodite vulva. Morphogenetic events as well as the underlying events of signal 
transduction and transcriptional activation have been intensively studied and serve as a general model 
for organogenesis, and tissue remodeling (Sternberg 2005). The C. elegans vulva is formed 
postembryonically by a complex sequence of highly orchestrated cell divisions and morphogenesis events, 
which are governed by several conserved signaling pathways (Horvitz and Sternberg 1991). Six 
multipotent vulval precursor cells (VPCs) are generated during early larval development from a set of 
ventral hypodermal blast cells of the P lineage (Sulston and Horvitz 1977). Three of these cells, P5.p to 
P7.p, respond to a graded EGF (LIN-3) signal from the anchor cell, a specialized cell of the somatic gonad, 
during the early L3 stage (Kimble 1981, Hill and Sternberg 1992). This signal initiates vulva development 
and coordinates vulva morphogenesis with the beginning development of the germ line (Figure 1). The 
P6.p cell, located closest to the anchor cell, receives the highest dose of LIN-3 signal, which initiates signal 
transduction from the EGF receptor LET-23 through the Ras homolog LET-60 to the MAP kinase MPK-1 
(Han et al. 1990, Beitel et al. 1990, Han and Sternberg 1990, Lackner et al. 1994). This in turn activates 
transcriptional programs characteristic for the primary vulva cell fate (1° VPC) (Tan et al. 1998). One 
important change in gene expression is the upregulation of Notch ligands and downregulation of the 
Notch receptor LIN-12 on the surface of the P6.p cell, which dampens the Notch signaling in the 1° cell 
(Greenwald et al. 1983, Levitan and Greenwald 1998, Chen and Greenwald 2004). Weaker EGF signal from 
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the anchor cell and the lateral Notch signal coming from the 1° VPC drive the adjacent P5.p and P7.p cells 
to downregulate LET-23/MAPK signaling. 
 
Figure 1 Vulva morphogenesis 
The six vulval progenitor cells (VPCs) P3.p to P8.p derive from hypodermal blast cells of the P lineage during L1 stage. During L3 
stage, an EGF signal from the anchor cell (AC), a specialized cell of the gonad, induces the P6.p cell and the P5.p and P7.p to adopt 
1° and 2° vulval cell fates, respectively (1). Subsequently, these cells produce 22 progeny, which differentiate to the final vulval 
cell types A to F, while the remaining vulval precursor cells give rise to daughter cells that fuse with hyp7. Parallel to the 
proliferation, the vulval cells move towards each other and start to invaginate at the end of L3 stage (3). This morphogenesis 
event establishes the tubular shape of the vulva and finally gives rise to seven toroids, which are generated through fusion of 
specific vulva cell subsets (4). Following VPC specification, the anchor cell breaks the basal membrane that separates uterus and 
hypodermis and invades between the 1° lineage daughters, contributing to their specification (2). During mid L4 stage, it 
withdraws from the vulF cells and fuses with the uterine utse cell, leaving only a thin process of cytoplasm to cover the connection 
between vulva and uterus. Figure modified from wormbook (Gupta et al. 2012). 
The therefore dominant Notch signaling pathway drives these cells to adopt a 2° VPC fate (Greenwald et 
al. 1983, Berset et al. 2001, Yoo et al. 2004). The remaining three uninduced VPCs automatically adopt a 
3° fate and subsequently produce daughter cells that become part of the hypodermis. Notably, all six VPCs 
have the capacity to adopt a vulval cell fate, and ectopic activation of EGF signaling can induce additional 
1° VPCs, resulting in multivulva phenotypes (Aroian and Sternberg 1991). Following cell fate specification 
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during early L3 stage, the 1° and 2° cells begin to divide to produce a distinct set of 22 daughter cells that 
eventually differentiate into the seven different vulval cell types (vulA to vulF). Even before proliferation 
has finished, the vulval cells start to migrate towards each other, which results in an invagination of the 
vulval tissue (Herman et al. 1999). Parallel to these morphogenetic changes the anchor cell breaks the 
basal membrane that separates gonad and body wall and invades between the 1° lineage cells at mid L3 
stage (Sherwood and Sternberg 2003). This event facilitates the establishment of a connection between 
uterus and vulva to form a functional egg-laying apparatus (Estes and Hanna-Rose 2009). Final 
morphogenetic events of vulva development occur during the late L4 stage, when the cells of the seven 
vulval cell types fuse with their sisters to form the seven vulva toroids, giving the vulva its final tubular 
shape (Sharma-Kishore et al. 1999), while the anchor cell fuses with the utse, a syncytium of uterine cells 
(Newman et al. 1996). 
A link between the heterochronic genes and vulva development became apparent even before the 
existence of a heterochronic pathway had been postulated. In addition to their inability to produce an 
adult specific cuticle, lin-4(e912) worms show a fully penetrant vulvaless phenotype (Horvitz and Sulston 
1980) due to complex deviations from the wild-type VPC division pattern (Chalfie et al. 1981). lin-14 and 
lin-28 loss-of-function mutants in contrast show premature proliferation of the VPCs during L2 stage due 
to a shortened G1 phase, resulting in a protruding vulva (pvl) phenotype (Euling and Ambros 1996) . A 
direct link between heterochronic genes and the cell cycle was established when lin-14 was shown to 
activate expression of cki-1, a cyclin-dependent kinase inhibitor of the CIP/KIP family (Hong et al. 1998) , 
pausing progression to S phase until mid L3 stage. 
 
Heterochronic regulation of hypodermis development 
 
A second process regulated by the heterochronic pathway is the postembryonic development of the 
hypodermis of C. elegans, an epidermal cell layer forming the outer body wall of the worm. Main function 
of the hypodermis is the secretion of the cuticle, a collagenous structure that protects the animal from 
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the environment and serves as a stable but very flexible exoskeleton. At the time of hatching, the 
hypodermis mainly consists of the large syncytial hyp7 cell and two major types of specialized epithelial 
cells (Sulston et al. 1983, Podbilewicz and White 1994). One group of these specialized cells are the seam 
cells, lateral hypodermal blast cells that maintain their proliferative potential after the completion of 
embryogenesis (Figure 2). Postembryonic lineaging revealed that the V1-V4 and V6 seam cells repeat a 
stem-cell-like division pattern during each larval stage (Sulston and Horvitz 1977). During this process one 
daughter cell fuses to the hyp7 syncytium while the other daughter maintains its proliferative potential 
Figure 2 C. elegans seam cell development 
Seam cells are a specified subset of hypodermal cells (H0-2, V1-6 and T) that line the lateral sides of the worm. All cells except H0 
divide during larval development, giving rise to multiple daughter cells that join the hypodermal syncytium, as well as a total 
number of 16 adult seam cells on each body side. The seam cells fuse at the L4-to-adult transition and secrete adult specific 
cuticular ridges called alae. A, Schematic of an adult hermaphrodite, lateral view. Seam cell nuclei (blue) are indicated with their 
respective parental blast cells. B, Postembryonic cell lineage of the V1-4 and V6 cells in wild-type animals. The division event at 
the beginning of each larval stage produces a daughter that differentiates and fuses with the hypodermis (H) as well as a daughter 
that retains proliferative potential. During L2 stage, a symmetrical division precedes the asymetrical event, increasing the total 
number of seam cells. C, indicated heterochronic mutants that either skip (Precocious) or reiterate (Retarded) stage-specific 
division patterns. Notably, let-7(n2853) is not a null mutation, but a temperature-sensitive hypomorph that shows seam cell 
differentiation failure at 15°C but a lethal bursting phenotype at the L4-to-adult transition at 25°C. Seam cell fusion followed by 
secretion of alae is represented by black horizontal triple bars (modified from Rougvie 2001). 
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for the next larval stage. This asymmetric division increases the number of hypodermal cells during 
development and allows growth of the animal from approximately 0.3mm in L1 to the adult size of 1mm. 
Moreover, symmetric division of a subset of seam cells during the L2 stage raises their total number from 
10 to 16 on each side. After the last asymmetric division in early L4 stage seam cell development finishes 
with the differentiation of the seam cells around the time of the L4 molt.  
This differentiation is marked by the fusion of each seam cell line to a lateral syncytium. As a result of the 
differentiation, the hypodermis starts to produce a cuticle with adult-specific collagen compounds, and 
the seam cells secrete alae, adult specific cuticular ridges along the lateral sides of the worm (Singh and 
Sulston 1978). Developmental control of hypodermis development can be divided into two major 
categories: mechanisms that time the larval specific division events, and mechanisms that ensure 
differentiation and establishment of the final adult state at the right time. The first isolated mutant for 
seam cell development was lin-4(e912), in which the L1 specific division pattern of the V1-V4 subset of 
the seam cells was reiterated, resulting in a failure to produce an adult specific cuticle (Horvitz and Sulston 
1980, Chalfie et al. 1981). Soon after this discovery, mutations in the genes lin-14 and lin-28 were 
identified that had the opposite effect on hypodermis development. Both displayed precocious alae 
formation due to skipping of L1 or L2 fates, respectively, indicating that the two factors were required for 
execution of stage specific division events (Ambros and Horvitz 1984, Ambros and Horvitz 1987). Careful 
analysis of the identified mutants revealed the requirement of lin-4 for their repression in order to permit 
progression to the next step in seam cell division (Ambros 1989). A second, exceptional class of lin-14 
mutations that phenocopied the retarded lin-4(e912) mutation was concluded to be immune to lin-4 
mediated repression. These interactions of the early heterochronic genes were deciphered exclusively 
through analysis of phenotypes combined with the laws of genetics, which resulted in a model according 
to which genes responsible for a given event needed to be repressed after their time of action by a master 
regulator. Surprisingly, when the molecular identity of the mutant genes was revealed, it became clear 
that the lin-4 locus did not, as expected, produce a protein. Instead it was found to produce a small RNA 
molecule that regulated its targets at the mRNA level through partial complementarity to their 3’ 
untranslated region (3’UTR) (Lee et al. 1993, Wightman et al. 1993, Moss et al. 1997). The exceptional lin-
14 mutants that showed the same division pattern as lin-4 mutants turned out to be immune to lin-4 
regulation because they carried deletions for these complementary sequences. This finding suggested a 
totally novel mechanism of gene regulaton, however, the molecular principle remained obscure for 
almost a decade. In the meantime, scientists continued to identify additional heterochronic mutations of 
C. elegans, among them lin-29, which was integrated into the heterochronic pathway as the most 
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downstream factor, controlling mature cuticle formation (Papp et al. 1991, Liu et al. 1995). In worms 
mutant for lin-29 seam cells fail to differentiate at the end of L4, and the worms continue to produce a 
new larval cuticle with each supernumerary molt. lin-29 codes for a transcription factor that regulates the 
activation of the adult-specific collagen col-19 and represses the larval specific col-17 (Rougvie and 
Ambros 1995). 
The surprise came in the year 2000, when a genetic screen for heterochronic mutants discovered a second 
small RNA regulating the L4-to-adult transition. Animals mutant for let-7 (lethal 7) execute early seam cell 
divisions properly but fail to initiate the differentiation event at the larval to adult transition. Instead, the 
seam cells go through an additional round of cell divisions and continue to express a larval specific cuticle 
without alae (Reinhart et al. 2000). Analogous to the relationship between lin-4 and lin-14, a mutation in 
a second novel heterochronic gene was identified that was able to suppress the retarded let-7 phenotype. 
Worms mutant for both let-7 and lin-41 (lineage variant 41) show wild-type seam cell differentiation at 
the end of L4 stage, while a lin-41 mutation alone results in precocious differentiation and alae formation 
(Slack et al. 2000). This phenotype is lost in lin-29 mutants, which led Slack and coworkers to conclude 
that lin-29 was repressed by lin-41 and activated in a let-7-dependent manner. These features defined let-
7 as the second master-regulator of the heterochronic pathway, initiating the final switch from 
proliferation to differentiation rather than execution of earlier division events. 
 
The microRNA let-7 
 
Soon after the discovery of let-7 as a second small RNA timing regulator, highly conserved let-7 
homologues were detected in other organisms ranging from simple molluscs to humans (Pasquinelli et al. 
2000). Those homologues also showed temporal expression and were proposed to function in regulation 
of developmental timing, leading to their definition as small temporal RNAs (stRNAs). The picture 
expanded when numerous additional small RNAs with potential regulatory functions were detected in C. 
elegans and a variety of other animal species, which were termed microRNAs (miRNAs) (Lau et al. 2001, 
Lee and Ambros 2001, Lagos-Quintana et al. 2001) . This discovery opened a new chapter in gene 
regulation. 
Biogenesis and function of microRNAs 
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miRNAs mediate posttranscriptional repression as small RNA molecules 22nt of length. Nonetheless, most 
miRNAs begin their life as long polyadenylated, 5’ 7-methylguanosine capped primary transcripts derived 
from their own polymerase II dependent promoters (Lee et al. 2004, Cai et al. 2004). Characteristic for 
these primary transcripts or pri-miRNAs are long hairpin structures that harbor the mature miRNA 
sequence within their stem. These primary transcripts are processed in the nucleus by the microprocessor 
complex, which contains the endonuclease Drosha (Lee et al. 2003) and the cofactor Pasha/DGCR8 that 
mediates binding to the precursor molecules and facilitates cleavage (Denli et al. 2004, Yeom et al. 2006, 
Gregory et al. 2004, Landthaler et al. 2004). This first processing step generates the ~70nt long precursor 
microRNAs or pre-miRNAs, hairpin molecules of individual sequence with an imperfectly paired stem of 
about 30 nucleotides. These precursors are exported to the cytoplasm by Exportin-5 in vertebrates, or 
Embargoed and its homologue XPO-1 in Drosophila melanogaster and C. elegans, respectively (Yi et al. 
2003, Bussing et al. 2010, Lund et al. 2004, Bohnsack et al. 2004), where a second endonucleolytic 
cleavage event mediated by the nuclease Dicer removes the loop of the hairpin (Grishok et al. 2001, 
Hutvagner et al. 2001, Ketting et al. 2001). This initially produces a miRNA duplex of 22nt, which is handed 
over to the miRNA induced silencing complex (miRISC) and incorporated into the Argonaute subunit 
(Grishok et al. 2001). Following incorporation the duplex is unwound and the miRNA passenger strand or 
miRNA* strand is discarded and degraded immediately, while the remaining mature miRNA facilitates 
binding of the complex to the 3’UTRs of target mRNAs (Meister and Tuschl 2004, Tomari and Zamore 
2005). This targeting process depends on partial complementarity of the miRNA to the 3’UTR of the 
targets and leads to posttranscriptional repression of the target. Although miRNAs can in principle induce 
Argonaute-mediated endonucleolytic cleavage of targets in case of perfect complementarity, this process 
typically does not take place in animal cells, where binding occurs through imperfect base-pairing. 
Moreover, early studies in C. elegans found no effect of lin-4 on lin-14 and lin-28 mRNA levels, which 
suggested a mechanism of translational repression (Olsen and Ambros 1999, Seggerson et al. 2002). Soon 
thereafter, several studies both in vivo and in vitro that used polysome-profiling to determine the 
translation status of miRNA targets could provide evidence for repression of translation at the initiation 
step (Pillai et al. 2005, Mathonnet et al. 2007, Ding and Grosshans 2009). Nonetheless,  genome-wide 
studies that analyzed steady-state protein and mRNA levels of miRNA targets could show that repression 
was mostly caused by changes in mRNA levels (Baek et al. 2008, Hendrickson et al. 2009, Guo et al. 2010, 
Eichhorn et al. 2014). Today, it has become increasingly clear that the GW182 subunit of the miRISC is 
essential for both translational repression as well as degradation of miRNA targets, making it the effector 
protein for miRNA mediated repression. Proteins of the GW182 family (AIN-1 and AIN-2 in C. elegans, 
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TNRC6A-C in mammals) interact with Argonaute through their N-terminal GW repeats, while mid and C-
terminal domains are required for silencing (Huntzinger and Izaurralde 2011)(Huntzinger and Izaurralde 
2011). Indeed, artificial tethering of the silencing domain (SD) to mRNAs is sufficient to induce repression 
and degradation, even in the absence of a miRNA loaded Argonaute (Lazzaretti et al. 2009, Zipprich et al. 
2009, Chekulaeva et al. 2009). GW182 proteins were shown to interact with cytoplasmic poly(A)-binding 
protein (PABPC), thereby  competing with the initiation factor eIF4G (Fabian et al. 2009, Zekri et al. 2009) 
which is required for mRNA circularization and reinitiation of translation. Molecular insight into the 
mechanism of mRNA degradation was obtained when GW182 proteins were shown to interact with the 
PAN2-PAN3 as well as the CCR4-NOT deandenylase complexes (Fabian et al. 2009, Braun et al. 2011, 
Chekulaeva et al. 2011). This interaction induces global deadenylation of miRNA targets, followed by 
decapping and ultimately mRNA decay through the 5’-3’ exonuclease XRN-1 (Rehwinkel et al. 2005, Behm-
Ansmant et al. 2006, Eulalio et al. 2009). Interestingly, the CCR4/NOT complex was also found to mediate 
Figure 3 Posttranscriptional repression by miRNAs 
When incorporated into Argonaute (AGO), the 
mature miRNA recruits the miRNA induced 
silencing complex (miRISC) to a target mRNA 
through partial sequence complementarity to 
miRNA binding sites typically located in the 3’ 
untranslated region (UTR). Binding of RISC to the 
target immediately leads to repression of 
translation, most likely at the initiation step. This 
repression is mediated through direct interaction 
of AGO with the translational initiation complex, as 
well as binding of the RISC effector protein GW182 
(AIN-2/AIN-2 in C. elegans) to the cytoplasmic 
poly(A) binding protein (PABPC). Moreover, GW182 
can recruit the multiprotein complex CCR4/NOT 
and thereby the DEAD-Box ATPase DDX6, which 
contribute to repression of translation. For the 
majority of miRNA/target interactions, initial 
repression is immediately followed by 
deadenylation of the target due to recruitment of 
deadenylases such as PAN2/PAN3 and the  
CCR4/CAF1 subunits of the CCR4/NOT complex via 
the GW182 protein. This leads to decapping by 
DCP2 and associated factors and subsequent 5’ to 
3’ degradation of the target (modified from Mathys 
et al. 2014). 
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translational repression. Work recently published in Molecular Cell could now attribute this activity to 
recruitment of the DEAD-Box protein DDX6, which interacts with the complex through the CNOT1 subunit 
of CCR4/NOT. The study identifies CNOT1 as a platform for different functions of the complex, mediating 
repression of translation through recruitment and activation of DDX6 while inducing degradation through 
association with the deadenylase subunits CCR4 and CAF1 (Mathys et al. 2014, Chen et al. 2014). 
Moreover, recent studies have suggested a GW182 independent role for Argonaute in displacing the 
initiation complex subunit eIF4A from target mRNAs (Fukao et al. 2014, Fukaya and Tomari 2012, Fukaya 
et al. 2014).Taken together, these findings indicate that repression of translation and degradation are 
mediated through the same protein complex (Figure 3), and indeed, high resolution studies of mRNA 
kinetics have led to a sequential model of posttranscriptional gene repression, such that repression 
precedes deadenylation and degradation (Bazzini et al. 2012, Djuranovic et al. 2012, Fukaya and Tomari 
2012, Bethune et al. 2012). 
 
miRNA targets 
 
Importantly, the miRNA pathway shares core components with a second cellular pathway involved in 
posttranscriptional regulation. Long double stranded precursor RNAs produced either by pathogens or 
from repetitive endogenous DNA loci can be processed into short duplexes of 22nt by Dicer (Bernstein et 
al. 2001, Ketting et al. 2001, Knight and Bass 2001). Incorporation of these short interfering RNAs (RNAi) 
into the RISC complex can target complementary mRNAs for endonucleolytic cleavage and degradation, 
and in some cases even transcriptional gene silencing (TGS) of the genomic locus of origin though 
heterochromatin formation (Hammond et al. 2000, Volpe et al. 2002, Mello and Conte 2004, Golden et 
al. 2008). To date, this phenomenon is widely used by researchers for transient knockdown of any gene 
of interest by RNA interference (RNAi) upon delivery of double-stranded RNA. A major difference between 
miRNAs and siRNAs in animals is the degree of complementarity to their targets. siRNAs are initially 
produced from their own targets, which results in perfect complementarity. miRNAs in contrast bind their 
targets through perfect Watson-Crick base pairing of their nucleotides 2-8 (miRNA “seed”) and variable, 
partial complementarity of the 3’ end (Carthew and Sontheimer 2009, Lai 2002). Therefore, identification 
of relevant miRNA targets has been a challenge ever since the discovery of miRNA mediated 
posttranscriptional regulation. The first miRNA targets were identified in C. elegans using classical genetic 
approaches by their ability to repress miRNA phenotypes (Reinhart et al. 2000, Ambros 1989). However, 
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this approach cannot distinguish between direct and indirect targets, and genetic screens are difficult to 
perform in higher organisms.  MicroRNA targets can be predicted computationally based on the 
complementarity between miRNA seed and the 3’UTR of annotated genes. Today, the major target 
prediction tools calculate miRNA:target pairs based on base-pairing of the seed sequence and 3’ end of 
the miRNA, free energy of this interaction, and conservation of the binding sites across species (Peterson 
et al. 2014). Based on these methods, up to 60% of mammalian protein-coding genes are predicted to 
subject to miRNA mediated regulation (Friedman et al. 2009). Depending on the miRNA of interest, these 
in silico approaches can result in hundreds of predicted targets, including numerous false positive hits. To 
complicate matters, individual 3’UTRs can contain multiple binding sites of a single miRNA, or even 
additional sites of multiple miRNAs (Bartel 2009). Thus, computational target prediction needs to be 
combined with biological validation to identify physiologically relevant interactions. A classical approach 
to verify miRNA mediated repression both in vitro and in vivo is the use of GFP or luciferase based target 
reporters. Here, the 3’UTR of the gene of interest is tested for its ability to mediate posttranscriptional 
repression to the reporter in the absence or presence of the candidate miRNA. Of note, while both in vivo 
and in vitro assays are insufficient to conclude functional relevance, analysis in vitro often depends on 
overexpression of the miRNA, which might alter miRNA:target interactions. Targets can also be predicted 
experimentally on a genome-wide level for their effect on global mRNA or protein abundance by RNA 
sequencing or SILAC proteomic approaches (Selbach et al. 2008, Baek et al. 2008). Again, such studies 
often use overexpression of the miRNA of interest and do not necessarily represent the in vivo situation. 
An alternative method to verify interactions is the biochemical detection of miRNA:target pairs by 
different crosslinking and immunoprecipitation (CLIP) techniques. For these experiments, target RNAs are 
chemically crosslinked to Argonaute by UV irradiation and coimmunoprecipitated from total lysates 
(Pasquinelli 2012, Hafner et al. 2010, Zisoulis et al. 2010). Bound RNAs can then be analyzed by high-
throughput sequencing and screened for miRNA binding sites in silico (HITS-CLIP or CLIP Seq). Moreover, 
the recently developed technique of crosslinking, ligation, and sequencing of hybrids (CLASH) allows direct 
allocation of miRNA and respective target (Helwak et al. 2013). Actual effects on mRNA molecules can be 
concluded from their translation status, which can be determined by polysome profiling or global analysis 
of ribosome occupancy by ribosome profiling (Eulalio et al. 2008, Ingolia et al. 2009). Taken together, the 
methods described above provide a good set of tools to identify interesting miRNA target candidates 
(Jovanovic et al. 2010). Nonetheless, these interactions have to be tested for functional relevance. A major 
obstacle for validations in vivo is the fact that many miRNAs exist as members of families that can 
potentially repress the same targets. This functional redundancy might be one of the reasons for the lack 
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of obvious phenotypes in many miRNA knockouts. An elegant solution for this issue will be the targeted 
mutation of endogenous miRNA binding sites in a gene of interest using TALENS or the CRISPR/Cas9 
system (Hsu et al. 2014, Kim et al. 2013). This will allow to determine both dimension and physiological 
impact of the targeting. 
 
The let-7 network in C. elegans 
 
As described above, let-7 acts as a regulator of differentiation in C. elegans. Analysis by Northern Blot has 
shown increasing expression of the mature miRNA from the early L3 stage on, reaching a plateau at the 
mid L4 stage (Reinhart et al. 2000, Esquela-Kerscher et al. 2005). This expression pattern coincides with 
the regulatory functions of let-7 during the L4 stage. let-7 mutants display a defect in seam cell 
differentiation at the L4 to adult transition. Instead of fusing with their neighbors to a lateral seam cell 
syncytium, some seam cells undergo an additional round of division, which results in increased seam cell 
numbers at the young adult stage and production of a larval specific cuticle without alae. These 
phenotypes are shared between let-7 null mutants and the temperature sensitive let-7(n2853) allele. 
Moreover, let-7 function is essential for viability, since both null mutants as well as the temperature-
sensitive strain at the restrictive temperature of 25°C die by bursting through the newly formed vulva at 
the L4 to adult transition (Reinhart et al. 2000). Interestingly, the let-7(n2853)ts strain can be maintained 
at 15°C, where it shows abnormalities in seam cell differentiation and an egg-laying defect, but only 
infrequent bursting in about 40% of the animals (Reinhart et al. 2000). While let-7(mn112) null mutants 
that fail to produce any mature miRNA carry a longer deletion disrupting the stem-loop formation, it was 
discovered that the let-7(n2853) allele harbors a single G to A transition in the seed sequence of the 
mature miRNA. Expression of let-7 is reduced, but not absent in these animals. 
The first target of let-7 to be identified was lin-41, which encodes a member of the conserved TRIM/NHL 
protein family of ubiquitin ligases. The family name derives from the tripartide motif (TRIM) of RING finger, 
B-box and coiled-coil domain, and the NHL domain , which was first identified in C. elegans NCL-1, human 
HT2A2 and C. elegans LIN-41 (Slack et al. 2000, Slack and Ruvkun 1998). Soon after its appearance on 
stage as a target of let-7 in C. elegans, it was found to be repressed by the let-7 homologues of  zebrafish, 
mouse, chicken, human and fly, revealing a conservation not only of let-7 and lin-41, but also of the 
relationship between miRNA and target (Kloosterman et al. 2004, Kanamoto et al. 2006, Lin et al. 2007, 
O'Farrell et al. 2008). Early studies in C. elegans identified LIN-41 as a repressor of the transcription factor 
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LIN-29, which can be detected at the protein level only from L4 stage on, even though the corresponding 
RNA is transcribed earlier (Rougvie and Ambros 1995, Bettinger et al. 1996). Therefore, LIN-41 was 
proposed to act as a translational repressor of lin-29, yet the mechanism remained elusive (Slack et al. 
2000). More recently, two studies could demonstrate translational repression of a luciferase reporter 
mediated by the 3’UTR of identified LIN-41 targets in mouse and human (Chang et al. 2012, Loedige et al. 
2013). This repression was attributed to the coiled-coil and filamin domains of the protein, while RNA 
binding crucially depended on the NHL repeats (Loedige et al. 2013). On the other hand, the TRIM domain 
of LIN-41 is found in a large group of mammalian proteins, multiple of which possess E3 ubiquitin ligase 
activity (Meroni and Diez-Roux 2005). Indeed, a study in mouse identified the Argonaute protein Ago2 as 
a target for mLin41 mediated ubiquitylation in stem cells , which was followed by degradation of Ago2 
(Rybak et al. 2009). This suggested the interesting possibility of a counter-regulation between a miRNA 
target and the miRNA machinery. However, the physiological relevance of the Ago ubiquitylation remains 
elusive, and Ago destabilization could not be reproduced in recent studies (Chang et al. 2012, Loedige et 
al. 2013). Furthermore, the Drosophila LIN-41 homologue dappled/wech lacks the RING domain 
responsible for ubiquitylation (O'Farrell et al. 2008). In contrast to the functions of LIN-41, the 
requirements for the binding of let-7 to the 3’UTR of lin-41 have been extensively studied. Six let-7 binding 
sites were predicted in silico based on partial sequence complementarity, and careful experimental 
validation identified 2 conserved let-7 complementary sites (LCSs) as the major effectors of repression 
(Vella et al. 2004). LIN-41 was shown to inhibit hypodermis differentiation through repression of the 
terminal heterochronic factor LIN-29 on a posttranscriptional level. Expression of LIN-29 protein at the 
late L4 stage depends on let-7-mediated repression of lin-41 (Slack et al. 2000). Despite this clear linear 
explanation of the let-7 phenotypes, additional genes were identified as potential let-7 targets by the 
presence of let-7 binding sites in their 3’UTR. RNAi mediated knockdown of the transcription factors daf-
12, pha-4, lss-4, die-1 and hbl-1 (Abrahante et al. 2003, Lin et al. 2003, Grosshans et al. 2005) was shown 
to rescue the lethal phenotype of let-7 null mutants, pointing indeed to a let-7 mediated regulation of 
these genes. Moreover, tissue-specific repression of several of these genes by let-7 could be shown. The 
connection between the early and the late timer of the heterochronic pathway was identified with the 
discovery of additional let-7 family members, the so called “let-7 sisters” mir-48, mir-84 and mir-241 (Lau 
et al. 2001). miRNAs of the same family share the seed sequence with their siblings and are thought to 
regulate the same targets. In C. elegans however, the let-7 sisters are expressed earlier than let-7 and 
show reiteration of the L2 specific seam cell division if present as a triple mutant (Abbott et al. 2005, 
Esquela-Kerscher et al. 2005), placing them upstream in the  heterochronic pathway (Figure 4). Indeed, 
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the sisters were shown to target the transcription factor HBL-1 during L3 stage, thereby blocking 
repetition of the L2 specific seam cell division pattern (Abbott et al. 2005). This finding  completes our 
view of the heterochronic pathway as a carefully timed succession of three miRNA triggers that repress 
stage-specific factors after their time of action to allow progression to the next developmental step 
(Ambros 2011). 
 
Figure 4 Simplified model of the heterochronic pathway 
Major effectors of the heterochronic pathway and their effect on division of the V1-V4 and V6 subset of seam cells during larval 
development. LIN-14 is required in L1 stage but needs to be repressed by lin-4 to permit progression to L2. The combination of 
symmetric plus asymmetric devision characteristic for L2 stage requires activity of HBL-1 and LIN-28, while progression to L3 
depends on the let-7 family members mir-48, mir-84, and mir-241. Finally, differentiation of the seam cells at the L4 to adult 
transition is mediated by posttranscriptional repression of lin-41 by let-7, which allows activation of the transcription factor LIN-
29. Factors in red boxes show retarded phenotypes if mutated (modified from Ambros 2011 and Rougvie 2001). 
 
let-7 activity is regulated at multiple levels 
 
The heterochronic function of let-7 crucially depends on its temporally controlled activity. let-7 is 
expressed in the form of two alternative primary transcripts that are subject to trans-splicing to the SL1 
splice leader, resulting in the most abundant pri-let-7 form (Bracht et al. 2004). Fusion of GFP to the let-7 
promoter reveals strong promoter activity in the seam cells as well as cells of the pharynx and intestine, 
muscles, and neurons from the L4 stage onwards (Johnson et al. 2003). This expression depends on the 
presence of a temporal regulatory element (TRE) as well as a second let-7 transcription element (LTE) in 
the let-7 promoter (Johnson et al. 2003, Kai et al. 2013).Surprisingly and in contrast to the expression 
pattern of the mature miRNA, low levels of pri- let-7 can be detected by Northern Blot from the L1 stage 
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onwards (Kai et al. 2013). Maturation of let-7 at these stages is repressed through binding of the 
heterochronic factor LIN-28, which recruits the poly(U) polymerase PUP-2 to target let-7 for degradation 
(Lehrbach et al. 2009, Van Wynsberghe et al. 2011, Vadla et al. 2012). Moreover, full transcriptional 
activity of the promoter is repressed by the heterochronic gene HBL-1 until the end of L3 stage (Roush 
and Slack 2009). Hence, the heterochronic pathway itself controls the onset of activity of its late master-
regulator let-7. Subsequent accumulation of mature let-7 allows targeting of the C. elegans miRNA specific 
Argonaute ALG-1 to a conserved complementary sequence in the let-7 precursor, which facilitates pri-let-
7 processing (Zisoulis et al. 2012). This creates a positive feedback loop that ensures robust let-7 
expression at the correct time point. In addition to transcription and processing, let-7 function is 
controlled at the level of mature miRNA by active turnover. Both the exonuclease XRN-2 as well as the 
decapping enzyme DCS-1 in complex with the XRN-2 homolog XRN-1 have been shown to degrade mature 
let-7 as well as other miRNAs in C. elegans (Chatterjee and Grosshans 2009, Bosse et al. 2013). Taken 
together, the many layers that control its expression imply that correct timing of let-7 activity is of utmost 
importance for C. elegans. Indeed, artificial expression of let-7 during earlier larval stages induces 
precocious seam cell fusion and alae formation, as well as egg-laying defects (Hayes and Ruvkun 2006). 
 
The antiproliferative function of let-7 is highly conserved in other organisms 
 
let-7 and the heterochronic  pathway of C. elegans are a beautiful example of posttranscriptional 
regulation of tissue development. Therefore, since its discovery let-7 has gained enormous attention 
beyond the worm community. The absolute sequence conservation of mature let-7 throughout most of 
the animal kingdom suggested an important function for the miRNA in all higher eukaryotes (Pasquinelli 
et al. 2000). Moreover, conservation of let-7 targets such as lin-41 (Slack et al. 2000, Kanamoto et al. 
2006), lin-28 (Moss and Tang 2003) and Ras (Johnson et al. 2005) as well as its temporal expression 
immediately pointed to a common role in the control of development. Indeed, let-7 was soon found to be 
involved in a variety of developmental contexts in multiple species, such as mouse epithelial progenitor 
cell differentiation (Ibarra et al. 2007) or differentiation of neuronal stem cells (Rybak et al. 
2008).Moreover, the effect of LIN-28 on let-7 maturation turned out to be a second highly conserved 
aspect of the let-7 pathway (Heo et al. 2008, Heo et al. 2009, Piskounova et al. 2011, Heo et al. 2012). It 
has become increasingly clear that let-7 and its target lin-28 play antagonistic roles in the control of 
stemness, LIN-28 acting as a pluripotency factor and let-7 acting as its repressor. A study by Melton and 
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coworkers identified the let-7 family miRNAs as the crucial factors to allow differentiation of mouse 
embryonic stem cells (ESCs) in the absence of canonical miRNA maturation in a Dgcr8-/- background 
(Melton et al. 2010, Shyh-Chang and Daley 2013, Wang et al. 2007). Moreover, they found let-7 to 
antagonize the ESC cell cycle regulating (ESCC) miRNAs, an opposing class of stem cell specific miRNAs 
which are required for cell cycle progression and stem cell proliferation, and which were shown to support 
dedifferentiation (Judson et al. 2009, Wang et al. 2008). The authors could demonstrate repression of the 
pluripotency factors Lin28, N-myc and Sall4 by let-7 using luciferase reporters, thereby offering an 
explanation for the antiproliferative function of let-7. Further insight on the downstream mechanism was 
gained when Trim71, the homologue of the let-7 target LIN-41 in mouse, was found to repress Cdkn1a in 
concert with Ago2 and the ESSC miRNAs miR-290 and miR-302 (Chang et al. 2012). The cyclin-dependent 
kinase inhibitor Cdkn1a acts as a negative regulator of the transition from G1 to S phase of the cell cycle, 
thereby slowing ESC proliferation (Wang et al. 2008). Moreover, identification of the transcription factors 
and cell cycle regulators RBL1 and RBL2 as TRIM71 targets on the mRNA level by Loedige and colleagues 
provided a second line of evidence for the role of TRIM71/LIN-41 as a cell cycle promoting factor in mouse 
ES cells (Loedige et al. 2013). Recently, it was shown that knockdown of let-7 can increase the efficiency 
of human induced pluripotent stem cell (iPSC) reprogramming, and that overcoming this “let-7 barrier” 
largely depends on upregulation of LIN-41, unveiling LIN-41 a key downstream factor of let-7 in ES cell 
differentiation (Worringer et al. 2014).  
In line with its role as an inhibitor of proliferation and stemness, reduced let-7 expression was found in 
lung cancer samples and associated with shorter survival of the patients (Takamizawa et al. 2004). Up to 
date, reduced let-7 expression has been reported in numerous types of cancer (Bussing et al. 2008). 
Notably, the role of LIN28 in neuroblastoma formation through repression of let-7 cements the 
importance of let-7 as a tumor suppressor (Molenaar et al. 2012). A molecular explanation for this 
function of let-7 was given when a number of potent oncogenes were discovered as let-7 targets. Johnson 
and coworkers were able to demonstrate repression of two human RAS isoforms as well as the C. elegans 
homolog let-60 by let-7 through conserved binding sites in the 3’UTR of these genes (Johnson et al. 2005). 
Soon thereafter, MYC and HMGA2 were identified as a let-7 targets in human Burkitt lymphoma and lung 
cancer (Sampson et al. 2007, Lee and Dutta 2007). Moreover, a study in a lung cancer cell line could detect 
a direct effect of let-7 on cell cycle progression, which was accompanied by expression changes of a large 
number of cell cycle factors, among them CDK-6 and CDC25A (Johnson et al. 2007). 
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In summary, the microRNA let-7 as well as its targets have been established as important regulators of 
development and differentiation in countless eukaryotic species. The work presented here characterizes 
the let-7 regulatory network in the model organism Caenorhabditis elegans. Moreover, the high 
conservation of the pathway allows conclusions for other organisms, making this work a resource for let-
7 related research all the way up to humans. 
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Results 
 
Project 1: A genome wide RNAi screen for characterization of the let-7 network 
 
Motivation and contributions 
 
Numerous studies over the last decade have highlighted the importance of miRNA regulation both in 
development and disease (Ha and Kim 2014, Mendell and Olson 2012). Nonetheless, while function and 
effects of miRNAs have been extensively studied, little was known about the mechanisms that ensure the 
right dose of miRNA activity when I started my PhD. Therefore I decided to perform a genome-wide RNAi 
screen for suppressors of the lethal let-7 bursting phenotype in C. elegans. A main goal was to identify 
potential negative regulators of let-7 function, which might even emerge as general suppressors of miRNA 
activity. The existence of such negative regulators was highlighted by the study of a postdoctoral fellow 
in our lab who demonstrated in vitro that the exonuclease XRN-2 degrades mature let-7 molecules, proven 
by in vitro rescue of let-7 bursting upon knockdown of xrn-2 (Chatterjee and Grosshans 2009). 
Nonetheless, the screen was also designed in a way that would allow to uncover novel players of the let-
7 pathway acting downstream of, or parallel to, let-7. 
 
I performed the initial screening of the genome-wide RNAi library, validation of suppressors and analysis 
of the candidates in the context of the reporter system for hypodermis differentiation, as well as 
generation of the in vivo let-7 target reporter and analysis of the suppressors in this system together with 
Matyas Ecsedi, a fellow PhD student. I then analyzed the suppressors for their effect on repression of 
endogenous let-7 targets by qPCR and determined let-7 levels upon suppressor knockdown by northern 
blot. Furthermore, I performed and analyzed the microarray experiments for gene expression in let-7 null 
mutants. In-depth analysis of the suppressors CDK-1 and CDC-25.2 was performed by Hrishikesh Bartake. 
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a b s t r a c t
The heterochronic pathway controls temporal patterning during Caenorhabditis elegans larval develop-
ment. The highly conserved let-7 microRNA (miRNA) plays a key role in this pathway, directing the
larval-to-adult (L/A) transition. Hence, knowledge of the genetic interactome of let-7 has the potential to
provide insight into both control of temporal cell fates and mechanisms of regulation and function of
miRNAs. Here, we report the results of a genome-wide, RNAi-based screen for suppressors of let-7
mutant vulval bursting. The 201 genetic interaction partners of let-7 thus identified include genes that
promote target silencing activity of let-7, seam cell differentiation, or both. We illustrate the suitability of
our approach by uncovering the mitotic cyclin-dependent kinase CDK-1 as a downstream effector of let-7
that affects both seam cell proliferation and differentiation, and by identifying a core set of candidate
modulators of let-7 activity, which includes all subunits of the condensin II complex. We propose that the
genes identified in our screen thus constitute a valuable resource for studies of the heterochronic
pathway and miRNAs.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Proper organismal development requires faithful temporal and
spatial control of gene expression. In the nematode Caenorhabditis
elegans, the heterochronic pathway controls temporal patterning
during larval development by ensuring successive occurrence of
specific developmental programs in distinct tissues at the correct
time (Ambros and Horvitz, 1984). Heterochronic mutations may
thus cause retarded phenotypes, where developmental events
characteristic of one larval stage are reiterated during subsequent
stages, or precocious phenotypes, where stage-specific programs
are skipped in favor of subsequent programs.
A classical example of a developmental process controlled by
the heterochronic pathway is the establishment of the adult C.
elegans hypodermis (skin), which mainly consists of the large
multinuclear hyp7 syncytium as well as two sets of lateral
hypodermal blast cells called seam cells (Sulston et al., 1983;
Podbilewicz and White, 1994). The seam cells are characterized by
a stem cell-like, asymmetric division during larval stages that, in
most lineages, generates posterior daughters that maintain the
proliferative potential and anterior daughters that differentiate
and fuse to the hypodermal syncytium (Sulston and Horvitz, 1977).
This mechanism allows elongation of the hypodermis proportional
to the growth in body size during larval development. Upon
transition from larval to adult stage, seam cells cease proliferation
and terminally differentiate, i.e., they fuse into a syncytium and
express adult-specific collagens to generate an adult cuticular
structure known as alae (Singh and Sulston, 1978). These events
depend on the let-7microRNA, which accumulates strongly during
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the last larval (L4) stage (Reinhart et al., 2000). let-7 exerts its
function by binding to partially complementary sequences in the
30 untranslated regions (30 UTRs) of target mRNAs, which silences
these through inhibition of their translation or through degrada-
tion (Slack et al., 2000, Lin et al., 2003; Abrahante et al., 2003;
Großhans et al., 2005; Ding and Großhans, 2009; Bagga et al.,
2005). Loss of let-7 activity leads to failed silencing of its targets
and, consequently, continued seam cell proliferation, failed fusion,
and sustained expression of larval- instead of adult-specific
cuticular collagens (Reinhart et al., 2000). let-7 mutant animals
also display a vulval rupturing phenotype that causes their death
(Reinhart et al., 2000), but it is currently unclear if and to what
extent this is linked to the retarded heterochronic seam cell
phenotypes (Roush and Slack, 2008; Ecsedi et al., 2015).
The sequence of let-7 is invariant across animal phylogeny
(Pasquinelli et al., 2000), and a number of targets are conserved
(Slack et al., 2000; Großhans et al., 2005). Indeed, function in
inhibition of proliferation and induction of differentiation is a
common feature of let-7 from invertebrates to mammals (Büssing
et al., 2008). Thus, let-7 suppresses self-renewal of embryonic
stem cells, promotes neural stem cell differentiation, and acts as a
tumor suppressor gene (Takamizawa et al., 2004; Melton et al.,
2010; Worringer et al., 2014; Rybak et al., 2008). These functions
may involve regulation of a number of direct let-7 targets, includ-
ing oncogenes such as MYC, RAS, and HMGA2, but also cell cycle
genes such as CDK6 and CDC25A (Johnson et al., 2007; Lee and
Dutta, 2007; Sampson et al., 2007; Johnson et al., 2005).
For C. elegans let-7, previously identified direct targets include the
TRIM-NHL protein LIN-41 (Slack et al., 2000), and the transcription
factors DAF-12 (Großhans et al., 2005) and HBL-1 (Lin et al., 2003;
Abrahante et al., 2003). In addition, genetic data revealed that
hypodermal LIN-41 represses, directly or indirectly, accumulation of
the zinc finger transcription factor LIN-29 (Slack et al., 2000), which
in turn is needed for expression of the adult-specific collagen col-19
and the cell cycle inhibitor cki-1 (Rougvie and Ambros, 1995; Liu
et al., 1995; Hong et al., 1998). Hence, let-7 may promote at least
some aspects of the L/A transition by relieving LIN-29 from LIN-41-
mediated repression. Whether it additionally exerts direct repression
of cell cycle genes is currently unknown.
Here, we conducted a genome-wide study for genetic inter-
actors of let-7. The purpose of this study was two-fold. First, we
sought to identify downstream effectors to obtain a better under-
standing of let-7 function in the heterochronic pathway. Second,
we aimed to establish a genome-wide collection of modulators of
let-7 activity to identify candidate components of the miRNA
pathway (Ding et al., 2008; Hunter et al., 2013; Großhans et al.,
2005; Büssing et al., 2010; Parry et al., 2007). We illustrate the
suitability of our approach for these purposes by identifying 201
suppressors of let-7 mutant vulval bursting, establishing the
mitotic cyclin-dependent kinase CDK-1 as a downstream effector
of let-7, and uncovering a core set of candidate modulators of let-7
activity that include all subunits of the condensin II complex.
Materials and methods
A genome-wide RNAi screen for suppressors of let-7(n2853) bursting
RNAi by feeding (Timmons et al., 2001) was performed using
primarily the RNAi library from the Ahringer group (Kamath et al.,
2003) supplemented with unique clones from the Vidal library
(Rual et al., 2004). The two libraries together are predicted to
target 180578 loci representing 94% of C. elegans protein coding
genes (Kim et al., 2005). L1 stage let-7(n2853) worms synchro-
nized by hatching overnight in M9 buffer were grown in 96-well
plates at a concentration of 25 worms per well in S-medium liquid
culture with RNAi bacteria; double-stranded RNA production was
induced by IPTG (4 mM final concentration in the bacterial growth
medium). Wells were scored for surviving adult worms after 70 h
of incubation at 25 1C using a dissecting microscope. let-7(n2853)
animals grown on mock RNAi showed a 490% penetrant bursting
phenotype under these conditions. Bacteria from positive wells
were streaked directly from the wells, and a single colony was
selected for retesting on RNAi plates at 20 1C and 25 1C as
described previously (Ding et al., 2008). For clones scoring positive
again, the RNAi plasmid was isolated, sequenced and retrans-
formed into HT115 bacteria. This new library of positive clones was
retested on RNAi plates at 20 1C and 25 1C. Bursting suppression
was scored as indicated in the legend of Table S1.
col-19::gfp assay
col-19::gfp; let-7(n2853) worms (n4100) were tested at 20 1C
and 25 1C on suppressor RNAi plates as in the bursting suppressor
screen. Worms were scored at two time points (48 h and 56 h for
25 1C and 56 h and 72 h, respectively, for 20 1C) for presence of
detectable GFP expression in the hypodermis using a Leica MZ16
FA fluorescence dissection microscope. At the magnification used,
it was not possible to differentiate between expression in hyp7 or
seam cell nuclei. As let-7(n2853) worms, at the permissive tem-
perature of 15 1C, undergo a larval-to-adult transition after an L5
molt and eventually express col-19::gfp, we scored suppressors
based both on the penetrance and timing of col-19::gfp expression
as indicated in the legend of Table S3. Certain suppressors (results)
were examined further on a Zeiss Z-1 microscope and imaged with
Zeiss Axiovision software.
let-7 target and cdc-25.2 and cdk-1 30UTR reporters
The hypodermal-specific wrt-2 promoter (Aspöck et al., 1999)
and indicated 30UTRs were amplified using the primers listed in
the supplementary methods and inserted into an appropriate
Gateway donor vector. Pwrt-2, gfp::h2b::PEST (pBMF2.7) and indi-
vidual 30UTR entry vectors were recombined into the MosSCI-
compatible pCFJ150 plasmid. All plasmids were verified by
sequencing. Transgenes were integrated in single copy at a defined
genomic location as described (Frokjaer-Jensen et al., 2008).
Integrant lines were outcrossed at least three times.
For examination of let-7 activity, reporter worms were sub-
jected to RNAi by feeding as for the suppressor screen and
hypodermal differentiation assay. Fluorescence intensity was
compared to the empty vector control after 32 h incubation at
25 1C using a Leica MZ16 FA fluorescence dissecting microscope.
Repression of the reporter was scored independently by two
observers for penetrance and degree of repression. Scores for the
lin-41 30 UTR and the control unc-54 30UTR reporters were
compared to identify positive hits. Selected suppressors (Results)
were imaged further on a Zeiss Z-1 microscope with Zeiss Axiovi-
sion software using equal exposure times.
To assess regulation of cdk-1 and cdc-25.2 30 UTR reporter
transgenes by let-7, synchronized worms were grown for 36 h at
25 1C on plates. Worms were observed on a Zeiss Z-1 microscope with
Axiovision software using Nomarski DIC and fluorescence microscopy.
Gene expression profiling
For microarray analysis synchronized L1 larvae were grown at
25 1C, the restrictive temperature of the temperature-sensitive
sterile glp-4(bn2) allele (Beanan and Strome, 1992), to L4 stage (33
and 34 h for glp-4(bn2) and glp-4(bn2); let-7(mn112), respectively,
to adjust for a minor growth delay of let-7 mutant animals) and
harvested in TRI Reagent (MRC). RNA was isolated according to the
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manufacturer's instructions. Total RNA (300 ng) was converted to
cDNA and amplified with 1 cycle of IVT using the Affymetrix
GeneChip WT Amplified Double Stranded cDNA Synthesis Kit,
fragmented using the Affymetrix GeneChip WT Double-Stranded
DNA Terminal Labeling Kit, and Biotin labeled using the GeneChip
WT Genechip WT Terminal Labeling Kit. 7.5 mg of labeled double-
stranded cDNA was hybridized to C. elegans tiling arrays for 16 h.
Scanning was performed with Affymetrix GCC Scan Control v.
3.0.0.1214 on a GeneChip Scanner 3000 with an autoloader. All
sequencing data generated for this study have been deposited in
NCBI's Gene Expression Omnibus (Edgar et al., 2002) and are
accessible through GEO Series accession number GSE52910
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52910).
Raw data CEL files from tiling arrays were processed in R using
a bioconductor and the packages tilingArray and preprocessCore.
The arrays were RMA background corrected and log 2 transformed
on the oligo level using the following command:
expr o- log 2(rma.background.correct(exprs(readCel2eSet(file-
names, rotated¼TRUE)))). We mapped the oligos from the tiling array
(bpmap file from www.affymetrix.com) to the C. elegans genome
assembly ce6 (www.genome.ucsc.edu) using bowtie allowing no error
and unique mapping position. Expression levels for individual tran-
scripts were calculated by intersecting the genomic positions of the
oligonucleotides with transcript annotation (WormBase WS190) and
averaging the intensity of the respective oligonucleotides.
miRNA target enrichment analysis
In order to test the identified suppressors of let-7(n2853) for
enrichment of miRNA targets, ALG-1 binding site locations of L4
stage worms (Zisoulis et al., 2010) were downloaded from the C.
elegans version ce6 (May 2008) UCSC genome annotation database
(http://hgdownload.soe.ucsc.edu/goldenPath/ce6/database/).
Gene annotations were previously downloaded from Worm-
Base for the C. elegans genome version WS190, corresponding to
UCSC version ce6. ALG-1 binding sites were assigned to the
nearest annotated transcript using the BedTools intersect utility
(Quinlan and Hall, 2010), and 3217 unique gene IDs were extracted
from the resulting list. The number of genes expressed during L4
stage was calculated based on published expression data
(Hendriks et al., 2014). To this end, samples from a total of 9 time
points of continuous development (28–36 h) were first normalized
for library size, averaged and log 2 transformed. We used a cutoff
of 4 (in log 2 space) to separate expressed from non-expressed
genes based on the bimodal expression distribution, yielding
15,179 expressed genes. An enrichment of putative miRNA targets
among the different classes of miRNA suppressors (see main text)
was tested by comparison against this baseline frequency of 0.212
(3217 of 15,179 genes) miRNA targets per expressed gene using a
hypergeometric test.
Results and discussion
A genome-wide RNAi screen identifies 201 suppressors of the let-7
(n2853) lethality phenotype
To study the let-7 regulatory network on a global level, we
sought suppressors of the temperature-sensitive (ts) let-7(n2853)
vulval bursting phenotype in a genome-wide, RNAi-based screen.
mock RNAi
smc-4 RNAi
cdc-25.2 RNAicdk-1 RNAi
lin-41 RNAi
let-7(n2853)
Fig. 1. A genome-wide RNAi screen for suppressors of let-7(n2853) bursting. Knock-down of the indicated suppressors by RNAi rescues bursting of let-7(n2853) worms.
Vulvae are marked with asterisks. Scale bar indicates 50 mm.
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let-7(n2853) worms carry a G-to-A point mutation in the seed
sequence of the mature miRNA, leading to impaired binding and
repression of let-7 targets as well as reduced expression of the
mature miRNA (Reinhart et al., 2000). The resulting vulval bursting
phenotype at the L/A transition is highly penetrant at the restric-
tive temperature of 25 1C. At 15 1C, let-7(n2853)ts animals are
viable, but seam cells continue to divide and fail to differentiate
(Reinhart et al., 2000), whereas at an intermediate temperature,
20 1C, lethality occurs but at reduced penetrance (Großhans et al.,
2005).
In a pilot experiment, we had previously used RNAi by feeding
against genes on C. elegans chromosome I to identify suppressor
genes of the let-7(n2853) lethality at 20 1C and 25 1C (Ding et al.
2008). To expand the screen from these 2400 genes to a genome-
wide scale, we complemented the “Ahringer library” with select
RNAi clones from the “Vidal library” to cover 490% of C. elegans
genes (Kamath et al., 2003; Rual et al., 2004). Moreover, we
streamlined the screening procedure further by performing it in
liquid medium, and at only one temperature, 25 1C, followed by
rescreening of primary candidates on RNAi plates at both 20 1C
and 25 1C. Plasmids from bacteria scoring positive in the second
round of screening were isolated, sequenced, and retransformed
into bacteria, which were then utilized for a final round of testing
for suppression. Through these three rounds of testing, we
validated 201 genes as suppressors of let-7 lethality that were
capable of restoring viability of at least 20% of the worms in one or
both conditions (Fig. 1 and Table S1). Note that some suppressed
animals retained a protruding vulva phenotype, reflecting incom-
plete suppression or a separate vulval defect due to depletion of
the targeted gene (see also below). Our screen also covered the
previously screened chromosome I (Ding et al., 2008), permitting
us to compare the two datasets. We found that we had re-
discovered a high 78% of the candidates identified in the previous
study (Table S1), which demonstrates the interactions to be robust
and reproducible even under distinct screening conditions.
Modulation of let-7 function by suppressors of vulval bursting
The list of 201 suppressors also contained five out of 61 genes
previously identified as enhancers of vulval bursting associated
with the weak let-7(mg279) hypomorphic allele in a total of 17,900
genes tested by RNAi (Parry et al., 2007). Although few, this
constitutes a 7.3-fold enrichment over background (p-Value¼
6104, hypergeometrical test). Possibly, the activity levels of
these specific genes need to be very tightly regulated. Hence, their
presumably greater depletion in the RNAi-sensitized strain used in
the previous study (Parry et al., 2007) might have resulted in
different effects from those seen here. Regardless of this possibi-
lity, the finding indicated a need for a better understanding of the
suppressor genes. As a first step, we sought to determine whether
any of the let-7(n2853) suppressor genes were negative regulators
of let-7-mediated gene silencing. Hence, we developed a GFP-
based let-7 target reporter system to directly analyze let-7-activity
in hypodermal cells in vivo. We fused the hypodermis-specificwrt-
2 promoter (Aspöck et al., 1999) to a gene encoding a destabilized
nuclear GFP (GFP-H2B-PEST) followed by the 30UTR of lin-41,
which we chose as the best-characterized target of let-7 (Vella
et al., 2004). In addition to this reporter, which we termed
pREP_lin-41, we generated control reporters, pREP_unc54 and
pREP_lin41ΔLCS, which contained the unregulated unc-54 30UTR
and a lin-41 30UTR lacking a 98nt fragment required for let-7-
mediated regulation (Vella et al., 2004), respectively. All three
transgenes were integrated into the same genomic site in single
copy through Mos1 transposon-mediated single copy transgene
integration (MosSCI) (Frokjaer-Jensen et al., 2008).
The reporter system faithfully recapitulated let-7-mediated
regulation: all three reporters were highly expressed in the
hypodermis of early wild-type larvae. Subsequently, pREP_lin41,
but not pREP_unc54 or pREP_lin41ΔLCS, showed repression starting
during L4 larval stage (Fig. 2A and data not shown). This correlates
well with the accumulation of let-7 during the L4 stage (Reinhart
et al., 2000). The differences in expression between the control
reporters and pREP_lin-41 increased further when adult animals
were examined. In old adults, even the signal from the control
reporters declined substantially, presumably reflecting decreased
promoter activity. We confirmed that repression of pREP_lin41
depended on let-7 by crossing the reporters into let-7(n2853)
mutant animals. This resulted in elevated pREP_lin41 expression
levels in L4 and adult stage animals relative to their wild-type
counterparts, whereas expression of pREP_unc54 and pRE-
P_lin41ΔLCS remained unaffected (Fig. 2A and data not shown).
Transcriptional profiling data from our lab recently revealed
periodic wrt-2 mRNA accumulation during larval development
(Hendriks et al., 2014), and the pREP_unc54 reporter indeed
exhibited increased wrt-2 promoter activity towards the end of
the L4 stage. As the fluctuation of GFP was less than that of the
endogenous wrt-2 mRNA, we could control for this potential
source of variability in pREP_lin41 experiments by the examination
of worms carrying the pREP_unc54 control transgene. Further-
more, a reporter carrying the 30UTR of the let-7 target daf-12
(Großhans et al., 2005) (pREP_daf12) was used to test indepen-
dently for restoration of let-7 activity. Analyzing the full set of our
identified suppressors, we found 73 genes to restore repression of
a let-7 target reporter in the let-7(n2853) background while
showing no or modest repression of the control 30UTR upon RNAi
(‘target reporter positives’, Fig. 2B and Table S2).
A subset of the suppressors affect let-7-dependent hypodermis
differentiation
It was conceivable that some suppressors modulated vulval
development and/or morphogenesis in a let-7-independent man-
ner, thus preventing bursting indirectly. Consistent with this
notion, we frequently observed protruding vulva (Pvl) phenotypes
upon suppressor RNAi on wild-type as well as on let-7(n2853)
animals (Table S1). Therefore, we wished to examine suppression
of another let-7 mutant phenotype, outside the vulva. We utilized
a previously established Pcol-19::gfp reporter (Abrahante et al.,
1998) to examine whether hypodermal cell differentiation was
also restored upon depletion of the suppressor genes. Transcrip-
tion of col-19, an adult-specific cuticular collagen gene, requires
the zinc-finger transcription factor LIN-29 (Rougvie and Ambros,
1995; Liu et al., 1995) (Fig. 3A), which, however, does not
accumulate in let-7(n2853) mutant animals (Reinhart et al.,
2000). Accordingly, Pcol-19::gfp is not expressed in let-7 mutant
animals (Fig. 3B). By contrast, depletion of 102 of the 201 let-7
suppressor genes resulted in GFP accumulation in adult animals
(‘col-19 positives’, Fig. 3B and Table S3). Hence, depletion of these
genes restores at least some aspect of hypodermal cell differe-
ntiation, further supporting their function in the heterochronic
pathway.
let-7 suppressor genes can be grouped into four functional classes
Taken together, the results of the three different assays that
measure restoration of viability, let-7 target gene repression, and
restoration of seam cell differentiation, yield four different groups
of suppressor genes (Fig. S2). ‘Suppressor-only’ genes are posit-
ive for restoration of viability, but none of the other assays.
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These genes may be enriched for false positive hits, modulate let-7
functions that are currently unknown, or act in tissues other than
the hypodermis.
The three other classes contain genes that are all positive for
restoration of viability, and additionally one or both of the other
assays. Thus, ‘target reporter-only’ genes are positive for target
reporter repression, but not for Pcol-19::gfp expression. In a linear
model, where increased let-7 target repression would proportion-
ally enhance let-7-dependent cellular differentiation, these genes
may be false positive hits. However, it seems equally possible that
modulation of the developmental phenotype, measured by Pcol-
19::gfp expression, needs restoration of target gene repression
beyond a certain threshold, and/or that the sensitivities of the two
assays differ. Finally, the genes in this class may only alter activity
of some let-7 target genes, with hypodermis differentiation
depending at least in part on some targets whose activity we have
not measured here.
Genes in the ‘col-19-only’ group affect Pcol-19::gfp expression
without apparent effects on let-7 target gene silencing. These
genes might act downstream of, or in parallel to, let-7, potentially
as direct let-7 targets or indirect effectors, and we provide a
detailed dissection of one example below.
Finally, a group of 36 genes scored positive in both the target
reporter and the col-19 expression assays (Table 1) and constitute
the ‘double-positive’ class. Although the mechanisms by which
these genes function remain to be established, they are strong
candidates for modulators of let-7 activity. Notably, this list
includes all five members of the C. elegans condensin II complex,
namely smc-4, mix-1, kle-2, capg-2, and hcp-6 (Csankovszki et al.,
2009) as well as plk-1, the C. elegans orthologue of Polo-like kinase
wild-type wild-type
pREP_lin-41 pREP_lin-41∆LCS
let-7(n2853)
GFP
DIC
mock RNAi lin-41 RNAi
cdc-25.2 RNAi cdk-1 RNAi
smc-4 RNAi mix-1 RNAi
let-7(n2853); pREP_lin-41
Fig. 2. let-7 suppressor RNAi restores repression of a let-7 target reporter. (A) Repression of a let-7 target reporter (Pwrt-2::gfp::lin-41 30UTR, “pREP_lin-41”) in late L4 worms
depends on let-7 and is lost upon mutation of the let-7 complementary sites (pREP_lin-41ΔLCS). Vulvae are marked with asterisks. (B) GFP intensity in pREP_lin-41, let-7
(n2853) worms subjected to the indicated RNAi; pictures were taken at the young adult stage. RNAi against smc-4 and mix-1, but not against the other genes, causes
repression of the reporter. Scale bar indicates 50 mm.
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(Ouyang et al., 1999), a known regulator of condensins in human
HeLa cells (Abe et al., 2011). RNAi of the condensin II complex
has been shown to result in chromosome condensation and
segregation defects both in mitosis and meiosis (Hagstrom et al.,
2002; Stear and Roth, 2002), but in addition to its structural
functions, the complex was reported to bind to interphase chro-
matin in C. elegans where it acts as a transcriptional repressor
(Kranz et al., 2013). Although we have currently no mechanistic
explanation for the ability of condensin II to modulate let-7
activity, the identification of this entire complex further corrobo-
rates the robustness of our analysis, and makes condensin II a
particularly interesting candidate miRNA pathway factor.
Most novel suppressors are unlikely to be direct let-7 targets
Zisoulis et al. (2010) previously identified candidate miRNA
targets through their association with the miRNA Argonaute
protein ALG-1. Interestingly, we found that 81 out of 201 suppres-
sors as well as 41 out of the 102 ‘col-19 positive’ suppressors were
also bound by ALG-1. This represents a moderate enrichment of
1.9-fold for both classes compared to the 3217 ALG-1 bound
mRNAs in a total of 15,179 genes expressed in L4 (total suppres-
sors: p-Value¼5.11010, ‘col-19 positives’: p-Value¼9.9106,
hypergeometric test; see Methods). To determine whether a subset
of these genes was indeed regulated by let-7, we compared gene
expression patterns of wild-type and let-7(mn112) null mutant
worms at the late L4 stage using C. elegans tiling arrays. Because
let-7 activity has not been reported in the germline, we performed
these experiments in germline-less glp-4(bn2) mutant animals
(Beanan and Strome, 1992), to examine gene expression levels
specifically in somatic tissues (Fig. 4 and S1). Analysis of the data
did reveal robust overexpression of the published let-7 targets lin-
41 (4.17 fold) and daf-12 (2.1 fold) in let-7(mn112) compared to
wild-type worms. By contrast, most of the novel suppressors did
not change in let-7 mutant worms. This finding implies that,
consistent with the moderate enrichment of ALG-1 binders, the
majority of let-7 suppressors are not direct let-7 targets. This
notion is also supported by our recent finding that vulval bursting
of let-7 mutant animals is explained by dysregulation of only LIN-
41 (Ecsedi et al., 2015). Alternatively, some of these genes may
either be let-7 targets regulated through mechanisms that do not
involve substantial mRNA degradation, e.g., translational control,
or their downregulation may occur in only a subset of tissues,
making detection impossible in whole worm RNA.
let-7 regulates CDK-1 expression in a LIN-29-dependent manner
Since gene expression profiling failed to reveal new let-7 targets or
downstream effectors, we sought to find specific examples of such
genes by examining the ‘col-19-only’ suppressors. Previous work on
cultured cells revealed that let-7 targets include a cyclin-dependent
kinase, CDK6, and a CDK-regulating phosphatase, CDC25A (Johnson
mock RNAi lin-41 RNAi
cdk-1 RNAi cdc-25.2 RNAi
smc-4 RNAi mix-1 RNAi
let-7 col-19lin-29lin-41
let-7(n2853); Pcol-19::gfp
Fig. 3. RNAi of let-7(n2853) suppressors restores hypodermis differentiation. (A) Activation of the adult-specific col-19 promoter is controlled by let-7 through activation of
the transcription factor LIN-29. (B) Expression of col-19::gfp in let-7(n2853) worms subjected to the indicated RNAi; pictures were taken at the young adult stage (100
magnification). RNAi against cdk-1 and cdc-25.2 but not against smc-4 or mix-1 causes upregulation of the reporter.
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et al., 2007). Although the functional relevance of these interactions
remained unclear, let-7 has a conserved function in regulation of cell
proliferation (Büssing et al., 2008). We were thus intrigued by the
identification of ncc-1/cdk-1 (Mori et al., 1994; Boxem et al., 1999) and
its activating phosphatase cdc-25.2 (Kim et al., 2010) among this class of
suppressors of vulval bursting. To place the two genes in the pathway,
we tested whether their depletion suppressed also vulval bursting
caused by the let-7(mn112) null mutation, which we found to be the
case. We observed 97% rescue of bursting for cdk-1 RNAi and 99%
rescue for cdc-25.2 (n4200 each). About half of the surviving worms
were vulvaless (data not shown). Although suppression of bursting
might therefore, in part, be indirect, restoration of col-19::gfp expression
in the hypodermis supported specificity of the genetic interaction
(Fig. 3, Table S3). To examine this further, we analyzed the formation of
adult alae in let-7(mn112) mutant animals. Strikingly, whereas only 9%
(n¼32) of let-7(mn112) animals on mock RNAi displayed any alae, 51%
(n¼47) of animals on cdk-1(RNAi) and 41% (n¼27) of animals on cdc-
25.2(RNAi) did. Similar to the lin-41(RNAi) positive control, knockdown
of cdk-1 and cdc-25.2 virtually always resulted in partial, rather than
complete alae, whereas the occasional animals on mock RNAi typically
exhibited weak but complete alae. Hence, cdk-1 and cdc-25.2 exhibit
hallmarks of a downstream effector of let-7.
Based on these results it seemed possible that cdk-1 and cdc-
25.2 were direct targets of let-7. Because let-7 targets that are
regulated in a tissue-specific manner and/or through translational
repression might not be evident from whole animal gene expres-
sion studies by microarray, we generated cdk-1 and cdc-25.2 30
UTR reporters to assess their potential for regulation by let-7.
When we analyzed these reporters, pREP_cdk1 and pREP_cdc-25.2,
respectively, we found them both to be repressed in L4 stage
animals in both seam cells and the hyp7 syncytium relative to the
unregulated pREP_unc54 control reporter (Fig. 5). For pREP_cdk1
this repression was more pronounced in hyp7 than the seam,
whereas the opposite was true for pREP_cdc-25.2. However,
whereas the positive control pREP_lin-41 was efficiently dere-
pressed in the let-7(n2853) mutant background, this was not
observed for pREP_cdk-1 and pREP_cdc25.2 in either tissue. We
conclude that although the 30 UTRs of these two mitotic genes
Table 1
List of suppressors positive for both target reporter repression and hypodermis differentiation assay (‘double-positive’ genes). Shown are all genes which upon RNAi rescue
both adult hypodermis formation (Pcol-19::gfp reporter assay) as well as repression of a let-7 target reporter (Pwrt-2::gfp-H2B-PEST::lin-41-30UTR or Pwrt-2::gfp-H2B-PEST::
daf-12-30UTR) in let-7(n2853) animals. Pcol-19::gfp reporter assay: weak (þ), medium (þþ) or strong (þþþ) activation of GFP upon RNAi. let-7 target reporter: weak (þ),
medium (þþ) or strong (þþþ) repression of GFP upon RNAi.
Predicted
gene
col-19 activation Target reporter repression Function
25 1C 20 1C
49 h 58 h 56 h 72 h lin-41 daf-12 unc-54
(ctrl.)
Cell cycle/chromosome maintenance and
segregation
hcp-6 — þþ — þþþ þþ þþþ þ Condensin II subunit
capg-2 — þþ — þþþ þþ þ — Condensin II subunit
kle-2 þ þþþ — þþþ þ — — Condensin II subunit
smc-4 — þþ — þþ þþ — — Condensin II subunit
mix-1 — — — þþ þþþ — — Condensin II subunit
scc-3 þ þþþ — þþþ — þ — Cohesin subunit
cyb-3 þ þþ — þþþ þþ — — Cyclin B
plk-1 þ þþ — þþþ þ þ — Polo-like kinase
knl-2 — þþ — þþ þþþ þþ — Kinetochore associated
him-1 þþ þþþ — þþþ þ — — Structural maintenance of
chromosome family
DNA/replication lig-1 þ þþ — þþþ þ — — DNA ligase
Y47D3A.29 — þ — — — þþ — DNA polymerase alpha subunit
pri-1 — þþ — þþ þþþ þþ — DNA primase
ruvb-2 — þ — þ þþ þ — Recombination protein homolog
rpa-1 — þ — þ — þþ — Replication protein A homolog
mRNA biogenesis rpb-7 — þ — þ þþ þ — RNA Pol II subunit
cpsf-2 — — — þ þþ þþ — Cleavage and polyadenylation
specificity factor
symk-1 — þ — — þ þ — Cleavage and polyadenylation factor
prp-21 þ þ — þþ — þ — Splicing factor related
uaf-1 — — — þþ þþ þþ — Splicing factor related
Ribosome biogenesis C37H5.5 — þ — þ — þ — Nucleolar complex protein 3 homolog
C47E12.7 — þ — — — þ — Ribosomal RNA processing protein
1 homolog
K12H4.3 — þ — — — þ — Ribosome biogenesis protein BRX1
homolog
Nuclear transport npp-3 — þ — þ — þþ — Nuclear pore protein
npp-9 — þ — — þþ þþ — Nuclear pore protein
npp-6 þ þþ — þ þþþ þþþ þ Nuclear pore protein
xpo-2 þ þ — þþ þ þ — Nuclear export receptor
Other aco-2 þ þþ — þþ þþ — — Aconitase
pyp-1 þ þ þ þþ þ — — Pyrophosphatase, nucleosome
remodeling?
ani-1 þ þ — þþ þ — — Actin binding protein
dut-1 — — — þþ þ — — DeoxyUTPase
toe-1 — — — þ — þ — Target of ERK kinase MPK-1
nhr-25 þþþ þþþ þþþ þþþ þ þ — Nuclear hormone receptor
T06E6.1 — — — þ — þ —
F44G4.1 — — — þ þ — —
C16A3.4 — þ — — — þþ —
Control hda-1 — — — — — — — Randomly chosen ‘suppressor-only'
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might confer post-transcriptional repression at the L4 stage, when
let-7 is present, this seems unlikely to be a consequence of let-7
function.
We therefore wondered if cdk-1 functioned further downstream of
let-7 in the heterochronic pathway. We utilized a previously published
cdk-1::gfp single copy-integrated transgene, which drives expression of
a functional fusion protein from the native cdk-1 promoter (Shirayama
et al., 2012), to examine the effect of let-7 on CDK-1 accumulation. We
observed that CDK-1/GFP was present in early L4-stage seam cells, but
that its levels declined rapidly upon entry into adulthood (Fig. 6A).
However, down-regulation was impaired in let-7(n2853) mutant
animals where CDK-1/GFP was well visible in the seam cell cytoplasm
and, prominently, nucleus. To understand better why CDK-1/GFP
protein levels responded so strongly to loss of let-7 activity although
let-7 did not appear to repress it directly, we tested whether cdk-1::gfp
expressionwas modulated by the downstream effector LIN-29. Indeed,
knock-down of lin-29 by RNAi resulted in elevated levels and redis-
tribution of CDK-1/GFP, similar to the effect of let-7(n2853) (Fig. 6B).
Finally, this was also observed for RNAi of mab-10 (Fig. 6B), a
transcription co-factor that acts in concert with LIN-29 to promote
differentiation of the hypodermis (Harris and Horvitz, 2011). Thus, we
conclude that let-7 regulates cdk-1 indirectly, in a manner that requires
the LIN-29 transcription factor.
Conclusion
Using a genome-wide screen, we have identified and characterized
here 4200 suppressors of let-7 mutant phenotypes. In combination
let-7 wildtype, glp-4(bn2) [log2]
le
t-7
(m
n1
12
), 
gl
p-
4(
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2)
 [l
og
2]
lin-41
daf-12
cdk-1
Fig. 4. Expression levels of novel let-7 suppressors are not affected in let-7 mutants.
Microarray analysis of somatic gene expression in let-7(mn112) null mutant in germline-
less glp-4(bn2) animals shows no changes in mRNA levels for genes identified as
suppressors of the let-7(n2853) bursting phenotype (marked in red). The known let-7
targets lin-41 and daf-12 are indicated in red for reference, cdk-1 in green.
pREP_unc-54
pREP_lin-41
pREP_cdk-1
pREP_cdc25.2
pREP_unc-54
pREP_lin-41
pREP_cdk-1
pREP_cdc25.2
wild-type let-7(n2853)
Fig. 5. The 30UTRs of cdk-1 and cdc-25.2 do not confer let-7-dependent regulation. (A) A hypodermis specific target reporter (wrt-2 promoter) containing gfp fused to the
unregulated unc-54 30UTR (pREP_unc-54) is expressed both in wild-type and let-7(n2853) background at the late L4 stage. (B–D) The reporter containing the lin-41 30UTR
(pREP_lin-41) is repressed in a let-7 dependent manner (B) while repression of reporters carrying the cdk-1 (pREP_cdk-1, C) or cdc-25.2 30UTR (pREP_cdc-25.2, D) in wild-type
worms is less extensive and persists in the let-7(n2853) background. Vulvae are marked with asterisks. Scale bar indicates 50 mm.
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let-7(n2853),
young adult
lin-29 RNAi
mab-10 RNAi
mock RNAi
Pcdk-1::cdk-1-gfp::cdk-1 3’UTR
let-7 wild-type; Pcdk-1::cdk-1-gfp::cdk-1 3’UTR
wild-type,
young adult
wild-type, L4 
Fig. 6. Repression of cdk-1::gfp depends on LIN-29 and MAB-10 (A) Expression of cdk-1::gfp from the cdk-1 promoter can be observed in seam cells (arrows) until the L4 stage.
GFP levels decrease during L4 stage in wild-type background. let-7(n2853) mutant animals continue to express cdk-1::gfp in adult stage. (B) Downregulation of cdk-1::gfp in
wild-type worms is lost upon RNAi-mediated knockdown of lin-29 or mab-10. Vulvae are marked with asterisks. Scale bar indicates 50 mm.
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with previous work using genetic enhancer screening (Parry et al.,
2007) and genomics analysis (Hunter et al., 2013) of let-7 mutant
strains, a comprehensive picture of the genetic interactome of let-7
becomes available, promoting a better understanding of this model
miRNA and key developmental regulator. Thus, among the newly
identified suppressors, we consider the ‘col-19 positive’ and the
‘double-positive’ genes to be of particular interest for studies of the
heterochronic pathway and miRNA function and regulation, respec-
tively. Our analysis of CDK-1, which we identified as a putative effector
of let-7 based on its placement in the ‘col-19-only’ class, illustrates the
utility of this approach: whereas CDK-1 was unremarkable in tran-
scriptome analysis, its proficiency in suppressing both let-7 mutant
lethality and hypodermis differentiation defects suggested a function-
ally relevant interaction with let-7, prompting us to test and confirm
its regulation by let-7 and via LIN-29 through more specific means.
As let-7 controls cell proliferation, it must, at some level,
interface with the cell cycle machinery. However, an interaction
with the mitotic CDK-1 is unexpected, as the exit of seam cells
from proliferation is expected to occur in G1, not G2/M. Therefore,
based on the facts that LIN-29 also regulates the cell cycle inhibitor
CKI-1 (Hong et al., 1998) and that additional cell cycle genes occur
among the ‘col-19-only’ and the ‘double-positive’ suppressor
genes, we speculate that repression of CDK-1 might be part of a
larger program of repression of cell cycle genes during exit of seam
cells from proliferation. The observation that CDK functions are
plastic such that CDK1 can partially substitute for other CDKs
during mouse embryonic development (Santamaria et al., 2007)
might explain the need for its repression.
Interestingly, depletion of CDK-1 not only prevents seam cell
overproliferation in let-7 mutant animals, but also promotes
hypodermis differentiation by two criteria, expression of Pcol-
19::gfp, and formation of adult alae. Conceivably, this reflects a
tight coupling of cell proliferation and differentiation in the seam
so that differentiation ensues when proliferation is blocked.
However, we note that cdk-1(RNAi) also promotes Pcol-19::gfp
expression in the postmitotic hyp7, potentially reflecting a more
direct role on differentiation. Moreover, we find that even pro-
liferating seam cells can express Pcol-19::gfp. For instance, we
observed that depletion of rnr-1, which codes for the large subunit
ribonucleotide reductase, promotes expression of Pcol-19::gfp
without preventing seam cell overproliferation. Thus, when scored
using the seam cell-specific scm::gfpmarker to visualize seam cells
(Koh and Rothman, 2001), let-7(n2853)mutant animals exposed to
mock or rnr-1(RNAi) have a comparable number of seam cells at
the young adult stage, i.e., an average of 23.6 cells (n¼22) and 22.5
(n¼21), respectively, per side, well above the wild-type 16. Yet
rnr-1(RNAi) promotes expression of col-19::gfp (Table S3). This
suggests that a potential coupling between cell cycle exit and
differentiation, if it exists, would be unidirectional.
Finally, the observation that the ‘double-positive’ group of
supressors contains a number of genes encoding structural com-
ponents of chromosomes and cell cycle factors, provides a further
illustration of the apparently complex relationship between let-7
function in the heterochronic pathway and the cell cycle. We
propose that our comprehensive genetic screen has thus opened a
new door to a deeper understanding of let-7 and miRNA function
more generally.
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Supplementary Methods 
Primers 
primer name purpose sequence 
pWRT2 GW F 
attB4  
Gateway cloning 
wrt-2 promoter 
GGGGACAACTTTGTATAGAAAAGTTGTATGACCATGAT
TACGCCAAG 
pWRT2 GW R 
attB1r  
Gateway cloning 
wrt-2 promoter 
GGGGACTGCTTTTTTGTACAAACTTGCCCGAGAAACAA
TTGGCA  
lin-41_3U F Gateway cloning lin-
41 3'UTR 
GACACTTTCTTCTTGCTCTTTAC 
lin-41_3U R Gateway cloning lin-
41 3'UTR 
GAAACTCGACTAGGAATTCGAG 
cdc-25.2 GW F 
attB2r 
Gateway cloning 
cdc-25.2 3'UTR 
GGGGACAGCTTTCTTGTACAAAGTGGAATTATTCCTCCT
TGATTTC 
cdc-25.2 GW R 
attB3 
Gateway cloning 
cdc-25.2 3'UTR 
GGGGACAACTTTGTATAATAAAGTTGCTTTCGCCAAATC
ACATTAC 
cdk-1 GW F 
attB2r 
Gateway cloning 
cdk-1 3'UTR 
GGGGACAGCTTTCTTGTACAAAGTGGTGATGTAATTCA
TTCATCATCA 
cdk-1 GW R 
attB3 
Gateway cloning 
cdk-1 3'UTR 
GGGGACAACTTTGTATAATAAAGTTGTCTTAATTCCCTA
TTCTCATTTA 
daf-12 3’UTR 
GW F attB2r 
Gateway cloning 
daf-12 3'UTR 
GGGG ACA GCT TTC TTG TAC AAA GTG 
GGACCTACTAGAAATCATCTACC 
daf-12 3’UTR 
GW R attB3 
Gateway cloning 
daf-12 3'UTR 
GGGG AC AAC TTT GTA TAA TAA AGT TG 
CCCTTATGGGTTGGCTGAG 
 
Strains 
Strain 
name 
genotype 
HW769 xeSi10[Pwrt-2::gfp(PEST)-h2b::lin-41 3'UTR, unc-119 (+)] II 
HW896 xeSi10[Pwrt-2::gfp(PEST)-h2b::lin-41 3'UTR, unc-119 (+)] II, let-7(n2853) X 
HW786 xeSi22[Pwrt-2::GFP(PEST)-H2B::unc-54 3'UTR, unc-119 (+)] II 
HW899 xeSi22[Pwrt-2::GFP(PEST)-H2B::unc-54 3'UTR, unc-119 (+)] II, let-7(n2853) X 
HW785 xeSi20[Pwrt-2::gfp(pest)-h2b::daf-12 3'UTR] II; let-7(n2853) 
WM242  neSi12 [cdk-1::gfp(+), cb-unc-119(+)] II; unc-119(ed3) III 
GR1434 wIs54[scm::gfp]; let-7(n2853) V 
HW651 let-7(n2853) V; maIs105 [col-19::gfp] 
HW1096 glp-4(bn2); let-7(mn112);  xeEx365[Ptbb-1::let-7::SL1_operon_GFP, unc-119 (+); 
Prab-3::mCherry; Pmyo-2::mCherry; Pmyo-3::mCherry] 
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Fig. S1, Replicate correlation of gene expression proling by microarray
Staged L4 worm populations of let-7(+) and let-7(mn112) animals were collected in parallel and on 
three dierent days to obtain three biological replicates (rep1-3). Both strains were additionally 
homozygous for the glp-4(bn2)ts mutation, and thus germline-less at the temperature used for 
growth. Gene expression changes in glp-4(bn2); let-7(mn112) relative to glp-4(bn2); let-7(+) are com-
pared between individual replicate pairs.
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Fig. S2, The suppressors of let-7(n2853) can be grouped into four classes
Out of 201 suppressors of let-7(n2853) bursting, we nd 37 genes that aect repression of a let-7 target 
reporter ('target reporter-only') and 66 genes that restore hypodermis dierentiation in the col-19:gfp 
assay ('col-19-only'). A group of 36 genes scores positive in both assays ('double-positive'), whereas 62 
genes are negative in both assays ('suppressor-only').
Table S1: Suppressors of let-7(n2853 ) lethal bursting phenotype
GenePairs 
Name
Wormbase ID Gene 
Name
Wormbase Concise Description Wormbase conserved orthologous group Found in 
Ding et al. 
2008
Chromosome second retest: 
[% burst]@ 
25°C
second retest: 
[% burst] @ 
20°C
Pcol-19::gfp - 
penetrance @25°C,  
t1
Pcol-19::gfp - 
penetrance 
@25°C,  t2
Pcol-19::gfp - 
penetrance 
@20°C,  t1
Pcol-19::gfp - 
penetrance 
@20°C,  t2
Pwrt-2::gfp::lin-
41 repression
Pwrt-2::gfp::daf-12 
repression
Pwrt-2::gfp::unc-
54 repression
Y54E10A_15WBGene00000413 cdt-1 cdt‐1 encodes the C. elegans ortholog of the replication‐licensing factor Cdt1; CDT‐1 activity is essential for DNA rep + I 20.3 36.9 ++ +++ + +++ + +
C03D6.1 WBGene00000466 cel-1 cel‐1 encodes a mRNA capping enzyme, with a N‐terminal reg mRNA capping enzyme + I 58.1 92.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + +
B0511.10 WBGene00001228 eif-3.E eif‐3.E encodes the C. elegans ortholog of the translation initiation factor 3 subunit e (eIF3e/Int‐6); by homology, EIF + I 6.9 33.3 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +++ +++ +++
B0511.10 WBGene00001228 eif‐3.E eif‐3.E encodes the C. elegans ortholog of the translation initiation factor 3 subunit e (eIF3e/Int‐6); by homology, EIF + I 24.1 52.4 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +++ +++ +++
C41D11.2 WBGene00001231 eif-3.H + I 70.3 92.3 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + ++ +
C47B2.5 WBGene00001234 eif-6 eif‐6 encodes the C. elegans ortholog of vertebrate anti‐assoc EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (EIF + I 50.0 60.3 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +
T08B2.9 WBGene00001497 fars-1 frs‐1 encodes a predicted phenylalanyl‐t‐RNA synthetase. phenylalanyl‐tRNA synthetase ‐ I 44.1 51.6 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + + ++
ZK484.2 WBGene00001819 haf-9 haf‐9 is orthologous to the human gene ATP‐BINDING CASSETTtransporter protein ‐ I 92.6 77.1 ‐‐‐ ‐‐‐ ‐‐‐ ++ ‐‐‐
T03F1.9 WBGene00001832 hcp-4 The hcp‐4 gene encodes a centromere protein (CENP)‐C homolog, holocentric protein (HCP)‐4. + I 39.6 73.2 + ++ ‐‐‐ ‐‐‐ ++ +
Y110A7A.1 WBGene00001833 hcp-6 hcp‐6 encodes a HEAT motif‐containing protein that displays similarity to the XCAP‐D2/CNAP1/Cnd1/YCS4 family of proteins that ar I 33.3 46.6 ‐‐‐ ++ ‐‐‐ +++ ++ +++ +
F28B3.7 WBGene00001860 him-1 him‐1 encodes a homolog of the conserved eukaryotic protein, SMC1, a member of the SMC (structural maintenance of chromosom I 51.8 69.8 ++ +++ ‐‐‐ +++ +
Y48G1A_54.WBGene00002079 xpo-2 imb‐5 encodes an importin‐beta‐like protein orthologous to mimportin beta, nuclear transport factor + I 52.0 94.4 + + ‐‐‐ ++ + +
Y48G1A_54.WBGene00002079 + I 37.7 84.0 ‐‐‐ ‐‐‐ + + ‐‐‐ ++
C01G8.7 WBGene00002717 let-526 let‐526 encodes a homolog of a component of the SWI/SNF complex; the let‐526(h185) mutation results in early larv + I 37.9 58.0 + ++ + ++ ‐‐‐
C01G8.8 WBGene00002717 + I 76.0 58.6 + ++ ‐‐‐ + ‐‐‐
F57B10.1 WBGene00002783 let-607 + I 32.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +
C12C8.3 WBGene00003026 lin-41 lin‐41 encodes a novel RBCC (Ring finger‐B box‐Coiled coil) protein that is a member of the NHL (NCL‐1, HT2A, and L + I 13.2 16.7 +++ +++ +++ +++ ‐‐‐
T19A6.2 WBGene00003596 ngp-1 AUTOANTIGEN NGP‐1 + I 47.6 51.0 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +
F56A3.3 WBGene00003792 npp-6 npp‐6 encodes a protein with weak similarity to mouse nuclear pore complex protein Nup160, and affects embryon + I 54.7 30.2 + ++ ‐‐‐ + +++ +++ +
T19B4.2 WBGene00003793 npp-7 + I 20.6 17.1 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++
Y71F9A_279WBGene00003836 nxt-1 + I 58.9 69.9 + + ‐‐‐ ‐‐‐ ‐‐‐
Y106G6H.2 WBGene00003902 pab-1 pab‐1 encodes a polyadenylate‐binding protein (i.e., poly(A)‐bRNA recognition motif. (aka RRM, RBD, or RNP domai + I 11.5 100.0 ‐‐‐ ‐‐‐ ‐‐‐ + ‐‐‐
W02D9.1 WBGene00004181 pri-2 pri‐2 encodes a homolog of the DNA polymerase alpha‐primasDNA primase 58 KD subunit + I 29.9 51.6 + + ‐‐‐ + ++ + +
C03D6.8 WBGene00004437 rpl-24.2 rpl‐24.2 encodes a large ribosomal subunit L24 protein paralogribosomal protein + I 31.0 59.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
K12C11.2 WBGene00004888 smo-1 smo‐1 encodes the C. elegans ortholog of SUMO, a small ubiquitin‐like moiety that, when attached to protein substr + I 45.5 88.6 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐/Burst ‐‐‐
F56A3.4 WBGene00004955 spd-5 spd‐5 encodes a coiled‐coil domain protein; spd‐5 activity is required for centrosome maturation, symmetry breakin + I 52.4 47.6 + ++ ‐‐‐ ++ ‐‐‐
Y63D3A.5 WBGene00006565 tfg-1 + I 21.2 30.8 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +++ ++ ++
C36B1.3 WBGene00007971 rpb-3 DNA directed RNA polymerase II + I 0.0 21.0 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++ +++
Y53C10A.3 WBGene00008670 F11A3.2 guanine nucleotide exchange factor ‐ I 84.8 78.9 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + ++ +
F14B4.3 WBGene00008781 F14B4.3 DNA‐directed RNA polymerase I + I 68.8 84.4 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
F14B4.3 WBGene00008781 rpoa‐2 + I 57.8 69.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
M04C9.6 WBGene00008878 ppfr-1 ‐ I 92.5 44.2 ‐‐‐ ‐‐‐ +++ +++ ‐‐‐
F20G4.1 WBGene00008990 smgl-1 + I 21.3 34.0 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
F58H10.1 WBGene00010291 F58H10.1 ‐ I 82.1 42.2 ++ +++ ++ +++ ‐‐‐
K04G2.1 WBGene00010560 iftb-1 iftb‐1 encodes the C. elegans ortholog of translation initiation translational initiation factor 2 beta subunit ‐ I 37.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +++ ++ +++
K07A1.2 WBGene00010609 dut‐1 dut‐1 encodes a deoxyuridine triphosphate nucleotidohydroladeoxyuridine 5'‐triphosphate nucleotidohydrolase ‐ I 74.5 96.6 ‐‐‐ ‐‐‐ ‐‐‐ ++ +
R06C7.5 WBGene00011064 The R06C7.5 gene encodes an ortholog of the human gene ADadenylosuccinate lyase ‐ I 60.4 61.9 2/3 burst, rest +  ++ ‐‐‐ + ‐‐‐
T23D8.3 WBGene00011944 T23D8.3 T23D8.3 encodes an ortholog of yeast and human LTV1 that inhibits DHC‐1 in vivo; in mass RNAi assays, T23D8.3 is r + I 45.7 62.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +
W04A4.6 WBGene00012234 W04A4.5 + I 43.9 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + ++
W06H12.1 WBGene00012317 ztf-6 ‐ I 94.1 57.9 ‐‐‐ ‐‐‐ ++ +++ ‐‐‐
Y105E8C.d WBGene00013676 ekl-4 ‐ I 92.9 17.9 + + +++ +++ ‐‐‐
B0511.6 WBGene00015232 B0511.6 B0511.6 encodes a DEAD‐box helicase; loss of B0511.6 activityhelicase + I 11.6 0.0 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
C43E11.9 WBGene00016607 C43E11.9 ‐ I 39.5 76.7 ‐‐‐ + ‐‐‐ + ‐‐‐
C53H9.2 WBGene00016907 C53H9.2 C53H9.2 encodes at least three protein isoforms orthologous to the GTP‐binding proteins human GNL1 (HSR1; OMIM + I 32.0 32.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + +
F55A12.8 WBGene00018866 F55A12.8 ‐ I 39.6 28.1 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
F55F8.3 WBGene00018891 F55F8.3 ‐ I 10.7 23.8 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
H27M09.2 WBGene00019246 rpb‐5 H27M09.2 encodes the C.elegans ortholog of RPB5 which, in eRNA polymerase ‐ I 5.9 14.0 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++ ++ ++
K06A5.4 WBGene00019432 knl-2 ‐ I 20.0 46.6 ‐‐‐ ++ ‐‐‐ ++ +++ ++
T09B4.9 WBGene00020383 T09B4.9 + I 50.0 48.7 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +
W01B11.3 WBGene00020915 nol-5 + I 100.0 0.0 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
Y48G1A_54.WBGene00021660 Y48G1A.4 + I 61.7 77.7 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +
Y54E10A.10 WBGene00021830 ‐ I 70.7 49.6 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
Y54E10BR.5 WBGene00021844 ‐ I 54.7 43.8 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
Y54E10B_15WBGene00021845 rpb-7 + I 79.5 56.5 ‐‐‐ + ‐‐‐ + ++ +
Y65B4B_10. WBGene00022042 Y65B4BR.5 + I 73.2 73.8 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
Y110A7A.m WBGene00022458 Y110A7AY110A7A.8 is orthologous to the human gene U4/U6 SNRNP‐AmRNA splicing protein ‐ I 66.7 38.6 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++
ZC581.1 WBGene00022631 nekl-2 nekl‐2 encodes a putative serine/threonine protein kinase ort ser/thr‐protein kinase + I 39.5 11.9 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
ZC581.1 WBGene00022631 nekl‐2 nekl‐2 encodes a putative serine/threonine protein kinase orthologous to Aspergillus nidulans nimA and human NEK + I 39.2 47.7 ‐‐‐ ‐‐(Burst‐ ‐‐‐ ‐‐‐ ‐‐‐
M106.5 WBGene00000293 cap-2 The beta subunit of actin capping protein that regulates actin  F‐actin capping protein beta subunit na II 41.0 87.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
R06F6.1 WBGene00000411 cdl-1 cdl‐1 encodes a homolog of human hairpin (stem‐loop) binding proteins (HBP/SLBP) that bind to the hairpin (stem‐lo na II 16.7 16.1 ‐‐‐ + ‐‐‐ +++ ‐‐‐
F33A8.3 WBGene00000472 cey-1 cey‐1 encodes a protein with a cold‐shock/Y‐box domain that  'Cold‐shock' DNA‐binding domain na II 91.1 26.1 ‐‐‐ ‐‐‐ +++ +++ ‐‐‐
F11G11.10 WBGene00000606 col‐17 col‐17 encodes a collagen which is expressed in all developmecollagen na II 95.3 24.0 ‐‐‐, burst ‐‐‐ ‐‐‐ ++ ‐‐‐
R53.3 WBGene00001207 egl-43 egl‐43 encodes a zinc finger protein that affects HSN cell migraZinc finger, C2H2 type (4 domains) na II 68.8 23.8 + + ‐‐‐ ++ ‐‐‐
M110.4 WBGene00002066 ifg-1 ifg‐1 encodes, by alternative splicing, two orthologs of the traneukaryotic initiation factor na II 36.4 13.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +++ ++ +++
Y17G7A.2 WBGene00003015 lin-29 lin‐29 encodes a zinc finger transcription factor of the C2H2 tytranscription factor lin‐29 na II 88.0 54.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
Y17G7B.5 WBGene00003154 mcm-2 MCM2/3/5 family na II 58.3 43.3 + ++ ++ +++ ‐‐‐
R06F6.10 WBGene00003367 mix-1 The mix‐1 gene encodes a homolog of SMC2 involved in chrommitotic chromosome and X‐chromosome associated M na II 13.8 8.8 ‐‐‐ ‐‐‐ ‐‐‐ ++ +++
K12D12.2 WBGene00003789 npp-3 npp‐3 encodes a nucleoporin that is a homolog of vertebrate Nup205; npp‐3 is required for normal nuclear pore com na II 18.9 0.0 ‐‐‐ + ‐‐‐ + ‐‐‐ ++
K01C8.9 WBGene00003821 nst-1 nst‐1 encodes a homolog of human GNL3 (OMIM:608011, nucGTP‐binding protein na II 72.7 60.9 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++
F10C1.5 WBGene00004015 phb-2 phb‐2 encodes one of two subunits of the mitochondrial proh Prohibitin na II 27.0 44.3 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +++ +++ ++
W07E6.4 WBGene00004188 prp-21 splicing factor na II 48.8 12.5 + + ‐‐‐ ++ ‐‐‐ +
Shown are all genes which upon knockdown by RNAi suppressed the let‐7(n2853)  bursting phenotype. 
Suppression was defined as ≥20% worms alive after 48h incubation at 25 °C or 66h incubation at 20°C.
ZK1290.3 WBGene00004398 rol-8 rol‐8 encodes a collagen that is enriched in dauer larvae; mutaCutical collagen 6, col‐6 na II 93.1 30.0 ‐‐‐ ‐‐‐ ‐‐‐ ++ ‐‐‐
C09H10.2 WBGene00004454 rpl‐41 rpl‐41 encodes a large ribosomal subunit L41 protein; by homo60S ribosomal protein na II 12.2 ++ ++ +++
C08B11.5 WBGene00004723 sap-49 sap‐49 encodes the C. elegans ortholog of mammalian SAP49, Poly(A) RNA binding protein na II 51.7 45.2 ‐‐‐ ‐‐‐ ‐‐‐ + ‐‐‐
B0491.2 WBGene00005016 sqt-1 sqt‐1 encodes a cuticle collagen; during larval and adult develocuticle collagen SQT‐1 na II 63.6 ‐‐‐ ‐‐‐ ‐‐‐ ++ ‐‐‐
C01B12.1 WBGene00005017 sqt-2 sqt‐2 encodes a collagen required for normal alae formation acuticular collagen na II 75.9 80.8 ‐‐‐ ‐‐‐ ‐‐‐
F10G7.1 WBGene00006497 tag-151 na II 23.8 84.4 ‐‐‐ + ‐‐‐ ‐‐‐ ‐‐‐
C56E6.1 WBGene00006522 abcx-1 na II 43.9 48.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
D2085.3 WBGene00008428 D2085.3 D2085.3 is orthologous to the human gene UNKNOWN (PROT translation initiation factor (EIF) na II 21.8 48.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++ +++ +
F44G4.1 WBGene00009711 F44G4.1 na II 66.2 87.2 ‐‐‐ ‐‐‐ ‐‐‐ + +
R03D7.1 WBGene00010988 metr-1 R03D7.1 is orthologous to the human gene METHIONINE SYNT5‐methyltetrahydrofolate‐homocysteine methyltransf na II 67.0 ‐‐‐ burst ‐‐‐ + ‐‐‐
W03H9.4 WBGene00012230 cacn-1 cacn‐1 encodes an ortholog of Drosophila CACTIN and human C19orf29 that is required for normal distal tip cell mig na II 40.9 60.0 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++ +
Y48B6A.1 WBGene00012978 Y48B6A.1Y48B6A.1 encodes an ortholog of human BOP1 (OMIM:610596, overexpressed in colon cancer) and S. cerevisiae ERB na II 31.3 36.4 ‐‐‐ ‐‐‐ ‐‐‐ + ‐‐‐
C01F1.3 WBGene00015298 na II 54.1 ‐‐‐ ‐‐‐ ‐‐‐ + ++ ++ ++
F40H3.5 WBGene00015941 C18A3.3 na II 57.8 30.8 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++
C18A3.3 WBGene00015941 na II 63.0 55.7 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++ ++ +++
C44B7.3 WBGene00016625 aff-1 aff‐1 encodes a cell‐surface protein required in late L4 larvae for various cell fusions, of which at least one (AC‐utse)  na II 74.7 66.7 + + + ++ ‐‐‐
F18A1.5 WBGene00017546 rpa-1 rpa‐1 encodes the C. elegans ortholog of the replication prote replication factor A na II 8.7 0.0 ‐‐‐ + ‐‐‐ + ‐‐‐ ++
F47F6.1 WBGene00018572 lin-42 lin‐42 encodes three PAS domain‐containing proteins orthologous to insect and vertebrate Period proteins that func na II 22.6 0.0 +++ +++ +++ +++ ‐‐‐
F47F6.2 WBGene00018572 na II 4.2 +++ +++ +++ +++ ‐‐‐
F54A3_31.e WBGene00018782 cct-3 cct‐3 encodes a putative gamma subunit of the eukaryotic cytosolic ('T complex') chaperonin, orthologous to human na II 23.9 45.7 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++ + +
C32D5.11 WBGene00018869 F55C12.1 na II 66.7 ‐‐‐ ‐‐‐ + + ‐‐‐
R153.1 WBGene00020114 pde-4 pde‐4 encodes a cAMP phosphodiesterase orthologous to Drocyclic nucleotide phosphodiesterase na II 100.0 59.4 ‐‐‐ ‐‐‐ + +++ ‐‐‐
Y51H7B_5.bWBGene00022042 na II 53.4 81.0 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
ZK430.1 WBGene00022739 toe-1 na II 22.0 33.3 ‐‐‐ ‐‐‐ ‐‐‐ + ‐‐‐ +
T12C9.2 WBGene00022739 na II 54.2 84.9 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
ZK430.7 WBGene00022742 ZK430.7 ribosomal processing protein na II 69.8 27.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +
ZK1127.5 WBGene00022852 ZK1127.5 na II 60.3 77.5 ‐‐‐ ‐‐‐ ‐‐‐ + ‐‐‐
F54H12.1 WBGene00000041 aco-2 aco‐2 encodes an aconitase homolog that is required for embrAconitate hydratase na III 56.3 85.0 + ++ ‐‐‐ ++ ++
F57B9.5 WBGene00000276 byn-1 byn‐1 encodes a homolog of mammalian BYSTIN‐LIKE (BYSL; OMIM:603871). na III 47.4 83.8 ‐‐‐ ‐‐‐ ‐‐‐ + ‐‐‐
T05G5.3 WBGene00000405 cdk-1 cdk‐1 encodes a cyclin‐dependent kinase, orthologous to and  serine/threonine kinase (CDC2/CDKX subfamily) na III 54.9 14.7 ++ ++ + +++ ‐‐‐
R08D7.3 WBGene00001227 eif‐3.D eif‐3.D encodes the C. elegans ortholog of the translation initiation factor 3 subunit d (eIF3d/Moe1); by homology, E na III 24.1 52.4 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +++ +++ ++
W07B3.2 WBGene00001561 gei-4 gei‐4 encodes a protein with a coiled‐coil domain (predicted to mediate protein‐protein interactions), an internal re na III 88.1 72.5 ‐‐‐ + + +++ ‐‐‐
T20B12.8 WBGene00001974 hmg-4 hmg‐4 encodes a protein with strong similarity to the highly conserved high mobility group protein SSRP1 (structure na III 23.7 15.9 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +++ ++ ++
Y22D7AL.5 WBGene00002025 hsp‐60 hsp‐60 encodes a nuclear‐encoded mitochondrion‐specific chaperone that is a member of the GroE/Hsp10/60 super na III 89.6 79.0 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++
C02F5.1 WBGene00002231 knl‐1 knl‐1 encodes a novel acidic protein with a coiled‐coil region at its C‐terminus; KNL‐1 is an essential kinetochore com na III 55.6 76.7 ‐‐‐ + ‐‐‐ +++ + +
C16A3.3 WBGene00002850 let-716 na III 11.5 66.3 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
C29E4.8 WBGene00002879 let-754 let‐754 was identified in screens for ethyl methane sulfonate‐ Adenylate kinase na III 70.0 90.9 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
C07H6.7 WBGene00003024 lin-39 lin‐39 encodes a homeodomain protein homologous to the DeC. elegans homeobox gene lin‐39 na III 68.1 68.9 + ++ + +++ ‐‐‐
R13A5.12 WBGene00003063 lpd-7 lpd‐7 encodes a BRCT domain‐containing protein that is orthologous to Saccharomyces cerevisiae Nop7p and the ve na III 32.1 30.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++ +
ZK632.1 WBGene00003158 mcm-6 mcm‐6 encodes a protein that has similarity to human DNA reMcm2/3 na III 35.1 7.7 ++ ++ ++ +++ ‐‐‐
F59A2.1 WBGene00003795 npp-9 Nucleoporin na III 86.4 ‐‐‐ + ‐‐‐ ‐‐‐ ++ ++
K06H7.1 WBGene00004042 plk-1 plk‐1 encodes a serine/threonine polo‐like kinase homologousProtein kinase na III 57.8 64.3 + + ‐‐‐ +++ ‐‐‐ +
C14B9.4 WBGene00004042 na III 40.0 65.8 + ++ ‐‐‐ ++ + +
F58A4.4 WBGene00004180 pri-1 pri‐1 encodes a homolog of the DNA polymerase alpha‐primasDNA primase 49Kd subunit na III 71.4 ‐‐‐ + ‐‐‐ +++ ++ +
F58A4.4 WBGene00004180 pri‐1 pri‐1 encodes a homolog of the DNA polymerase alpha‐primase subunit D that is required in embryos for the norma na III 37.1 59.0 ‐‐‐ ++ ‐‐‐ ++ +++ ++
K04G7.10 WBGene00004390 rnp‐7 SN‐RNP U1 na III 11.1 47.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +
WBGene00004391 rnr-1 rnr‐1 encodes the large subunit of ribonucleotide reductase; bRibonucleoside‐disphosphate reductase large chain na III 49.3 65.9 ++ ++ ‐‐‐ +++ ‐‐‐
C54C6.1 WBGene00004451 rpl‐37 rpl‐37 encodes a large ribosomal subunit L37 protein. 60S ribosomal protein L37 na III 20.5 36.4 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++ ++ ++
Y47D3A.26 WBGene00004873 smc‐3 na III 38.7 55.6 + +++ ++ +++ ++ + +++
F35G12.8 WBGene00004874 smc-4 The smc‐4 gene encodes a homolog of the SMC4 subunit of mchromosome segregation protein na III 39.8 74.4 ‐‐‐ ++ ‐‐‐ ++ ++
ZK652.1 WBGene00004918 snr-5 snr‐5 encodes an ortholog of human small nuclear ribonucleopsmall nuclear ribonucleoprotein Sm F (snRNP core pro na III 23.1 30.4 ‐‐‐ + + + ‐‐‐
T27E9.1 WBGene00006439 ant-1.1 ant‐1.1 encodes one of four C. elegans mitochondrial adenine ADP/ATP carrier protein na III 4.3 17.1 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
T27E9.1 WBGene00006439 ant‐1.1 ant‐1.1 encodes one of four C. elegans mitochondrial adenine nucleotide transporters; by homology, ANT‐1.1 is pred na III 1.1 22.3 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
Y92C3B.2 WBGene00006697 uaf‐1 uaf‐1 encodes the large subunit of splicing factor U2AF (U2 Auxiliary Factor), orthologous to mammalian and Drosop na III 22.1 10.8 ‐‐‐ ‐‐‐ ‐‐‐ ++ ++ ++
R10E11.2 WBGene00006911 vha-2 vha‐2 and vha‐3 encode an ortholog of subunit c of the membVacuolar ATP synthase subunit na III 79.2 80.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + +
Y111B2C.m WBGene00007030 epc-1 enhancer of polycomb‐like na III 87.8 79.8 ++ ++ (many burst) +++ +++ ‐‐‐
Y111B2A.11WBGene00007030 epc‐1 na III 18.9 13.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
M01F1.7 WBGene00010813 pitp‐1 pitp‐1 encodes a phosphatidylinositol transfer protein, with a RETINAL DEGENERATION B PROTEIN (PROBABLE CALC na III 70.6 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++ +++ +++
T04A8.6 WBGene00011408 T04A8.6 T04A8.6 encodes an ortholog of S. cerevisiae NOP15 that may ribonuleoprotein na III 63.0 71.8 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
WBGene00012059 T26G10.1 RNA helicase na III 22.0 27.6 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
WBGene00012936 Y47D3A.2Y47D3A.29 encodes the catalytic subunit of DNA polymerase aDNA polymerase alpha subunit na III 14.0 46.8 ‐‐‐ + ‐‐‐ ‐‐‐ ‐‐‐ ++
Y49E10.19 WBGene00013038 ani-1 ani‐1 encodes one of three C. elegans anillins; ANI‐1 activity is PH (pleckstrin  homology) domain na III 69.7 30.0 + + ‐‐‐ ++ +
C16A3.4 WBGene00015809 C16A3.4 na III 72.0 65.9 ‐‐‐ (but many have burs ‐‐‐ ‐‐‐ ‐‐‐ ++
C16A3.6 WBGene00015811 na III 54.2 82.6 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
C23G10.8 WBGene00016015 C23G10.8 S. pombe adenylyl cyclase‐associated protein (weak) na III 57.0 81.9 ‐‐‐ + + + ‐‐‐
C23G10.9 WBGene00016015 na III 88.2 86.7 ‐‐‐ + + ‐‐‐ ‐‐‐
C29E4.2 WBGene00016202 kle-2 na III 44.2 54.7 + +++ ‐‐‐ +++ +
F09F7.3 WBGene00017300 F09F7.3 na III 17.4 21.7 + + ‐‐‐ ‐‐‐ ‐‐‐
F26F4.11 WBGene00017830 rpb-8 na III 42.9 60.6 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++
F37C12.13 WBGene00018154 exos-9 na III 32.4 62.7 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
H06I04.3 WBGene00019168 na III 36.6 17.0 ‐‐‐
H06I04.3 WBGene00019168 na III 38.6 31.3 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +
K12H4.3 WBGene00019678 K12H4.3 na III 38.0 18.8 ‐‐‐ + ‐‐‐ ‐‐‐ ‐‐‐ +
K12H4.4 WBGene00019679 K12H4.4 Signal peptidase na III 80.3 48.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
F57H12.1 WBGene00000183 arf-3 arf‐3 encodes a member of the ADP‐ribosylation factor relatedGTP‐binding protein na IV 69.6 92.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + ++
Y41E3.2 WBGene00001066 dpy-4 dpy‐4 encodes a cuticle collagen; dpy‐4 activity is required for CUTICLE COLLAGEN 1 na IV 36.8 8.1 ‐‐‐ ‐‐‐ ‐‐‐ ++
F35H10.1 WBGene00001904 his-30 his‐30 encodes an H2A histone; by homology, HIS‐30 is predicthistone H2A na IV 60.7 73.3 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +++ +++ +++
T11G6.1 WBGene00002001 hars-1 hrs‐1 encodes predicted cytoplasmic and mitochondrial histidyhistidyl‐tRNA synthetase (cytoplasmic), histidyl‐tRNA  na IV 42.3 60.6 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
F32E10.4 WBGene00002074 ima-3 ima‐3 encodes one of three C. elegans importin alpha nuclear importin alpha, nuclear transport factor na IV 69.4 93.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
M7.1 WBGene00002344 let-70 let‐70 encodes a class I E2 ubiquitin conjugating enzyme; let‐7ubiquitin‐conjugating enzyme E2‐17 KD na IV 82.5 64.5 + ++ + ++ ‐‐‐
F36H1.4 WBGene00002992 lin-3 lin‐3 encodes a member of the EGF family of peptide growth f lin‐3 growth factor precursor na IV 23.8 23.1 + + + +++ ‐‐‐
C08F8.8 WBGene00003657 nhr-67 nhr‐67 encodes a nuclear receptor that is orthologous to Dros nuclear hormone receptor na IV 1.9 3.5 ‐‐‐ ‐‐‐ ‐‐‐ ++ ‐‐‐
Y41D4A_307WBGene00003794 npp-8 na IV 4.3 56.3 ‐‐‐ ‐‐‐ ‐‐‐ + ++ ++ ++
Y41D4A_307WBGene00003794 na IV 11.3 2.4 ‐‐‐ ‐‐‐ ‐‐‐ + ++ ++ +++
Y41D4A_345WBGene00003794 na IV 2.3 2.4 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + ++ +
Y41D4A_345WBGene00003794 na IV 17.3 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +++ +++ ++
T23F6.4 WBGene00004315 rbd-1 rbd‐1 encodes an ortholog of S. cerevisiae Mrd1p; RBD‐1 is reqRNA recognition motif. (aka RRM, RBD, or RNP domai na IV 74.0 85.7 ‐‐‐ ‐‐‐ ‐‐‐ + ++ + ++
Y62E10A.d WBGene00004410 rla-2 rpa‐2 encodes an acidic ribosomal subunit protein P2. na IV 69.0 48.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + ++
C42D4.8 WBGene00004411 rpc-1 DNA‐directed RNA polymerase II largest subunit na IV 31.0 75.6 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++
K11H12.12 WBGene00004427 rpl-15 rpl‐15 encodes a large ribosomal subunit L15 protein. 60S ribosomal protein L15 na IV 23.1 31.3 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++ ++ +++
K08E4.1 WBGene00005015 spt-5 translation initiation protein SPT5 like na IV 1.3 24.7 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +++ +++ +
M03D4.1 WBGene00006974 zen-4 zen‐4 encodes a kinesin‐like protein that is a member of the k kinesin‐like protein na IV 30.2 49.1 + + ‐‐‐ +++ ‐‐‐
C33D9.3 WBGene00007898 C33D9.3 na IV 88.1 58.3 burst burst +(mostly burst) +++(mostly burst) ‐‐‐
C47E12.4 WBGene00008149 pyp-1 pyp‐1 encodes, by alternative splicing, three isoforms of an inoinorganic pyrophosphatase na IV 47.9 66.2 + + + ++ +
C47E12.7 WBGene00008151 C47E12.7 Yeast YD78 like na IV 61.7 45.2 ‐‐‐ + ‐‐‐ ‐‐‐ ‐‐‐ +
F28D1.1 WBGene00009211 F28D1.1 Yeast hypothetical protein YER2 like na IV 64.4 73.7 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
F40F11.2 WBGene00009587 F40F11.2 na IV 15.2 69.8 ++ ++ ‐‐‐ ‐‐‐ ++ ++ +++
M18.5 WBGene00010890 ddb-1 M18.5 is orthologous to the human gene DAMAGE‐SPECIFIC DDNA repair protein like na IV 32.7 93.8 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐/Burst + +
T11G6.8 WBGene00011722 RNA recognition motif. (aka RRM, RBD, or RNP domai na IV 55.7 38.1 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++
Y45F10D.8 WBGene00012887 Y45F10DY45F10D.7 encodes a WD40 repeat‐containing protein that is the C. elegans ortholog of human WDR36, mutations i na IV 80.0 95.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
C42C1.3 WBGene00016581 C42C1.3 na IV 26.3 86.0 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
H06H21.3 WBGene00019162 eif-1.A translation initiation factor na IV 45.3 60.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + + +
T22D1.10 WBGene00020687 ruvb-2 na IV 69.4 82.8 ‐‐‐ + ‐‐‐ + ++ +
Y55F3A_750WBGene00021934 cct-8 cct‐8 encodes a putative theta subunit of the eukaryotic cytosolic ('T complex') chaperonin, orthologous to human C na IV 2.9 35.4 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +
Y55F3A_750WBGene00021934 na IV 0.0 45.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
F29G9.3 WBGene00000159 aps-1 aps‐1 encodes an adaptin: specifically, it encodes an ortholog  clathrin coat assembly protein na V 20.0 55.9 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++
K11C4.5 WBGene00000159 na V 6.7 43.8 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
F29G9.3 WBGene00000159 aps‐1 aps‐1 encodes an adaptin: specifically, it encodes an ortholog of the sigma1 subunit of adaptor protein complex 1 (A na V 16.7 57.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + +
K07C5.1 WBGene00000200 arx-2 arx‐2 encodes the C. elegans ortholog of the Arp2 subunit of t actin na V 60.9 80.9 ‐‐‐ ‐‐‐/Burst ‐‐‐ +++/or burst ‐‐‐
F16B4.8 WBGene00000387 cdc-25.2 cdc‐25.2 encodes a putative homolog of Cdc25 phosphatase pprotein‐tyrosine phosphatase na V 14.3 65.5 + + + +++ ‐‐‐
T06E6.2 WBGene00000868 cyb-3 cyb‐3 encodes a member of the cyclin B family that is requiredcyclin B like na V 49.2 31.4 + ++ ‐‐‐ +++ ++
F29G9.4 WBGene00001345 fos-1 fos‐1 encodes two basic region‐leucine zipper (bZip) transcriptBZIP transcription factor na V 47.5 52.7 + ++ ‐‐‐ +++ ‐‐‐
C53A5.3 WBGene00001834 hda-1 The hda‐1 gene encodes a histone deacetylase 1, similar to hisYeast RPD3 protein like na V 42.9 80.9 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
ZK742.1 WBGene00002078 xpo-1 xpo‐1 encodes exportin‐1, an importin‐beta‐like protein ortho importin beta, nuclear transport factor na V 40.5 71.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
Y73C8B.b WBGene00002246 lag-2 lag‐2 encodes a transmembrane protein of the Delta/Serrate/ intercellular signal protein na V 28.6 95.0 + + + ++ ‐‐‐
C29A12.3 WBGene00002985 lig-1 lig‐1 is orthologous to the human gene LIM HOMEOBOX PROTDNA ligase I na V 49.0 52.2 + ++ ‐‐‐ +++ +
F32D1.10 WBGene00003159 mcm-7 cell division control protein na V 21.4 53.2 ++ +++ ‐‐‐ +++ ‐‐‐
F38A6.1 WBGene00004013 pha‐4 pha‐4 encodes a FoxA transcription factor; during embryonic dFork head domain, eukaryotic  transcription factors na V 4.1 + + ‐‐‐ + ‐‐‐
F18E2.3 WBGene00004738 scc-3 scc‐3 encodes a cohesin complex subunit homologous to Saccharomyces cerevisiae Irr1p/Scc3p; SCC‐3 is required du na V 16.7 39.6 + +++ ‐‐‐ +++ ‐‐‐ +
F23H12.4 WBGene00005018 sqt-3 sqt‐3 encodes a cuticle collagen; during development, sqt‐3 accollagen na V 95.0 40.3 ‐‐‐ Burst ‐‐‐ +++ ‐‐‐
D1054.15 WBGene00006481 plrg‐1 beta transducin like protein na V 9.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + ++ +++
Y80D3A.a WBGene00006945 wars-1 wrs‐1 encodes a predicted tryptophanyl‐tRNA synthetase thattryptophanyl‐tRNA synthetase na V 48.7 72.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +
B0250.7 WBGene00007124 B0250.7 na V 48.6 93.1 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++ ++ +++
C14C10.3 WBGene00007586 ril-2 na V 32.0 77.1 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + +
C15H11.9 WBGene00007617 rrbs-1 Human HA0609 protein like na V 27.8 10.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +
C27H6.2 WBGene00007784 ruvb-1 ruvb‐1 encodes a AAA+ ATPase orthologous to the RUVBL1 famYeast hypothetical 50.5 KD protein like na V 42.9 73.0 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + +
F11A3.2 WBGene00008670 na V 22.6 95.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + +
C50F4.13 WBGene00008670 na V 41.4 88.6 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++
F53B7.3 WBGene00009966 F53B7.3 na V 55.2 21.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ++
F53F4.11 WBGene00009993 F53F4.11 na V 23.9 17.9 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
F53F4.11 WBGene00009993 na V 8.3 28.6 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
F55C5.4 WBGene00010093 capg-2 na V 12.5 26.5 ‐‐‐ ++ ‐‐‐ +++ ++ +
F55C5.8 WBGene00010097 F55C5.8 signal recognition particle 68 KD protein na V 11.1 2.0 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
K07C5.4 WBGene00010627 K07C5.4 yeast protein L8167.9‐like na V 28.6 54.2 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + ++
T06E6.1 WBGene00011538 T06E6.1 na V 50.0 81.1 ‐‐‐ ‐‐‐ ‐‐‐ + ‐‐‐ +
C37H5.5 WBGene00016508 C37H5.5 na V 54.3 85.9 ‐‐‐ +(many burst( ‐‐‐ +(many burst) ‐‐‐ +
F09G2.4 WBGene00017313 cpsf-2 Cleavage and Polyadenylation Specificity Factor na V 56.7 16.2 ‐‐‐ ‐‐‐ ‐‐‐ + ++ ++
F25G6.2 WBGene00017797 symk-1 na V 26.4 27.8 ‐‐‐ + ‐‐‐ ‐‐‐ + +
F32D1.2 WBGene00017982 F32D1.2 ATP synthase epsilion chain na V 50.0 89.1 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
T08B1.1 WBGene00020340 T08B1.1 sugar transporter na V 51.3 ‐‐‐/Burst Burst ‐‐‐ ‐‐‐ ‐‐‐
T19A5.3 WBGene00020554 na V 18.4 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + ++ ++
F08C6.1 WBGene00000083 adt-2 Thrombospondin na X 74.5 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
C42D8.8 WBGene00000149 apl-1 apl‐1 encodes two almost identical isoforms orthologous to human APP (OMIM:104760, mutated in familial Alzheim na X 9.1 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ +
F18H3.5 WBGene00000406 cdk-4 cdk‐4 encodes two isoforms of a cyclin‐dependent serine/threserine/threonine kinase (CDC2/CDKX subfamily) na X 100.0 63.3 2/3 burst, rest  ++ S ++(mostly burst) + + ‐‐‐
F11A1.3 WBGene00000908 daf-12 daf‐12 encodes a member of the steroid hormone receptor superfamily that is homologous to human VITAMIN D RE na X 0.0 0.0 +++ +++ +++ +++ ‐‐‐
C02C6.1 WBGene00001130 dyn-1 dyn‐1 encodes the C. elegans ortholog of the dynamin GTPasedynamin na X 10.8 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ + ++
W01C8.2 WBGene00001182 egl-13 egl‐13 encodes a SOX domain transcription factor; egl‐13 is required for maintenance of the uterine pi cell fate; mut na X 28.9 83.6 + +++ +++ +++ ‐‐‐
C33D3.1 WBGene00001250 elt-2 elt‐2 encodes a GATA‐type transcription factor most similar tozinc finger protein (GATA type) na X 76.2 7.0 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
F52D10.3 WBGene00001502 ftt-2 14‐3‐3 protein na X 82.9 42.9 + + ++ +(also many burst) ‐‐‐
F13D11.2 WBGene00001824 hbl-1 hbl‐1 encodes a C2H2‐type zinc finger transcription factor relaC2H2‐type zinc finger na X 34.1 6.5 ++ +++ +++ +++ ‐‐‐
F46F2.2 WBGene00002203 kin-20 casein kinase I (epsilon/delta) na X 38.8 9.1 + ++ ++ ++ ++ + +
C17G1.6 WBGene00003553 nas-37 nas‐37 encodes a Astacin‐class metalloprotease required for f zinc metalloprotease na X 62.7 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
F11C1.6 WBGene00003623 nhr-25 nhr‐25 encodes a nuclear hormone receptor orthologous to D nuclear hormone receptor na X 43.1 13.2 +++ +++ +++ +++ + +
C49F5.1 WBGene00008205 sams‐1 sams‐1 encodes an S‐adenosyl methionine synthetase; by homs‐adenosylmethionine synthetase na X 39.2 85.4 ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐ ‐‐‐
Table S2: let‐7  suppressor genes that restore let‐7 target reporter gene repression ('target reporter positives')
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cell cycle/ chromosome maintenance & segregation
mix‐1 WBGene00003367 +++ ‐‐‐ ‐‐‐ condensin II subunit
smc‐4 WBGene00004874 ++ ‐‐‐ ‐‐‐ condensin II subunit
capg‐2 WBGene00010093 ++ + ‐‐‐ condensin II subunit
hcp‐6 WBGene00001833 ++ +++ + condensin II subunit
kle‐2 WBGene00016202 + ‐‐‐ ‐‐‐ condensin II subunit
scc‐3 WBGene00004738 ‐‐‐ + ‐‐‐ cohesin subunit
plk‐1 WBGene00004042 + + ‐‐‐ polo‐like kinase
cyb‐3 WBGene00000868 ++ ‐‐‐ ‐‐‐ cyclin B
him‐1 WBGene00001860 + ‐‐‐ ‐‐‐ structural maintenance of chromosome family
knl‐2 WBGene00019432 +++ ++ ‐‐‐ kinetochore associated
DNA/replication
Y47D3A.29 WBGene00012936 ‐‐‐ ++ ‐‐‐ DNA polymerase alpha subunit
pri‐1 WBGene00004180 +++ ++ ‐‐‐ DNA primase
rpa‐1 WBGene00017546 ‐‐‐ ++ ‐‐‐ replication protein A homolog
lig‐1 WBGene00002985 + ‐‐‐ ‐‐‐ DNA ligase
ruvb‐1 WBGene00007784 + + ‐‐‐ recombination protein homolog
ruvb‐2 WBGene00020687 ++ + ‐‐‐ recombination protein homolog
dbb‐1 WBGene00010890 + + ‐‐‐ DNA damage binding protein, replication, LET‐23 signaling in the vulva
mRNA biogenesis
rpb‐3 WBGene00007971 ++ +++ ‐‐‐ RNA Pol II subunit
rpb‐7 WBGene00021845 ++ + ‐‐‐ RNA Pol II subunit
rpb‐8 WBGene00017830 ++ ‐‐‐ ‐‐‐ RNA Pol II subunit
spt‐5 WBGene00005015 +++ +++ + transcription elongation
uaf‐1 WBGene00006697 ++ ++ ‐‐‐ splicing factor related
prp‐31 WBGene00022458 ‐‐‐ ++ ‐‐‐ spilceosome
prp‐21 WBGene00004188 ‐‐‐ + ‐‐‐ splicing factor
cpsf‐2 WBGene00017313 ++ ++ ‐‐‐ cleavage and polyadenylation
symk‐1 WBGene00017797 + + ‐‐‐ cleavage and polyadenylation
cel‐1 WBGene00000466 + + ‐‐‐ mRNA capping
nuclear transport
npp‐6 WBGene00003792 +++ +++ + nuclear pore protein
npp‐9 WBGene00003795 ++ ++ ‐‐‐ nuclear pore protein
npp‐7 WBGene00003793 ‐‐‐ ++ ‐‐‐ nuclear pore protein
npp‐3 WBGene00003789 ‐‐‐ ++ ‐‐‐ nuclear pore protein
xpo‐2 WBGene00002079 + + ‐‐‐ nuclear export receptor
xpo‐2 WBGene00002079 ‐‐‐ ++ ‐‐‐ nuclear export receptor
Suppressors of let‐7(n2853)  bursting phenotype were analyzed for repression of a destabilized GFP fused to the 3’UTR 
of the let‐7  targets lin‐41  and daf‐12  (Pwrt‐2::gfp‐H2B‐PEST::lin‐41‐3’UTR  or Pwrt‐2::gfp‐H2B‐PEST::daf‐12‐3’UTR ) or 
the unregulated unc‐54  3’UTR (negative control) in let‐7(n2853)  worms. Shown are genes which upon RNAi restored 
weak (+), medium (++) or strong (+++) repression in one of the let‐7  target reporters while showing no or minor 
repression in the negative control.
ribosome biogenesis
rpc‐1 WBGene00004411 ‐‐‐ ++ ‐‐‐ RNA Pol III subunit
rrbs‐1 WBGene00007617 ‐‐‐ + ‐‐‐ ribosome biogenesis
nst‐1 WBGene00003821 ‐‐‐ ++ ‐‐‐ ribosome biogenesis?
C37H5.5 WBGene00016508 ‐‐‐ + ‐‐‐ nucleolar complex protein 3 homolog
C47E12.7 WBGene00008151 ‐‐‐ + ‐‐‐ rRNA processing?
K12H4.3 WBGene00019678 ‐‐‐ + ‐‐‐ BRX1 homolog (ribosome biogenesis)
C18A3.3 WBGene00015941 ‐‐‐ ++ ‐‐‐ rRNA processing?
translation
eif‐6 WBGene00001234 + ‐‐‐ ‐‐‐ initiation factor
D2085.3 WBGene00008428 ++ +++ + eIF2B subunit
wars‐1 WBGene00006945 ‐‐‐ + ‐‐‐ tRNA synthetase
vesicle trafficing
aps‐1 WBGene00000159 ++ ‐‐‐ ‐‐‐ vesicle trafficing
aps‐1 WBGene00000159 + + ‐‐‐
arf‐3 WBGene00000183 + ++ ‐‐‐ intracellular traffikcing
dyn‐1 WBGene00001130 + ++ ‐‐‐ dynamin related
other
rnp‐7 WBGene00004390 + ‐‐‐ ‐‐‐ RNA binding
ani‐1 WBGene00013038 + ‐‐‐ ‐‐‐ actin binding protein
pyp‐1 WBGene00008149 + ‐‐‐ ‐‐‐ pyrophosphatase, nucleosome remodelling?
dut‐1 WBGene00010609 + ‐‐‐ ‐‐‐ deoxyUTPase
ril‐2 WBGene00007586 + + ‐‐‐ RNAi induced longevity
ngp‐1 WBGene00003596 ‐‐‐ + ‐‐‐ GTP‐binding protein
aco‐2 WBGene00000041 ++ ‐‐‐ ‐‐‐ aconitase
apl‐1 WBGene00000149 + ‐‐‐ ‐‐‐ amyloid precursor like
vha‐2 WBGene00006911 + + ‐‐‐ proton transporting ATPase
hsp‐60 WBGene00002025 ‐‐‐ ++ ‐‐‐ mitochondial HSP
T09B4.9 WBGene00020383 ‐‐‐ + ‐‐‐ mitochondrial import
toe‐1 WBGene00022739 ‐‐‐ + ‐‐‐ target of erk kinase
cct‐8 WBGene00021934 ‐‐‐ + ‐‐‐ Chaperonin complex
cacn‐1 WBGene00012230 ++ + ‐‐‐ DTC migration vulva morph?
let‐607 WBGene00002783 ‐‐‐ + ‐‐‐ CREB family transcription factor
nhr‐25 WBGene00003623 + + ‐‐‐ nuclear hormone receptor transcription factor
F44G4.1 WBGene00009711 + ‐‐‐ ‐‐‐
C53H9.2 WBGene00016907 + + ‐‐‐
F11A3.2 WBGene00008670 + + ‐‐‐
F11A3.2 WBGene00008670 ‐‐‐ ++ ‐‐‐
C16A3.4 WBGene00015809 ‐‐‐ ++ ‐‐‐
ZK430.7 WBGene00022742 + ‐‐‐ ‐‐‐
T11G6.8 WBGene00011722 ‐‐‐ ++ ‐‐‐
F53B7.3 WBGene00009966 ‐‐‐ ++ ‐‐‐
W04A4.5 WBGene00012234 + ++ ‐‐‐
T06E6.1 WBGene00011538 ‐‐‐ + ‐‐‐
T23D8.3 WBGene00011944 ‐‐‐ + ‐‐‐
Y48G1A.4 WBGene00021660 ‐‐‐ + ‐‐‐
H06I04.3 WBGene00019168 ‐‐‐ + ‐‐‐
Table S3:  let‐7  suppressor genes that restore expression of the hypodermal differentiation marker col‐19::gfp  ('col‐19 posi
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cell cycle/ chromosome maintenance & segregation
plk‐1 WBGene00004042 + ++ ‐‐‐ +++ polo‐like kinase
cyb‐3 WBGene00000868 + ++ ‐‐‐ +++ Cyclin B
cdc‐25.2 WBGene00000387 + + + +++ Cdc25 phosphatase homolog
cdk‐1 WBGene00000405 ++ ++ + +++ cyclin‐dependent kinase
cdk‐4 WBGene00000406 ++ ++ + + cyclin‐dependent kinase
smc‐4 WBGene00004874 ‐‐‐ ++ ‐‐‐ ++ condensin II complex
capg‐2 WBGene00010093 ‐‐‐ ++ ‐‐‐ +++ condensin II complex
mix‐1 WBGene00003367 ‐‐‐ ‐‐‐ ‐‐‐ ++ condensin II complex
hcp‐6 WBGene00001833 ‐‐‐ ++ ‐‐‐ +++ condensin II complex
kle‐2 WBGene00016202 + +++ ‐‐‐ +++ condensin II complex
him‐1 WBGene00001860 ++ +++ ‐‐‐ +++ structural maintenance of chromosome family
hcp‐4 WBGene00001832 + ++ ‐‐‐ ‐‐‐ CENP‐C homolog
scc‐3 WBGene00004738 + +++ ‐‐‐ +++ cohesin subunit
smc‐3 WBGene00004873 + +++ ++ +++ cohesin subunit
spd‐5 WBGene00004955 + ++ ‐‐‐ ++ centrosome
knl‐1 WBGene00002231 ‐‐‐ + ‐‐‐ +++ kinetochore associated
knl‐2 WBGene00019432 ‐‐‐ ++ ‐‐‐ ++ kinetochore associated
collagens
col‐17 WBGene00000606 burst ‐‐‐ ‐‐‐ ++ collagen
dpy‐4 WBGene00001066 ‐‐‐ ‐‐‐ ‐‐‐ ++ collagen
rol‐8 WBGene00004398 ‐‐‐ ‐‐‐ ‐‐‐ ++ collagen
sqt‐1 WBGene00005016 ‐‐‐ ‐‐‐ ‐‐‐ ++ collagen
sqt‐3 WBGene00005018 ‐‐‐ burst ‐‐‐ +++ collagen
cytoskeleton
zen‐4 WBGene00006974 + + ‐‐‐ +++ kinesin, mitosis
ani‐1 WBGene00013038 + + ‐‐‐ ++ actin binding protein
arx‐2 WBGene00000200 ‐‐‐ burst ‐‐‐ +++ Arp2/3 complex
gei‐4 WBGene00001561 ‐‐‐ + + +++ cytoskeleton rearrangement, vulva dev.
DNA/replication
cdt‐1 WBGene00000413 ++ +++ + +++ repl. licensing
mcm‐2 WBGene00003154 + ++ ++ +++ repl. licensing
mcm‐6 WBGene00003158 ++ ++ ++ +++ repl. licensing
mcm‐7 WBGene00003159 ++ +++ ‐‐‐ +++ repl. licensing
rnr‐1 WBGene00004391 ++ ++ ‐‐‐ +++ ribonucleotide reductase
lig‐1 WBGene00002985 + ++ ‐‐‐ +++ ligase
pri‐1 WBGene00004180 ‐‐‐ + ‐‐‐ +++ primase
pri‐2 WBGene00004181 + + ‐‐‐ + primase
Suppressors of let‐7(n2853)  bursting phenotype were screened for rescue of activation of the Pcol‐19::gfp  reporter in let‐
7(n2853)  worms. Worms grown at 25°C were analyzed after 48h and 56h, worms grown at 20°C were scored after 56h 
and 72h. Shown are genes that resulted in weak (+), medium (++) or strong (+++) activation of GFP upon RNAi at one or 
multiple time points.
ruvb‐2 WBGene00020687 ‐‐‐ + ‐‐‐ + recombination protein homolog
rpa‐1 WBGene00017546 ‐‐‐ + ‐‐‐ + replication protein A homolog
Y47D3A.29 WBGene00012936 ‐‐‐ + ‐‐‐ ‐‐‐ DNA polymerase alpha subunit
mRNA biogenesis
rpb‐7 WBGene00021845 ‐‐‐ + ‐‐‐ + RNA Pol II subunit
cpsf‐2 WBGene00017313 ‐‐‐ ‐‐‐ ‐‐‐ + cleavage and polyadenylation
symk‐1 WBGene00017797 ‐‐‐ + ‐‐‐ ‐‐‐ cleavage and polyadenylation
sap‐49 WBGene00004723 ‐‐‐ ‐‐‐ ‐‐‐ + spliceosome associated
snr‐5 WBGene00004918 ‐‐‐ + + + splicing
prp‐21 WBGene00004188 + + ‐‐‐ ++ splicing factor
uaf‐1 WBGene00006697 ‐‐‐ ‐‐‐ ‐‐‐ ++ splicing factor
specific transcription
lin‐42 WBGene00018572 +++ +++ +++ +++
daf‐12 WBGene00000908 +++ +++ +++ +++ nuclear hormone receptor
nhr‐25 WBGene00003623 +++ +++ +++ +++ nuclear hormone receptor
hbl‐1 WBGene00001824 ++ +++ +++ +++ zinc finger TF
egl‐13 WBGene00001182 + +++ +++ +++ SOX domain TF
lin‐39 WBGene00003024 + ++ + +++ homeodomain TF
fos‐1 WBGene00001345 + ++ ‐‐‐ +++ FOS TF
ztf‐6 WBGene00012317 ‐‐‐ ‐‐‐ ++ +++ zinc finger TF
egl‐43 WBGene00001207 + + ‐‐‐ ++ zinc finger TF
pha‐4 WBGene00004013 + + ‐‐‐ + FoxA transcription factor
nhr‐67 WBGene00003657 ‐‐‐ ‐‐‐ ‐‐‐ ++ nuclear hormone receptor
nuclear transport
ftt‐2 WBGene00001502 + + ++ + nuclear trafficking?
xpo‐2 WBGene00002079 + + ‐‐‐ ++ nuclear export receptor
npp‐6 WBGene00003792 + ++ ‐‐‐ + nuclear pore protein
npp‐3 WBGene00003789 ‐‐‐ + ‐‐‐ + nuclear pore protein
nxt‐1 WBGene00003836 + + ‐‐‐ ‐‐‐ export protein
npp‐8 WBGene00003794 ‐‐‐ ‐‐‐ ‐‐‐ + nuclear pore protein
npp‐9 WBGene00003795 ‐‐‐ + ‐‐‐ ‐‐‐ nuclear pore protein
nucleosome remodelling
epc‐1 WBGene00007030 ++ ++ +++ +++ NuA4 histone acetyltransferase complex
ekl‐4 WBGene00013676 + + +++ +++ NuA4 histone acetyltransferase complex
let‐526 WBGene00002717 + ++ + ++ SWI/SNF complex
pyp‐1 WBGene00008149 + + + ++ pyrophosphatase, nucleosome remodelling?
ribosome biogenesis
rpc‐2 WBGene00017300 + + ‐‐‐ ‐‐‐ RNA pol III
C37H5.5 WBGene00016508 ‐‐‐ + ‐‐‐ + nucleolar protein
C43E11.9 WBGene00016607 ‐‐‐ + ‐‐‐ + ribosome biogenesis
tag‐151 WBGene00006497 ‐‐‐ + ‐‐‐ ‐‐‐ ribosome biogenesis
rbd‐1 WBGene00004315 ‐‐‐ ‐‐‐ ‐‐‐ + ribosome biogenesis
Y48B6A.1 WBGene00012978 ‐‐‐ ‐‐‐ ‐‐‐ + ribosome biogenesis, chromosome segregation?
K12H4.3 WBGene00019678 ‐‐‐ + ‐‐‐ ‐‐‐ ribosome biogenesis
C47E12.7 WBGene00008151 ‐‐‐ + ‐‐‐ ‐‐‐ ribosomal RNA processing protein 1 homolog
signaling
kin‐20 WBGene00002203 + ++ ++ ++ protein kinase
lag‐2 WBGene00002246 + + + ++ notch ligand
lin‐3 WBGene00002992 + + + +++ EGF ligand
other
lin‐41 WBGene00003026 +++ +++ +++ +++ RBCC/NHL domain protein
F58H10.1 WBGene00010291 ++ +++ ++ +++
let‐70 WBGene00002344 + ++ + ++ class I E2 ubiquitin conjugating enzyme
aff‐1 WBGene00016625 + + + ++ cell fusion
adsl‐1 WBGene00011064 +  ++ ‐‐‐ + ADenyloSuccinate Lyase homologue
aco‐2 WBGene00000041 + ++ ‐‐‐ ++ aconitase
ppfr‐1 WBGene00008878 ‐‐‐ ‐‐‐ +++ +++ protein phosphatase subunit
cey‐1 WBGene00000472 ‐‐‐ ‐‐‐ +++ +++ Y‐box protein, DNA binding?
mig‐38 WBGene00009587 ++ ++ ‐‐‐ ‐‐‐ DTC migration
pde‐4 WBGene00020114 ‐‐‐ ‐‐‐ + +++ cAMP phosphodiesterase
C33D9.3 WBGene00007898 burst burst + +++
cdl‐1 WBGene00000411 ‐‐‐ + ‐‐‐ +++ histone mRNA binding
haf‐9 WBGene00001819 ‐‐‐ ‐‐‐ ‐‐‐ ++ HAlF transporter (PGP related)
dut‐1 WBGene00010609 ‐‐‐ ‐‐‐ ‐‐‐ ++ deoxyUTPase
C23G10.8 WBGene00016015 ‐‐‐ + + +
F55C12.1 WBGene00018869 ‐‐‐ ‐‐‐ + +
byn‐1 WBGene00000276 ‐‐‐ ‐‐‐ ‐‐‐ +
metr‐1 WBGene00010988 ‐‐‐ burst ‐‐‐ + methionine synthase
ZK1127.5 WBGene00022852 ‐‐‐ ‐‐‐ ‐‐‐ + RNA 3'‐terminal phosphate cyclase?
toe‐1 WBGene00022739 ‐‐‐ ‐‐‐ ‐‐‐ +
pab‐1 WBGene00003902 ‐‐‐ ‐‐‐ ‐‐‐ + cytoplasmic PolyA binding protein
F44G4.1 WBGene00009711 ‐‐‐ ‐‐‐ ‐‐‐ +
T06E6.1 WBGene00011538 ‐‐‐ ‐‐‐ ‐‐‐ +
C01F1.3 WBGene00015298 ‐‐‐ ‐‐‐ ‐‐‐ +
C16A3.4 WBGene00015809 ‐‐‐ + ‐‐‐ ‐‐‐
Remarks and open questions 
 
We decided to perform this screen for novel let-7 pathway members on a genome-wide scale because we 
reasoned that this would, in contrast to a  candidate screen, allow to identify important genes that had 
not yet been suggested to be involved in the regulation of let-7 or its downstream targets. While survival 
as opposed to bursting is a rather obvious phenotype, which allowed us to determine the initial list of 
suppressors with high confidence, it became more challenging to analyze these for specificity with 
microscopy-based in vivo assays. Since we were faced with a list of 200 candidates, we chose to analyze 
these in reporter assays in a semi-quantitative manner, ensuring a degree of reliance through 
independent analysis by two different people. However, we know that the lack of an additional RFP-
coupled unregulated 3’UTR reporter as an internal normalization control may have resulted in false 
positive hits for the target reporter for let-7 activity, where most suppressors scoring positive had modest 
effects. We tried to circumvent this by testing the positive candidates on a reporter with an unregulated 
3’UTR (pREP_unc-54) to identify factors that affect GFP accumulation in the nucleus independently of let-
7. However, the wrt-2 promoter that was used to drive expression of the reporters was later found to be 
subject to a strong cyclic expression (Hendriks et al. 2014), and slight developmental delays caused by 
RNAi might result in differences in GFP levels. We can therefore not exclude that the list of genes 
modulating let-7 function still contains false positive hits. 
 
Table 1 Effects of suppressor RNAi on endogenous let-7 target levels. 
Shown are top hits for repression of daf-12 (yellow) and lin-41 (red). Note that two individual clones scored positive for plk-1, 
one of which affected both lin-41 and daf-12. Experiments were performed in duplicates unless SEM indicated as “n.d.”. 
SEM=standard error of the mean. 
Nonetheless, the target reporter assay identified a number of interesting candidates. I decided to proceed 
by testing the effect of the positive candidates on expression levels of the let-7 targets lin-41 and daf-12, 
48 
 
which should ideally mirror the let-7 dependent downregulation of the reporter. To my surprise, only few 
of the tested suppressors showed a significant effect on repression of endogenous lin-41 or daf-12 upon 
knockdown. Hence, it remains to be determined whether this signals a tissue-specific effect of the 
involved suppressors, or whether they constitute false positive hits. If the suppressors affect let-7 activity 
and thereby lin-41 levels only in the hypodermis or with moderate impact, the effects of RNAi might be 
masked by lin-41 expression in the germline, which is strongly activated during the L4 stage (Tocchini et 
al. 2014). At any rate, those suppressors that affect endogenous let-7 target levels still contain interesting 
candidates, including known heterochronic factors as well as novel candidates such as genes involved in 
cell cycle regulation (Table 1). Unfortunately, I could not detect effects on mature let-7 levels for any of 
the candidates by northern blot. Therefore, it remains to be determined how these genes affect the ability 
of let-7 to repress its targets.  
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Project 2: The role of let-7 in C. elegans vulva development 
 
Motivation and contributions 
 
Our genome-wide RNAi screen for let-7 suppressors identified a surprisingly large number of genes that 
were able to suppress the let-7 bursting phenotype. This notion lead us to an important question: Since 
its discovery, the classical model for let-7 function has been the hypodermis of C. elegans. However, while 
developmental phenotypes and molecular mediators are well characterized in this tissue, a satisfactory 
explanation for the lethal bursting phenotype has been missing. Therefore we decided to ask whether let-
7 was playing an additional role in the vulva that was independent from its function in the hypodermis. 
As a first step, I started to clone a construct for expression of full-length pri-let-7, as well as a number of 
ubiquitous and tissue-specific promoters that allowed to express let-7 in different subsets of cells. These 
constructs were then used for tissue-specific rescue of the let-7 null mutant by Matyas Ecsedi. When these 
initial experiments suggested a role for let-7 in the vulva, he continued to analyze let-7 function in this 
tissue in detail, both by studying vulva morphogenesis in let-7 mutants as well as by developing a 
quantitative target reporter system to identify the relevant let-7 target in this tissue.  With this approach, 
he was able to propose lin-41 as the crucial let-7 target in the vulva. I subsequently confirmed this 
hypothesis both by phenotypic analysis as well as at the molecular level when I characterized the lin-41 
strains mutant for let-7 binding that were generated through CRISPR/Cas9-mediated genome-editing by 
Matyas Ecsedi and Iskra Katic. 
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The let-7 microRNA (miRNA) regulates stemness in
animals ranging from worms to humans. However,
the cause of the dramatic vulval rupturing phenotype
of let-7 mutant C. elegans has remained unknown.
Consistent with the notion that miRNAs function by
coordinately tuning the expression of many targets,
bursting may result from joint dysregulation of
several targets, possibly in the epidermis. Alterna-
tively, overexpression of LET-60/RAS, a key vulva
development gene and a phylogenetically conserved
target of let-7, may be responsible. Here, we show
that let-7 functions in the vulval-uterine system to
ensure vulval integrity but that regulation of most tar-
gets of let-7, including LET-60/RAS, is dispensable.
Using CRISPR-Cas9 to edit endogenous let-7 target
sites, we found that regulation of LIN-41/TRIM71
alone is necessary and sufficient to prevent vulval
rupturing. Hence, let-7 does not function to reduce
gene expression noise broadly, but to direct vulval
development through extensive regulation of a sin-
gle, defined target.
INTRODUCTION
The lethal-7 (let-7) microRNA (miRNA) is essential for viability in
C. elegans, with let-7mutant hermaphrodites dying by exploding
through the vulva (Reinhart et al., 2000; Slack et al., 2000). Mod-
ulation of this phenotype has been used extensively and produc-
tively to identify and validate let-7 targets, temporal patterning
genes, as well as more general miRNA pathway factors (e.g.,
Andachi, 2008; Banerjee et al., 2010; Ding et al., 2008; Großhans
et al., 2005; Hunter et al., 2013; Johnson et al., 2005; Lin et al.,
2003; Parry et al., 2007; Slack et al., 2000). However, its basis
has remained obscure.
Strikingly, individual depletion of several of the known targets
of let-7 suffices to prevent vulval bursting and restore viability
(Andachi, 2008; Großhans et al., 2005; Hunter et al., 2013; John-
son et al., 2005; Slack et al., 2000). As miRNAs might primarily
function to counter gene expression noise (Bartel, 2009; Ebert
and Sharp, 2012), ensuring optimal expression levels of some
genes and promoting complete repression, to inconsequentialDevelopactivity, of other genes, vulval rupturing thus might be a conse-
quence of joint dysregulation of several targets.
Not only the identity and number of targets that let-7 needs to
regulate to ensure vulval integrity, but also let-7’s general biolog-
ical function in this process remain unclear. Thus, although let-7
miRNA functions as an ancient and fundamental regulator of
stemness in animals (Bu¨ssing et al., 2008), it is not known
whether and how this accounts for vulval bursting. Specifically,
C. elegans let-7 promotes differentiation and blocks proliferation
of the epidermal seam cells at the transition from fourth larval (L4)
to the adult stage (Reinhart et al., 2000; Slack et al., 2000). It does
so, at least in part, by regulation of the TRIM-NHL (tripartite
motif-NCL-1, HT2A2, and LIN-41 domain) protein LIN-41/
TRIM71, itself a key regulator of pluripotency and proliferation
(reviewed in Ecsedi and Großhans, 2013). Genetic interactions
further suggest that let-7 functions through the transcription fac-
tor LIN-29, which may itself be a direct target of LIN-41 (Slack
et al., 2000). As loss of lin-29 expression in seam cells causes
vulval rupturing (Bettinger et al., 1997), possibly by impairing
attachment of the vulva to the seam, vulval rupturing of let-7
mutant animals may similarly result from let-7 dysfunction in
the seam, rather than the vulva (Roush and Slack, 2008).
On the other hand, known targets of let-7 include a key vulval
development gene, let-60/ras (Großhans et al., 2005; Johnson
et al., 2005), which is required for specification of vulval precur-
sor cell (VPC) fates (Beitel et al., 1990; Han et al., 1990; Han and
Sternberg, 1990). Conservation of RAS regulation by let-7 in
mammals (Johnson et al., 2005) implies a particularly important
function of this small GTPase as a let-7 target, possibly in the
vulva. However, regulation has thus far only been demonstrated
in seam cells (Johnson et al., 2005), and its physiological rele-
vance is unknown for any tissue.
Here, we report that let-7 activity in the seam alone does not
suffice to ensure vulval integrity, and that let-7 is needed in the
vulval-uterine system to prevent vulval bursting. Nonetheless,
VPC fates are specified correctly in the absence of let-7, and
vulval integrity depends neither on regulation of LET-60/RAS
nor broad repression of gene expression noise. Instead, it re-
quires regulation of one let-7 target alone, LIN-41, with uncou-
pling of all other targets from let-7 being inconsequential for
viability. Moreover, although both LIN-41/TRIM71 and let-7 are
known regulators of self-renewal, vulval bursting appears to be
a consequence of morphogenesis, not cell proliferation defects.
Our results demonstrate that genome-editing approaches can
be utilized for direct and unequivocal target validation, reveal
that regulation of a single target suffices to explain a majormental Cell 32, 335–344, February 9, 2015 ª2015 Elsevier Inc. 335
biological function of amiRNA, and indicate that let-7 and LIN-41
may function as a versatile regulatory module that can be inte-
grated into distinct functional pathways.
RESULTS
Quantitative Imaging Reveals Repression of let-60 by
let-7 in the L4 Stage
To obtain insight into potential let-7 functions in the vulva, we
sought to test if and to what extent let-60 was regulated by let-
7. To this end, we made use of a quantitative two-color fluores-
cent reporter system (Figure 1A) that we recently established and
that will be described in more detail elsewhere (M.E. and H.G.,
unpublished data). Briefly, a ubiquitously and constitutively
active dpy-30 promoter drives expression of a destabilized
nuclear GFP (GFP/PEST/H2B, green). The transgene further
contains either the unregulated unc-54 30UTR (yielding the
gfp_unc-54 reporter) or the let-60 30UTR (gfp_let-60). Integration
of the transgenes in a defined genomic locus (Frøkjær-Jensen
et al., 2008) and in single copy permits standardized and physi-
ological transgene expression levels, which we surveyed in
different tissues through confocal imaging. Finally, a second
transgene, similarly integrated in the genome in single copy but
in a distinct location, uses the same dpy-30 promoter and an un-
regulated artificial 30 UTR to express mCherry/H2B (red), permit-
ting identification and digital segmentation of distinct cells as
well as correction for biases arising in the imaging process.
The let-60 30UTRwas previously shown to confer let-7-depen-
dent repression on a lacZ reporter in the epidermal seam cells
(Johnson et al., 2005), andwe confirmed repression of gfp_let-60
in this tissue (Figure 1B, arrow) as well as an additional epidermal
compartment, the large syncytial hyp7 cell (Figure 1B, arrow-
head). In both cell types, repression depended on both let-7
and the 30UTR, i.e., it was relieved by the let-7(n2853) loss-of-
function mutation or substitution of the let-60 30UTR through
the unc-54 30UTR (Figure 1B). To quantify the extent of silencing,
we computed repression of the gfp_let-60 reporter relative to the
gfp_unc-54 reporter at the L4 stage (Experimental Procedures).
The results of this analysis confirmed let-7-dependent repres-
sion of gfp_let-60 in the epidermis (Figure 1C). By contrast,
let-7 repressed gfp_let-60 very modestly in the vulva (Figures
1B and 1C).
The extent of regulation of an mRNA may not be a good pre-
dictor of its relevance as an miRNA target if a gene is expressed
at levels very close to its activity threshold (Bartel, 2009). How-
ever, as detailed below, LET-60 functions in the vulva to specify
VPC fates during the L3 stage (Sternberg, 2005), and repression
of gfp_let-60 was undetectable prior to the L4 stage in both
the vulva and the epidermis (Figure 1C). The timing of repression
is consistent with accumulation of bulk let-7 during the L4
stage, and suggests that the dynamics of let-7 accumulation in
whole worm RNA are also representative of let-7 accumulation
in the vulva. However, it argues against a role of let-7-mediated
repression of let-60 in VPC specification, which occurs during
the L3 stage.
let-7 Is Dispensable for VPC Specification by LET-60
Despite the use of a short-lived reporter fluorophore (Frand et al.,
2005), it remained formally possible that the kinetics of repres-336 Developmental Cell 32, 335–344, February 9, 2015 ª2015 Elsevision of endogenous let-60 differed from those revealed by
the target reporter. Therefore, we examined VPC specification
directly. In this process (reviewed in Sternberg, 2005), epidermal
growth factor signaling from the anchor cell specifies the primary
(1) fate in its closest epidermal neighbor, P6.p, by activating
LET-60 signaling. This cell then expresses an inhibitory lateral
Notch signal, which suppresses LET-60 activity in the adjacent
P5.p and P7.p VPCs so that these adopt the 2 fate. Conversely,
elevated LET-60 activity results in ectopic induction of the 1 cell
fate in P5.p and P7.p, which can be visualized through expres-
sion of the 1 cell fate marker egl-17::cfp (Inoue et al., 2002).
Consistent with unaltered let-60 expression in the L3 stage,
let-7 mutant animals do not exhibit any ectopic induction of the
1 cell fate in the descendants of P5.p and P7.p (Figure 1D).
Indeed, these cells express a 2 cell fate reporter, lin-11::gfp
(Gupta and Sternberg, 2002), at the same time and in the same
pattern as wild-type animals, confirming their proper specifica-
tion (Figure 1E). These results are reflected by proper formation
of a morphologically normal vulva observed in the L4 stage (see
below) and lack of vulvaless and multivulva phenotypes in let-7
mutant animals (n > 250). Moreover, as we show below, uncou-
pling of let-60 from let-7-mediated silencing fails to invoke vulva
bursting. In sum, although the let-60 30UTR confers some repres-
sion by let-7 at the L4 stage, particularly in the epidermis, let-7
and its regulation of let-60 are dispensable for early VPC fate
specification.
Loss of let-7 Activity Leads to Vulva Morphogenesis
Defects
Since VPC specification appeared unaffected in let-7mutant an-
imals, we examined subsequent stages of vulva development
and found the vulva of let-7(n2853) worms to be morphologically
normal until the late L4 stage (Figures 2A–2C; Movie S1 available
online). Specifically, the vulva includes the normal number of 22
cells forming seven ring-like structures (toroids), and the anchor
cell invades the vulva as in wild-type, forming an utse (uterine-
seam) cell with a thin cytoplasm over the vulva lumen (n > 250;
Figure 2A, arrow). Vulval eversion is also executed properly, re-
sulting in a closed, compacted vulva at the transition to adult-
hood. However, at a variable time point in the young-adult stage,
just before bursting, the middle portion of the vulva starts pro-
truding from the plane of the worm and an empty space between
the vulva, uterus, and intestinal tube is created (Figure 2D). Sub-
sequently, the intestine herniates through the vulva leading to the
death of the animals (Movie S1).
Notably, there is neither loss of vulva toroids nor herniation
between the vulva and the epidermis. Instead, the let-7 mutant
animals burst through the lumen of an apparently normal vulva.
This suggests that the connection between the ventralmost
vulva toroid, vulA, and the epidermis is unaffected, and AJM/
mCherry, a marker of cell-cell contacts, does in fact accumulate
strongly at the site between vulA and hyp7 (Figures 2B and 2C,
arrowhead). We also clearly observed a connection between the
dorsalmost toroid, vulF, and utse (Figures 2B and 2C, arrow).
Finally, the utse cell has a wild-type morphology (Figure 2A).
With much of vulva development in let-7 mutant animals thus
occurring normally, bursting appears to be a consequence of
subtle defects in morphogenesis rather than gross develop-
mental aberrations.er Inc.
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Figure 1. let-7 and Its Regulation of let-60 Are Dispensable for VPC Specification
(A) Schematic depiction of a dual-color miRNA target reporter system. Chr II and chr IV indicate the respective chromosomes into which the transgenes were
integrated.
(B and C) Reporter assays reveal that the let-60 30UTR confers let-7-dependent repression mostly in the epidermis (arrowhead, hyp7; arrow, seam cell; encircled,
vulval cells) and from L4 stage on. The unregulated unc-54 30UTR does not confer repression. Error bars (C), SEM.
(DandE)Expressionof the1 and2 fate reporteregl-17and lin-11, respectively, isunaffected in let-7mutant animals.Fractionofanimalswithexpression is indicated.
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Figure 2. Loss of let-7 Leads to Vulva Morphogenesis Defects at the Young-Adult Stage
(A) Differential interference contrast images of the developing vulva at the L4 stage show no evident abnormalities in let-7 mutant worms. Arrows, utse cell
process.
(B and C) Vulval toroids and the vulval-uterine connection are formed properly in let-7(n2853) animals. Arrowheads point to the vulA-hyp7 and arrows point to the
vulF-utse connection, respectively, as (B) highlighted by AJM-1/mCherry accumulation and (C) shown in a schematic representation of an L4 stage vulva. In (C),
relevant vulval toroids and nonvulval cells are indicated. For simplicity, toroids are shown as continuous rings, although they typically consist of unfused cells at
this stage.
(D) Characteristic vulva defects of let-7(n2853) and lin-41(xe8) worms at the young-adult stage immediately before bursting. See Figure 4 for details on lin-41(xe8).
WT, wild-type N2.
See also Movie S1.In the seam cells, the LIN-29 transcription factor is an impor-
tant, albeit indirect effector of let-7, which is regulated, directly
or indirectly, by the let-7 target LIN-41 (Slack et al., 2000). How-
ever, although lin-29 is expressed in the vulva, let-7 mutant
worms do not exhibit the uterine and anchor cell defects charac-
teristic for lin-29mutants. Thus, the anchor cell invades normally
and fuses to form a wild-type utse in let-7 (Figure 2A), but not lin-
29mutant (Newman et al., 2000) worms. Additionally, the uterine
p-cell fate is specified in let-7mutant worms just as in wild-type,
as assessed by a lin-11::gfp reporter (data not shown). More-
over, and in contrast to the reported effect of lin-29 loss on
gene expression in the L4 vulva (Inoue et al., 2005), we could
not detect any abnormality in the vulval expression of the lin-
11::gfp or egl-17::cfp reporters at the L4 or young-adult stage
in let-7(n2853) worms (data not shown). We conclude that the
vulva defects caused by loss of let-7 and lin-29 are fundamen-
tally different, suggesting that LIN-29 is not the key effector of
let-7 in the vulva.338 Developmental Cell 32, 335–344, February 9, 2015 ª2015 Elsevilet-7 Activity beyond the Epidermis Is Required to
Prevent Vulval Bursting
Although we found the putative let-7 promoter to be active in the
vulva (Figure S1A), as previously reported by others (Esquela-
Kerscher et al., 2005; Kai et al., 2013), the extensive posttran-
scriptional regulation known to act on miRNAs generally and
let-7 specifically (Krol et al., 2010) left open the possibility that
there were only small amounts of active let-7 in the vulva. This
would explain both the modest repression of gfp_let-60 in the
vulva and the incongruence of let-7 and lin-29mutant vulva phe-
notypes. Hence, to test whether let-7 function was entirely
dispensable in the vulva, we sought to uncouple vulval and
epidermal functions by expressing let-7 from heterologous pro-
moters in a tissue-specific manner (Figure S1). As a control,
ubiquitous and constitutive expression of pri-let-7 from the
tbb-1 promoter restored epidermal differentiation, assayed by
formation of cuticular alae, and prevented bursting of let-
7(mn112)-null mutants (Figure S1). By contrast, expression ofer Inc.
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Figure 3. let-7 Mediates Extensive Repression of lin-41 in the Vulva
(A–C) A reporter system analogous to Figure 1A, but using a lin-41 30UTR, reveals extensive let-7 activity in the vulva; lin-41DLCS denotes a variant lacking the two
functional let-7 complementary sites in the lin-41 30UTR. In (A and B), vulval cells are encircled, arrows mark seam cells, and asterisks mark intestinal cells. Error
bars (C), SEM. Data for the control unc-54 reporter from Figure 1C is included for reference.
(D) let-7 is active in all vulval and the uterine uv3 cells at the late L4 stage. Error bars, SEM.
See also Figure S1.let-7 from the epidermis-specific elt-3 promoter restored
epidermal differentiation, but failed to suppress the bursting
phenotype (Figure S1). Hence, let-7 activity in other tissues,
either in addition or alternatively to the epidermis, is needed to
prevent vulva bursting.
We were unable to find a promoter that drove let-7 expression
exclusively in the vulva (data not shown), either as a conse-
quence of the shared developmental history of epidermis and
vulva, or due to an epidermal enhancer element in the pri-let-7
(Kai et al., 2013). This precluded direct demonstration that let-7
activity in the vulva sufficed to prevent bursting. However,
let-7 expression in only the seam, uterus, and vulva from the
his-2 promoter restored both epidermal differentiation and vulva
function (Figure S1). Hence, we conclude that epidermal differ-
entiation defects are not, or not solely, responsible for vulva
rupturing, and that let-7 activity in the uterus and/or the vulva
is required for vulval integrity.Developlet-7 Is Highly Active against lin-41 in the Vulva
The above results suggested that let-7 was functional in the
vulva but argued against LET-60 as a relevant target. Hence,
we sought to establish other targets. We focused on LIN-41
because of its important developmental functions and the fact
that its regulation by let-7 is highly conserved among animals.
As expected, a gfp_lin-41 reporter was extensively (R4-fold)
silenced in the epidermis at the late L4 stage (Figures 3A and
3C). Deletion of the two functional let-7 complementary sites
(LCSs) (Vella et al., 2004) abolished this regulation (gfp_lin-
41DLCS, Figures 3A and 3C). Extensive silencing of gfp_lin-41
also occurred in the vulva, and was again relieved for the
gfp_lin-41DLCS reporter (Figures 3B and 3C). The let-7(n2853)
mutation similarly desilenced gfp_lin-41. Finally, and consistent
with let-7 promoter activity, we found let-7-mediated repression
of lin-41 to occur in all vulval cells, as well as the uterine uv3 cell
(Figure 3D). We conclude that let-7 displays robust activity in themental Cell 32, 335–344, February 9, 2015 ª2015 Elsevier Inc. 339
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Figure 4. lin-41 Is the Key let-7 Target
(A and B) 30UTRmutant lin-41 alleles created by genome editing. (B) illustrates how gene conversion in LCS2 restores complementarity to the let-7(n2853) mutant
miRNA. Note that xe11 carries the corresponding double mutation in LCS1 and LCS2, restoring activity of let-7(n2853) to both sites; for simplicity, only LCS2 is
shown.
(C) The let-7(n2853ts) animals are viable but egg-laying defective (Egl), causing internal hatching of progeny (Bag) when reared at 15C; lin-41(xe11) seed-match
point mutations cause similar Egl and Bag phenotypes at all temperatures tested. Inactivation of let-7 by growth of let-7(n2853ts) at 25C leads to vulva bursting,
(legend continued on next page)
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Figure 5. Schematic Depiction of the Effects of let-7
and lin-41 Alleles on let-7 Target Expression and
Phenotypes
Spheres represent individual targets with larger sphere size
and darker shades of gray symbolizing higher expression
levels. The number of actual or predicted let-7 targets may
differ and, for clarity, only LIN-41 and LET-60 are labeled. See
main text for details.vulva. Repression in this organ is likely to reflect physiological
regulation of lin-41, because the lin-41 promoter is active in the
vulva (Slack et al., 2000) and yields GFP accumulation levels
comparable to that achieved with the dpy-30 promoter that we
used to express reporter genes (data not shown).
Dysregulation of lin-41 Is Necessary and Sufficient for
let-7Mutant Phenotypes
To test to what extent dysregulation of lin-41 contributed to
let-7 mutant phenotypes, we sought to uncouple lin-41 from
let-7 regulation. We used targeted genome modification by
CRISPR-Cas9 to modify the endogenous lin-41 30UTR
(Figure 4A). Strikingly, a partial 30UTR deletion, lin-41(xe8
[DI:9,335,206:9,335,654]), which eliminated a sequence stretch
of450 nt from the lin-41 30UTR that includes the two LCSs, suf-
ficed to phenocopy loss of let-7, causing penetrant vulva
bursting (Figure 4C, i–iv). By contrast, expression of a functional
let-60 transgene, which contained the unregulated unc-54as does loss of LCSs in the lin-41 30UTR (lin-41(xe8)). The lin-41(xe11) point mutations suppress b
gravid animals continue to exhibit Egl and Bag phenotypes. Wild-type (WT) N2 animals are shown
bar, 50 mm.
(D and E) Egl and bursting phenotypes were scored for the indicated mutant animals at the indicate
mutant animals are dead by 50 h and thus fail to develop an Egl phenotype. Egl phenotypes develop
(F) Quantification by quantitative real-time PCR confirms reduced lin-41 levels in lin-41(xe11);let-7(
Shown are the fold changes of the indicated mRNAs in the indicated mutant relative to wild-type
Developmental Cell 32,30UTR in place of the let-60 30UTR, failed to invoke
bursting even in the presence of the two endoge-
nous, wild-type let-60 alleles (n = 100).
To dissect further the relevance of lin-41 regula-
tion by let-7, we made more specific mutations,
introducing one C-to-U point mutation in each of
the endogenous LCS1 and LCS2. Althoughmerely
replacing a canonical Watson-Crick base pair in
the miRNA:target duplex with a G-U wobble (Fig-
ure 4B), this not only caused a partial derepression
of lin-41 (Figure 4F), but also sufficed to pheno-
copy hypomorphic let-7 mutations: Similarly to
let-7(n2853ts) animals reared at lower tempera-
tures that are permissible for viability, lin-41(xe11
[I:C9,335,211T, I:C9,335,260T]) displayed egg-
laying defects (Egl) and subsequent internal hatch-
ing of progeny (bag of worms, Bag) (Figure 4C, v
and vi). Vulval dysfunction was highly penetrant
with >95% of lin-41(xe11) mutant animals exhibit-
ing the Egl phenotype (n > 100, Figure 4D).
We introduced these specific mutations into the
lin-41(xe11) strain, because they are compensa-
tory to the G-to-A change in the seed of thelet-7(n2853) mutant miRNA (Figure 4B). This permitted us to
engineer a situation where all let-7 targets except for lin-41
were dysregulated by generating lin-41(xe11);let-7(n2853) dou-
ble-mutant animals (Figure 5). Strikingly, whereas 99% of let-
7(n2853) single-mutant animals succumbed to vulval bursting
at 25C, 0% of lin-41(xe11);let-7(n2853) animals did (Figure 4C,
iii and vii; Figure 4E, n = 96 each). Thus, restored regulation of
this single target is fully sufficient to suppress let-7 mutant
lethality (Figure 5).
Quantitative real-time PCR confirmed that lin-41mRNA levels
are reduced in lin-41(xe11);let-7(n2853) double-mutant relative
to let-7(n2853) single-mutant animals (Figure 4F). By contrast,
the levels of daf-12, hbl-1, and let-60 were comparable between
the single- and double-mutant animals (Figure 4F). However,
consistent with the fact that older lin-41(xe11);let-7(n2853) ani-
mals develop the Egl phenotype characteristic of lin-41(xe11)
single-mutant animals (Figure 4C,viii; Figure 4D), lin-41 mRNA
levels were not completely restored to wild-type levelsursting when present in let-7(n2853) animals at 25C. Older,
for comparison. Arrows, embryos; arrowheads, vulvae. Scale
d time of growth after hatching at 25C. Note that let-7(2853)
progressively as egg production only starts at the adult stage.
n2853) double- relative to let-7(n2853) single-mutant animals.
N2 strains in late L4-stage animals (n = 3; error bars, SEM).
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(Figure 4F), presumably because let-7miRNA levels are reduced
in the let-7(2853) mutant relative to wild-type worms (Chatterjee
and Großhans, 2009; Reinhart et al., 2000), and/or because the
thermodynamically less favorable A-U base pair may not fully
substitute for the original G-C base pair.
Taken together, these data reveal that lin-41(xe11) phenotypes
are due to uncoupling from regulation by let-7, and demonstrate
that lin-41 is the key target of let-7 in the vulva.
DISCUSSION
Although vulval bursting is the most prominent phenotype that
let-7 mutant worms exhibit, its basis has remained unknown.
Here, we have tested and refuted two possible models, namely
that vulval bursting is simply a consequence of let-7 dysfunction
in the epidermis or that it is a result of defects in VPC fate deter-
mination due to dysregulation of LET-60. Instead, we find that
vulval integrity requires let-7 activity in the vulval-uterine system
and regulation of LIN-41, but not LET-60. Indeed, LIN-41 is the
single key target for let-7 in this process, with regulation of all
other targets being dispensable (Figure 5).
A detailed understanding of how LIN-41 promotes vulval
integrity may require further insight into the process of vulval
morphogenesis itself, which is currently not well understood.
However, we note that, intriguingly, the fly LIN-41 homolog
dappled/wech has been shown to mediate muscle attachment
to the body wall by linking integrins and the cytoskeleton (Lo¨er
et al., 2008). Thus, it will be interesting to determine in future
research whether LIN-41 directs vulval integrity by contributing
directly to structural integrity of the vulva, or whether its preferred
mode of action involves posttranscriptional and/or posttransla-
tional regulation of specific target genes (Ecsedi and Großhans,
2013). Indeed, one may speculate that it is the diverse molecular
activities of LIN-41 that provide the versatility of the let-7/LIN-41
regulatory module, which regulates tissue integrity in the
vulva (this study), but self-renewal and differentiation in the
C. elegans epidermis as well as many other contexts (Ecsedi
and Großhans, 2013; Bu¨ssing et al., 2008).
It remains well possible that targets distinct from LIN-41 could
mediate other functions of let-7, be it in other tissues or when
examining animals grown in more challenging environments.
Nonetheless, that regulation of LIN-41 alone is central to let-
7’s function in vulva development surprised us. It contrasts not
only with the general notion that miRNAs typically function by
coordinately regulating a large number of targets in a given
cell (Bartel, 2009; Ebert and Sharp, 2012), but, more specifically,
also with the fact that depletion of numerous other target genes
can suppress vulval bursting of let-7 mutants (Andachi, 2008;
Großhans et al., 2005; Hunter et al., 2013; Johnson et al., 2005).
An explanation of why depletion of these let-7-regulated
genes prevents vulval bursting is currently elusive. In one sce-
nario, let-7 targetsmight be part of a complex regulatory network
where targets regulate one another in a coherent manner. Thus,
depletion or overexpression of any one target would cause
codepletion and co-overexpression, respectively, of all other
targets. However, we found that the expression of a let-60 trans-
gene uncoupled from let-7 regulation fails to yield vulval bursting.
This was true even when present in addition to the two endoge-
nous let-60 alleles, leading to a >2-fold increase in let-60 mRNA342 Developmental Cell 32, 335–344, February 9, 2015 ª2015 Elsevilevels. Hence, we can rule out let-60 as part of such a network.
Moreover, the reduction of lin-41 mRNA levels in the lin-
41(xe11);let-7(n2853) double-mutant relative to the let-7(n2853)
single-mutant animals did not lead to a codepletion of hbl-1,
daf-12, or let-60 mRNAs. Similarly, none of these mRNAs were
increased in the lin-41(xe11) mutant relative to wild-type animals,
despite an increase in lin-41mRNA levels. Indeed, further testing
revealed that depletion of let-60 and hbl-1 mRNA by RNAi also
failed to invoke a codepletion of lin-41mRNA (M.R. andH.G., un-
published data). Only in the case of daf-12(RNAi) did we see a
decrease of lin-41mRNA levels, albeit to a highly variable degree
(5%–87% decrease relative to a mock RNAi control; M.R. and
H.G., unpublished data). Hence, although the formal possibility
remains that some let-7 targets cross-regulate one another in a
coherent manner, we can exclude this as a general principle. In
particular, there is no evidence for lin-41 regulating any of the
other targets.
Whereas complex cross-regulation among let-7 targets thus
appears unlikely, we note that the previous experiments that
showed suppression of vulval bursting involved depletion of
candidate target genes by RNAi or constitutive inactivation
throughout development, almost inevitably resulting in different
kinetics and/or extents of target silencing relative to the physio-
logical regulation by let-7. This might put the affected cells and
tissues on a different developmental trajectory, a concern that
seems particularly relevant for genes such as lin-14, lin-28, or
daf-12 that are known to specify temporal cell fates.
Irrespective of the mechanisms by which knockdown of
additional let-7-regulated genes prevents vulval bursting, our
findings clearly illustrate the pitfalls of functional miRNA target
validation through circumstantial evidence, and highlight the
utility of genome editing to obtain more direct evidence for a
physiologically relevant interaction. Indeed, by combining this
approach with genetic interaction studies as we have done
here, it becomes feasible to dissect the extent to which individual
targets contribute to particular functions of a specific miRNA.
This will then not only provide insight into the biological functions
of miRNAs and their targets, but it may also facilitate the devel-
opment of targeted therapeutic approaches through modulation
of miRNA activity.EXPERIMENTAL PROCEDURES
Worm Handling and Strains
Worms were grown using standard methods, and experiments were per-
formed at 25C unless indicated otherwise. The genotypes of the strains inves-
tigated are listed in the Supplemental Experimental Procedures.
miRNA Target Reporters
Reporter constructs were generated as described in the Supplemental Exper-
imental Procedures and integrated in single copy in defined genomic locations
via MosSCI (Frøkjær-Jensen et al., 2008, 2012). Integrant worms were out-
crossed at least three times. To examine transgene expression, z stacks of
0.4 mm thickness were acquired in green, red, and transmitted light channels
at 403 magnification (633 for analysis of different vulva cells) on a Zeiss
LSM 700 confocal microscope coupled to Zeiss Zen 2010 software equipped
with a multiposition tile scan macro (Life Imaging Centre). The z stacks were
stitched together and compiled into a single image using XUVtools software
(Emmenlauer et al., 2009). Worms were staged based on gonad length and
vulva morphology. Cells of interest were selected in the red channel in the
cell counter macro in Image Fiji. Images were segmented around these seeder Inc.
points using a k-means segmentation algorithm in MATLAB (MathWorks).
Signal intensity in the green channel was divided by the red signal intensity
for each cell, and relative signal intensities were averaged for each tissue in
each worm. Finally, the mean signal intensity per group of worms (or group
of cells) and the corresponding SEM were calculated. To quantify regulation
of target reporters in different tissues (Figures 1C and 3C), at least 20 worms
per condition (genotype, stage) were analyzed; to quantify target reporters in
different vulva cell types (Figure 3D), 30 worms per condition were analyzed.
AJM-1/mCherry Imaging and 3D Reconstruction
AJM-1/mCherry worms in wild-type and let-7(n2853) animals were imaged on
a Zeiss LSM 700 confocal microscope at 633 magnification in red and trans-
mitted light channels; z stacks of 0.4 mm thickness were acquired. Maximum
intensity projections were generated using Bitplane Imaris and MATLAB
software.
Time-Lapse Imaging
Worms were immobilized on a 3% agarose pad in 10 mM levamisole. Images
were acquired on a Zeiss Z1 microscope with a motorized stage and coupled
to ZEN blue software. Pictures were taken every 2 min in several focal planes.
Pictures taken at different time points were compiled together in a movie using
Image Fiji software.
Tissue-Specific let-7 Rescue
Plasmids with a tissue-specific promoter, let-7 rescue fragment (X chromo-
some: 14743506-14744528) and operon linker_gfp-h2b (Merritt et al., 2008)
were recombined in a MosSCI-compatible Gateway destination vector and
integrated into the C. elegans genome in position ttTi5605 as a single copy
(Frøkjær-Jensen et al., 2008). Following backcrossing, the worm lines
obtained were crossed into the let(mn112)-null mutant balanced with an extra-
chromosomal let-7 rescue array, and the progeny without the array was used
for experiments. See also Figure S1B.
Targeted Genome Editing using Cas9-CRISPR
Worms were injected with an injection mix containing 200 ng/ml pIK82 [peft-
3::Cas9::2xNLS::tbb-2], a derivative of pIK86 (Katic and Großhans, 2013);
200 ng/ml pU6::lin-41sgRNA, a derivative of pU6::unc-119sgRNA (Friedland
et al., 2013); 100 ng/ml lin-41 30UTR repair template (pENTR_R2-L3_lin-
41(n2853) 30UTR); and 5 ng/ml pCFJ104 (pmyo-2::mCherryM) (Frøkjær-Jensen
et al., 2008) as a coinjection marker. Single F1 worms carrying the coinjection
marker were picked to individual plates. In the progeny, potential mutants were
identified by vulva phenotypes, analyzed by DNA sequencing, and, upon loss
of the coinjection marker, backcrossed three times.
let-60::unc-5430UTR
To uncouple let-60 from regulation by let-7, we created a transgene, in which
the let-60 30UTR was replaced with that of unc-54, and integrated it in single
copy in chromosome (chr) II (Frøkjær-Jensen et al., 2008). The transgene
was functional as it was capable of restoring viability of let-60(ok1932) mutant
animals. When tested in wild-type animals, i.e., in the presence of two endog-
enous let-60 alleles, a 2.3-fold increase in let-60 mRNA levels resulted as
determined by quantitative real-time PCR on RNA collected from L4-stage an-
imals (data not shown). Irrespective of the status of the endogenous let-60 lo-
cus, presence of the transgene failed to cause the vulval rupturing phenotype
characteristic of let-7 loss of function and lin-41 gain of function, respectively.
RNA Isolation and Quantitative Real-Time PCR
RNA was isolated from worm pellets using TRI Reagent (Molecular Research
Center) following the manufacturer’s instructions after a freeze-thaw process.
cDNA was generated from 500 ng of total RNA per sample using ImProm-II
Reverse Transcription System (Promega) and random hexamers according
to the manufacturer’s protocol. Quantitative real-time PCR was performed
on a StepOnePlus Real-time PCR System using SYBR Green PCR Master
Mix (Applied Biosystems) following the supplier’s protocol in a 25 ml reaction
containing 6 ml 1:480 diluted cDNA. Transcript levels of pgk-1 or act-1 were
used for normalization. Oligonucleotide primer sequences are provided in
the Supplemental Experimental Procedures.DevelopSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
one figure, and one movie and can be found with this article online at http://
dx.doi.org/10.1016/j.devcel.2014.12.018.
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  Legend	
  to	
  Movie	
  S1:	
  Representative	
  time-­‐lapse	
  movie	
  of	
  a	
  young	
  adult	
  let-­‐7(n2853)	
  worm	
  grown	
  at	
  25	
  °C.	
  Related	
  to	
  Figure	
  2.	
  	
  	
  	
   	
  
Ecsedi_FigS1
L4 stage
let-7(mn112), tbb-1::let-7
hypodermis vulva
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*
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*
strain let-7 expression  % burst % alae
let-7(mn112) - 100 0
let-7(mn112), tbb-1::let-7 ubiquitous 0 100
let-7(mn112), elt-3::let-7 epidermis 93 100
let-7(mn112), his-2::let-7 epidermis, vulva, uterus   0 100
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Fig. S1: let-7 is active in the vulva. Related to Fig. 3.
A, let-7 is transcribed in both hypodermis and vulva. Arrow: seam cell; arrowhead: hyp7, asterisk 
indicates vulva lumen.
B, Schematic of tissue-specific let-7 expression. Pri-let-7 is expressed in a tissue-specific manner in 
worms lacking endogenous let-7 in all cells. A gfp marker is transcriptionally linked to pri-let-7 through 
use of an operon linker, permitting visualization of promoter activity.
C, Bursting (n>100) and alae (n>25) in animals expressing let-7 in a tissue-specific manner.
D, Expression patterns of tissue-specific let-7 rescue constructs as visualized by the co-transcribed gfp 
marker. Arrows indicate seam cells, arrowheads point to hyp7 cells, asterisks show the vulva lumen.
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Worm	
  handling	
  and	
  strains	
  Worms	
  were	
  grown	
  using	
  standard	
  methods,	
  experiments	
  were	
  performed	
  at	
  25°C	
  unless	
  indicated	
  otherwise.	
  The	
  genotypes	
  of	
  the	
  strains	
  investigated	
  are	
  listed	
  in	
  the	
  Supplemental	
  Table	
  below.	
  	
  
Construction	
  of	
  miRNA	
  target	
  reporters	
  3’UTRs	
  were	
  amplified	
  using	
  primers	
  indicated	
  in	
  the	
  Supplemental	
  Table	
  below	
  and	
  inserted	
  into	
  the	
  Multisite	
  Gateway	
  pDONR	
  P2R-­‐P3	
  vector.	
  The	
  3’	
  UTR	
  entry	
  vectors	
  obtained	
  were	
  recombined	
  together	
  with	
  a	
  pdpy-­‐30	
  and	
  a	
  GFP(PEST)-­‐H2B	
  (Wright	
  et	
  al.,	
  2011)	
  or	
  mCherry-­‐H2B	
  plasmids	
  (Supplemental	
  Table	
  below)	
  into	
  MosSCI	
  compatible	
  destination	
  vectors.	
  All	
  plasmids,	
  listed	
  in	
  the	
  Supplemental	
  Table	
  below,	
  were	
  verified	
  by	
  sequencing.	
  Transgenic	
  worms	
  were	
  created	
  by	
  Mos1-­‐mediated	
  single-­‐copy	
  insertion	
  (Frøkjær-­‐Jensen	
  et	
  al.,	
  2012)	
  (MosSCI)	
  in	
  position	
  ttTi5605	
  or	
  cxTi10882	
  (mCherry	
  control	
  reporter).	
  All	
  transgenic	
  lines	
  were	
  outcrossed	
  at	
  least	
  three	
  times.	
  	
  	
  
qPCR	
  primers	
  
Name	
   Sequence	
  lin-­‐41	
  R2	
  qPCR	
   aagcgttgacgtgtgtatcg	
  act-­‐1	
  F1	
  qPCR	
   gttgcccagaggctatgttc	
  act-­‐1	
  R1	
  qPCR	
   caagagcggtgatttccttc	
  pgk-­‐1	
  qPCR	
  F2	
   ctcctactttagcaaggccctcg	
  pgk-­‐1	
  qPCR	
  R2	
   ttgactccctgggcaactttc	
  daf-­‐12	
  qPCR	
  F2	
   gatcctccgatgaacgaaaa	
  daf-­‐12	
  qPCR	
  R2	
   ctcttcggcttcaccagaac	
  let-­‐60	
  qPCR	
  F1	
   ttggagatggaggagttggt	
  let-­‐60	
  qPCR	
  R1	
   agaaatccttcgcctgtcct	
  hbl-­‐1	
  qPCR	
  F1	
   actgcacatatgccaccaaa	
  hbl-­‐1	
  qPCR	
  R1	
   tgatgtaaccggctcaactg	
  	
   	
  
	
  	
  
DNA	
  cloning	
  primers	
  
Name	
   Sequence	
  	
  
(genomic	
  sequence	
  indicated	
  in	
  uppercase)	
   Use	
   Reference	
  his-­‐2	
  GW	
  	
  fwd	
   ggggacaactttgtatagaaaagttgcaTTGCGACGACTTTGGGAG	
   GW	
  primer	
  to	
  create	
  promoter	
  entry	
  clone	
  his-­‐2	
  GW	
  	
  rev	
   ggggactgcttttttgtacaaacttggAATCCGATAAGGACTGTG	
   GW	
  primer	
  to	
  create	
  promoter	
  entry	
  clone	
  elt-­‐3	
  GW	
  fwd	
   ggggacaactttgtatagaaaagttgaaCGCTGATGGGGGTACGGTC	
   GW	
  primer	
  to	
  create	
  promoter	
  entry	
  clone	
  elt-­‐3	
  GW	
  rev	
   ggggactgcttttttgtacaaacttgtGAAGTTTGAAATACCAGGTAGCCG	
   GW	
  primer	
  to	
  create	
  promoter	
  entry	
  clone	
  let-­‐60	
  promoter	
  GW	
  fwd	
   ggggacaactttgtatagaaaagttgcgCAGTCAGTAGAATACAAAATTTTAG	
   GW	
  primer	
  to	
  create	
  promoter	
  entry	
  clone	
  let-­‐60	
  promter	
  GW	
  rev	
   ggggactgcttttttgtacaaacttgcTACCCTTTTCTGAAAAAAGACGC	
   GW	
  primer	
  to	
  create	
  promoter	
  entry	
  clone	
  lin-­‐41	
  p	
  GW	
  fwd	
   ggggacagctttcttgtacaaagtggtaCCACGCAGACAAGGAGCTAC	
   GW	
  primer	
  to	
  create	
  promoter	
  entry	
  clone	
  lin-­‐41	
  p	
  GW	
  rev	
   ggggacaactttgtataataaagttgtCACTTTTTCCAAGTCTGAAAAGG	
   GW	
  primer	
  to	
  create	
  promoter	
  entry	
  clone	
  pri-­‐let-­‐7	
  GW	
  f	
   ggggacaagtttgtacaaaaaagcaggctTCGCGGGTTTCTGTTCATATA	
   GW	
  primer	
  to	
  create	
  pri-­‐let-­‐7	
  entry	
  clone	
  pri-­‐let-­‐7GW	
  r	
   ggggaccactttgtacaagaaagctgggtTATTTCCTGCTCGTTCTTCAC	
   GW	
  primer	
  to	
  create	
  pri-­‐let-­‐7	
  entry	
  clone	
  let-­‐60	
  CDS	
  Gibson	
  f	
   ATGACGGAGTACAAGCTTGTG	
   PCR	
  primer	
  for	
  cloning	
  of	
  let-­‐60	
  CDS::unc-­‐54	
  3'UTR	
  let-­‐60	
  CDS	
  Gibson	
  r	
   TCACATTATTTGACACTTCTTCTTC	
   PCR	
  primer	
  for	
  cloning	
  of	
  let-­‐60	
  CDS::unc-­‐54	
  3'UTR	
  
unc-­‐54	
  Gibson	
  f	
   AGAAGTGTCAAATAATGTGAgtccaattactcttcaacatccc	
   PCR	
  primer	
  for	
  cloning	
  of	
  let-­‐60	
  CDS::unc-­‐54	
  3'UTR,	
  sequence	
  complementary	
  to	
  let-­‐60	
  CDS	
  indicated	
  in	
  uppercase	
  unc-­‐54	
  Gibson	
  r	
   accccatagacactactccac	
   PCR	
  primer	
  for	
  cloning	
  of	
  let-­‐60	
  CDS::unc-­‐54	
  3'UTR	
  unc-­‐54	
  Gibson	
  r	
  attB2	
   ggggaccactttgtacaagaaagctgggtaACCCCATAGACACTACTCCAC	
   GW	
  primer	
  to	
  create	
  let-­‐60	
  CDS::unc-­‐543'UTR	
  entry	
  clone	
  let-­‐60	
  CDS	
  GW	
  fwd	
   ggggacaagtttgtacaaaaaagcaggctaaATGACGGAGTACAAGCTTGTGGTAG	
   GW	
  primer	
  to	
  create	
  let-­‐60	
  CDS::unc-­‐54	
  3'UTR	
  entry	
  clone	
  lin-­‐41	
  3'UTR	
  GW	
  f	
   ggggacagctttcttgtacaaagtggACACTTTCTTCTTGCTCTTTACCC	
   GW	
  primer	
  to	
  create	
  3'UTR	
  entry	
  clone	
   Slack	
  et	
  al,	
  2000.	
  To	
  create	
  lin-­‐41	
  ∆LCS,	
  pFS1031	
  lacking	
  LCS1and	
  2	
  was	
  used	
  as	
  a	
  template	
  (Vella	
  et	
  al,	
  2004)	
  lin-­‐41	
  3'UTR	
  GWr	
   ggggacaactttgtataataaagttgTTTATTCCAATTATGTTATCAGC	
   GW	
  primer	
  to	
  create	
  3'UTR	
  entry	
  clone	
  	
  	
  
	
   	
  
C.	
  elegans	
  strains	
  	
  
Strain	
  
number	
   Genotype	
  HW1120	
   xeSi104[Pdpy-­‐30::GFP(PEST)-­‐H2B::unc-­‐54	
  3'UTR,	
  unc-­‐119	
  (+)]	
  II,	
  xeSi36[Pdpy-­‐30::mCherry::H2B::artificial	
  3'UTR,	
  unc-­‐119(+)]	
  IV	
  HW1169	
   xeSi104[Pdpy-­‐30::GFP(PEST)-­‐H2B::unc-­‐54	
  3'UTR,	
  unc-­‐119	
  (+)]	
  II,	
  xeSi36[Pdpy-­‐30::mCherry::H2B::artificial	
  3'UTR,	
  unc-­‐119(+)]	
  IV;	
  let-­‐7(n2853)	
  X	
  HW1113	
   xeSi78	
  [Pdpy-­‐30::GFP(PEST)-­‐H2B::lin-­‐41	
  3'UTR,	
  unc-­‐119	
  (+)]	
  II,	
  xeSi36[Pdpy-­‐30::mCherry::H2B::artificial	
  3'UTR,	
  unc-­‐119(+)]	
  IV	
  HW1114	
   xeSi78	
  [Pdpy-­‐30::GFP(PEST)-­‐H2B::lin-­‐41	
  3'UTR,	
  unc-­‐119	
  (+)]	
  II,	
  xeSi36[Pdpy-­‐30::mCherry::H2B::artificial	
  3'UTR,	
  unc-­‐119(+)]	
  IV;	
  let-­‐7(n2853)	
  X	
  HW1159	
   xeSi87[Pdpy-­‐30::GFP(PEST)-­‐H2B::lin-­‐41	
  deltaLCS	
  3'UTR,	
  unc-­‐119	
  (+)]	
  II,	
  xeSi36[Pdpy-­‐30::mCherry::H2B::artificial	
  3'UTR,	
  unc-­‐119(+)]	
  IV	
  HW1128	
   xeSi80[Pdpy-­‐30::GFP(PEST)-­‐H2B::let-­‐60	
  3'UTR,	
  unc-­‐119	
  (+)]	
  II,	
  xeSi36[Pdpy-­‐30::mCherry::H2B::artificial	
  3'UTR,	
  unc-­‐119(+)]	
  IV	
  HW1129	
   xeSi80[Pdpy-­‐30::GFP(PEST)-­‐H2B::let-­‐60	
  3'UTR,	
  unc-­‐119	
  (+)]	
  II,	
  xeSi36[Pdpy-­‐30::mCherry::H2B::artificial	
  3'UTR,	
  unc-­‐119(+)]	
  IV;	
  let-­‐7(n2853)	
  X	
  HW1191	
   xeSi117[Plet-­‐7::GFP(PEST)-­‐H2B::unc-­‐54	
  3'UTR,	
  unc-­‐119	
  (+)]	
  II	
  HW1097	
   let-­‐7(mn112)	
  X;	
  xeEx365[Ptbb-­‐1::let-­‐7::SL1_operon_GFP	
  ,	
  unc-­‐119	
  (+);	
  Prab-­‐3::mCherry;	
  Pmyo-­‐2::mCherry;	
  Pmyo-­‐3::mCherry]	
  HW1175	
   xeSi34[Ptbb-­‐1::let-­‐7::SL1_operon_GFP]	
  ,	
  unc-­‐119	
  (+)]	
  II;	
  let-­‐7(mn112)	
  X,	
  	
  HW1186	
   xeSi95.[Phis-­‐2::let-­‐7::SL1_operon_GFP]	
  ,	
  unc-­‐119	
  (+)]	
  II,	
  let-­‐7(mn112)	
  X	
  	
   	
  
Plasmids	
  
	
  
Name	
   Use,	
  reference	
  pENTR_L4-­‐R1_Pdpy-­‐30	
   dpy-­‐30	
  promoter	
  GW	
  entry	
  clone	
  covering	
  the	
  V:12189538-­‐12191540	
  genomic	
  region	
  pENTR_L4-­‐R1_Phis-­‐2	
   his-­‐2	
  promoter	
  GW	
  entry	
  clone	
  pENTR_L4-­‐R1_Pelt-­‐3s	
   elt-­‐3	
  promoter	
  GW	
  entry	
  clone	
  pENTR_L4-­‐R1_Ptbb-­‐1	
   tbb-­‐1	
  promoter	
  GW	
  entry	
  clone	
  pENTRL4-­‐R1_Plet-­‐60	
   let-­‐60	
  promoter	
  GW	
  entry	
  clone	
  pBMF2.7	
   Gfp(PEST)-­‐H2b	
  GW	
  enty	
  clone,	
  Wright	
  et	
  al,	
  2011	
  pCM1.151	
   mCherry-­‐H2b	
  GW	
  enty	
  clone,	
  Merrit	
  et	
  al,	
  2008	
  pENTRL1-­‐L2_let-­‐7	
  rescue	
  fragment	
   pri-­‐let-­‐7	
  GW	
  entry	
  clone	
  pENTR_L1-­‐L2_let-­‐60-­‐unc54-­‐3'UTR	
   let-­‐60::unc-­‐54	
  3'UTR	
  GW	
  entry	
  clone	
  
pENTR_R2-­‐L3_operon-­‐GFP-­‐H2b	
   gpd-­‐2/gpd-­‐3	
  intergenic	
  region:GFP:Histone	
  H2B:tbb-­‐2	
  3’UTR	
  GW	
  entry	
  clone,	
  contains	
  25	
  nucleotides	
  of	
  the	
  gpd-­‐2	
  3'UTR	
  followed	
  by	
  the	
  gpd-­‐2	
  polyadenylation	
  signal;	
  based	
  on	
  Merritt	
  et	
  al,	
  2008	
  pCM5.37	
   unc-­‐54	
  3'UTR	
  GW	
  entry	
  clone	
  (Seydoux	
  lab)	
  pENTR_R2-­‐L3_	
  (6xmir-­‐35mut)l3'UTR	
   artificial	
  (control)	
  3'UTR	
  GW	
  entry	
  clone	
  containing	
  6xmir-­‐35	
  scrambled	
  sites,	
  adapted	
  from	
  Wu	
  et	
  al,	
  2012	
  pENTR_R2-­‐L3_lin-­‐41	
  3'UTR	
   lin-­‐41	
  3'UTR	
  GW	
  entry	
  clone	
  pENTR_R2-­‐L3_lin-­‐41	
  3'UTR	
  ∆LCS	
   lin-­‐41	
  3'UTR	
  GW	
  entry	
  clone	
  lacking	
  LCS1	
  and	
  2	
  pENTR_R2-­‐L3_lin-­‐41(n2853)	
  3'UTR	
   lin-­‐41(n2853)	
  3'UTR	
  GW	
  entry	
  clone	
  containing	
  compensatory	
  mutations	
  to	
  let-­‐7(n2853)	
  in	
  LCS	
  1	
  and	
  2,	
  derived	
  from	
  pENTR_R2-­‐L3_lin-­‐41	
  3'UTR	
  using	
  site-­‐directed	
  mutagenesis	
  pIK82	
   peft-­‐3::Cas9::2xNLS::tbb-­‐2	
  	
  plin-­‐41sgRNA	
   pU6::lin-­‐41sgRNA	
  pCFJ104	
   pmyo-­‐2::mCherry	
  
	
  HW1207	
   xeSi97.[Pelt-­‐3s::let-­‐7::SL1_operon_GFP]	
  ,	
  unc-­‐119	
  (+)]	
  II;	
  let-­‐7(mn112)	
  X,	
  xeEx365[Ptbb-­‐1::let-­‐7::SL1_operon_GFP	
  ,	
  unc-­‐119	
  (+);	
  Prab-­‐3::mCherry;	
  Pmyo-­‐2::mCherry;	
  Pmyo-­‐3::mCherry]	
  HW	
  1187	
  	
   syIs103[unc-­‐119(+)	
  +	
  pPGF11.13(lin-­‐11::GFP)],	
  outcrossed	
  from	
  PS4198	
  HW1188	
   syIs103[unc-­‐119(+)	
  +	
  pPGF11.13(lin-­‐11::GFP)],	
  let-­‐7(n2853)	
  X	
  HW1192	
   arIs92[egl-­‐17p::NLS-­‐CFP-­‐LacZ	
  +	
  unc-­‐4(+)	
  +	
  ttx-­‐3::GFP],	
  from	
  the	
  CGC	
  strain	
  GS3582	
  HW1193	
   arIs92[egl-­‐17p::NLS-­‐CFP-­‐LacZ	
  +	
  unc-­‐4(+)	
  +	
  ttx-­‐3::GFP],	
  let-­‐7(n2853)	
  X	
  HW1230	
   mjIs15[ajm-­‐1::mCherry]	
  HW1277	
   mjIs15[ajm-­‐1::mCherry];	
  let-­‐7(n2853)	
  X	
  HW1320	
   lin-­‐41(xe8)	
  I	
  HW1329	
   lin-­‐41(xe11)	
  I	
  HW1330	
   lin-­‐41(xe11)	
  I,	
  let-­‐7(n2853)	
  X	
  HW1413	
   xeSi145[Plet-­‐60::let-­‐60CDSw/intr-­‐unc-­‐54	
  3’UTR::gfp	
  operon]	
  II	
  HW1594	
   xeSi145[Plet-­‐60::let-­‐60CDSw/intr-­‐unc-­‐54	
  3’UTR::gfp	
  operon]	
  II,	
  let-­‐60(ok1932)	
  IV	
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Remarks and open questions 
 
With this study, we present the first systematic analysis of the let-7 vulval bursting phenotype and the 
process of vulval morphogenesis in let-7(n2853) mutants. As a conclusion, we can exclude gross defects 
in vulval development and morphogenesis, especially during early stages when VPC specification and the 
division pattern of the vulval cells are induced. Unfortunately, we fail to identify the critical step, and the 
actual cause of bursting remains unexplained. This is at least in part due to the fact that the mechanisms 
that control the later stages of vulval morphogenesis are generally less well understood than the early 
steps. Moreover, while we can prove that let-7 is required outside of the hypodermis, it remains to be 
determined if let-7 function in the vulva is sufficient to rescue bursting. Even though we tested a number 
of candidate promoters, we had to accept the fact that exclusively vulva-specific promoters do apparently 
not exist in C. elegans. Hence, we cannot formally rule out that let-7 functions in the uterus. One possible 
way to address this would be mosaic analysis of a transgene expressed from an extrachromosomal array. 
The second major conclusion of this study is the fact that regulation of lin-41 alone is sufficient to suppress 
let-7 bursting in the background of the let-7(n2853) mutation. While this has somewhat been expected 
based on experiments from earlier publications, the work presented here can for the first time provide 
direct support of this hypothesis in the context of the endogenous genomic loci without using any 
transgenes. Our results suggests a major role for derepression of lin-41 not only in respect to the 
hypodermal phenotypes, but also in the vulva (or, as mentioned, the uterus) of let-7(n2853) animals. It 
will be interesting to determine why the vulval cells, in contrast to the seam cells, do not present cell 
division defects. A potential explanation might be a tissue-specific function for LIN-41, maybe with 
different downstream effectors. To this end, the phenotypical differences between the unregulated lin-
41 mutants and let-7(n2853) and wild-type worms will have to be characterized in more detail, both in 
the context of the vulva as well as regarding seam cell differentiation. Furthermore, a combination of 
biochemical and genetic approaches may help to identify potential interacting-partners and targets of 
LIN-41 and could be the basis for further research.  
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Discussion 
 
 
miRNAs: active switches or collective modulators? 
 
The first known miRNAs, lin-4 and let-7, were discovered for their obvious loss-of function phenotypes in 
genetic screens. Moreover, the absolute sequence conservation of let-7 from nematodes all the way up 
to humans seemed to promise a crucial importance for miRNA mediated control of gene activity in 
development, similar to the effects observed for transcription factors. Today, almost fifteen years after 
the discovery of the biological process of posttranscriptional gene regulation by miRNAs, these initial 
hopes have been somewhat dampened. Apart from exceptional cases of genetic disorders that were 
linked to miRNA mutations, as found for the miR-183/miR-96/ miR-182 cluster in familiar hearing loss 
(Mencia et al. 2009), few examples of miRNAs essential in development have been found in humans. 
Moreover, the majority of miRNA knockouts in mice, despite the high conservation of these miRNAs 
across different species, do not show major defects. Even in C. elegans, where it was possible to analyze 
deletions for about 75% of the miRNAs encoded in the worm genome, the majority of them were found 
to be non-essential (Miska et al. 2007). A potential explanation for this is the predicted redundancy of 
miRNA families that share the same seed sequence and are thought to target the same mRNAs.  However, 
when this was addressed in worms, few phenotypes were identified even if whole miRNA families were 
deleted (Alvarez-Saavedra and Horvitz 2010). Nonetheless, mammalian genomes encode hundreds of 
evolutionary conserved miRNAs, which argues for a profound role of these loci for survival of the species. 
To make matters more complicated, these miRNAs are computationally predicted to target conserved 
binding sites on hundreds of targets per miRNA, and mRNAs typically contain binding sites for several 
different miRNAs (Bartel 2009). The question of miRNA-target interactions remains a topic of intensive 
debate. Several large-scale studies suggest that the effects of miRNAs on protein levels are mostly modest 
(Baek et al. 2008, Hendrickson et al. 2009, Guo et al. 2010, Selbach et al. 2008). Even though coordinated 
effects of different miRNAs on a single target are experimentally very difficult to test and were not yet 
analyzed on a global level, these observations led to the conclusion that miRNAs might in most cases act 
as fine tuners rather than active switches of gene expression. Does this explain the lack of phenotypes for 
the majority of analyzed miRNA knockouts? If individual miRNAs act by moderate, but coordinated 
regulation of numerous targets, putting some targets under strong repression by an additive mechanism 
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in concert with other miRNAs, then phenotypes for individual miRNAs should not be detectable. In stark 
contrast to this hypothesis of miRNAs as broad fine-tuners of gene regulation is the existence of miRNAs 
such as lin-4 and let-7, which show strong mutant phenotype and the significant repressive capacity 
towards their targets in C. elegans. Studying the heterochronic pathway, it became sufficiently clear that 
lin-4 mediated its function solely through linear repression of lin-14 and lin-28, even before it was 
understood that lin-4 acted as a miRNA. My PhD work now proves that lin-41 stands in a similar linear 
regulatory relationship with let-7 (Ecsedi et al. 2015). lin-41 has been proposed as the major effector of 
let-7 phenotypes in the hypodermis, yet other targets of let-7 have been found. In order to address this 
issue, we decided to artificially design a situation in which only lin-41 would escape let-7 mediated 
repression, while all other targets would remain unaffected. In order to create such a situation in vivo, we 
used CRISPR/Cas9 based genome engineering to modify the let-7 complementary sites (LCSs) in the 3’UTR 
of lin-41. To our great satisfaction, we can indeed show that deletion of the LCSs can induce bursting, and, 
more importantly, that a molecular situation that changes the binding sites back to a Watson-Crick base-
pairing between let-7(n2853) and lin-41 can fully rescue the let-7 bursting phenotype. This experiment is 
an elegant proof of concept for lin-41 being the single let-7 target responsible for the bursting phenotype 
in C. elegans. For now, miRNAs with such strong relations to key targets as in the case of lin-4 and let-7 
seem to be the exception, rather than the rule. Nonetheless, even if miRNAs have subtle modulative 
effects in many cases, keeping targets within a physiological level, important examples for miRNAs actively 
inducing changes in gene expression over development do exist. Moreover, although results from C. 
elegans suggest otherwise, it cannot be excluded that miRNAs have crucial roles in higher organisms. The 
existence of multiple miRNA family members, e.g. in the case of humans, where let-7 homologues are 
encoded in 13 genomic loci, might reflect the importance of these miRNAs and could provide a mechanism 
to protect the genome from detrimental effects in case of mutation of the miRNA. Unfortunately, this 
widespread distribution of miRNA family genes makes it extremely difficult to engineer fully functional 
miRNA deletions and prevents them from occurring spontaneously. Therefore, the genomes of higher 
organisms might harbor additional miRNAs with important functions in development. 
 
let-7 targets in C. elegans – not quite as simple as “just” lin-41 
 
My work has clearly highlighted the importance for lin-41 as the key let-7 target in development of C. 
elegans. Misregulation of lin-41 alone can induce bursting, and repaired target binding of the point-
71 
 
mutant let-7(n2853) allele only for lin-41 in a situation where all other targets are derepressed can 
suppress the bursting phenotype.  Nevertheless, multiple let-7 targets were proposed and confirmed in 
different in vivo or in vitro systems, and several of them, such as daf-12, hbl-1, lss-4, die-1 and pha-4 have 
been found to rescue the bursting phenotype of let-7 null mutants (Slack et al. 2000, Andachi 2008, 
Grosshans et al. 2005, Johnson et al. 2005, Hunter et al. 2013). This phenomenon still awaits a sufficient 
explanation. First of all, it remains to be determined if these factors are indeed physiological let-7 targets. 
Using microarray analysis of let-7 mutant animals, apart from lin-41 I find only daf-12 levels to change 
significantly upon loss of let-7. Indeed, high-resolution time-course studies performed in our lab indicate 
that only two genes initially respond to let-7 upregulation during early L4 stage. These genes are the 
known let-7 targets lin-41 and daf-12 (F. Aeschimann, unpublished data). However, if these suppressors 
are tissue-specific let-7 targets, it might be impossible to pick up let-7-dependent mRNA changes in total 
worm lysates. Targets or not, we cannot exclude that these genes affect the processes that lead to vulval 
bursting, either downstream of or parallel to lin-41/let-7. Therefore it will be critical to identify the 
molecular and morphological determinants of this process. Notably, the transcription factors DAF-12 and 
PHA-4 co-regulate genes involved in the morphological changes upon dauer entry, which is a physiological 
response to stress caused by starvation (Ao et al. 2004). It might be possible that lin-41 represents the 
crucial let-7 target under normal conditions, regulated in a switch-like manner, while regulation of other 
targets might gain importance in stress conditions such as food withdrawal.  
An alternative model predicts cross-regulation between the let-7 targets. This idea is supported by the 
fact that the genes daf-12, pha-4, die-1 and hbl-1 that can suppress the lethality associated with the let-7 
null allele code for transcription factors, and lss-4 acts as a chromatin remodeling factor (Grosshans et al. 
2005). The let-7 targets might activate expression of each other such that knockdown of one results in 
reduced expression of lin-41. However, this would have to account for a strong reduction in lin-41 levels, 
since I find lin-41 derepressed up to five-fold in let-7(n2853) mutants. Furthermore, I do not detect 
significant changes in lin-41 levels upon RNAi of daf-12 or hbl-1. Alternatively, the transcriptional 
regulators might dampen expression of the let-7 precursor. Such a role has indeed been confirmed in the 
case of HBL-1 (Roush and Slack 2009).Nonetheless, this would not account for rescue in a let-7 null 
background.  A completely different mechanism would be the function of the other let-7 targets as mRNA 
sponges that titrate let-7 away from the physiological target lin-41. Indeed, I find lin-41 and daf-12 to 
increase repression of each other upon RNAi. This notion is further supported by my observation that loss 
of lin-41 binding in lin-41(xe11) animals results in stronger repression of daf-12. However, rescue of let-7 
phenotypes in a context where knockdown of one let-7 target would leave more let-7 molecules “free” to 
72 
 
repress the other target again only makes sense in a situation where let-7 is present as a hypomorph, but 
not in case of a let-7 null. Therefore, this model does not provide a satisfactory explanation for the ability 
of the other targets to rescue the phenotype. It is therefore more likely that the other targets act parallel 
to lin-41, maybe even, as mentioned above, in a tissue-specific manner. Indeed, hbl-1 RNAi can rescue 
only lethality, but not the hypodermis phenotype of let-7 mutants (Vadla et al. 2012). Moreover, the fact 
that many of the let-7 targets are expressed in the gut, it remains possible that homeostasis of this tissue 
has an effect on let-7 bursting. Even lin-41 itself seems to act in a tissue-specific manner. As a matter of 
fact, lin-41 mutations do cause precocious alae formation in only about 50% of the animals (Slack et al. 
2000), indicating that let-7 might have additional targets in the hypodermis. This observation nicely 
correlates with the fact that in human induced pluripotent stem cell (iPS) generation, the beneficial effect 
of let-7 repression can be explained largely, but not to 100% by lin-41 upregulation (Worringer et al. 2014). 
Moreover, LIN-29, the major downstream target of LIN-41 in the hypodermis, is not required for male 
tale-tip development, a tissue in which LIN-41 controls activity of the transcription factors DMD-3/MAB-
3 (Del Rio-Albrechtsen et al. 2006, Mason et al. 2008). We note that LIN-41 might also act in a different 
context in the vulva as compared to the hypodermis. First of all, we can show that VPC specification as 
well as early morphogenesis during L3 stage are not affected by let-7 mutations. This correlates with the 
time of let-7 expression and the onset of let-7 phenotypes in the hypodermis only at the late L4 stage. 
However, we also do not observe any obvious morphogenesis effects during later stages of vulval 
development, and most importantly, no additional divisions of the vulval cells. This is surprising because 
it stands in contrast to the let-7 hypodermis differentiation defect that is accompanied by a supernumeral 
division of the seam cells. Moreover, LIN-29 levels were found reduced in the seam cells of let-7(n2853) 
animals, but unchanged in the vulval cells at the late L4 stage, arguing that LIN-29 expression in the vulva 
might not be controlled by let-7 (Reinhart et al. 2000). Third, LIN-29 mutants show a defect in fusion of 
the anchor cell (AC) with the uterine π cells (Newman et al. 2000). This phenotype does not occur in let-
7(n2853) animals, were π cells and AC fuse to an utse cell of wild-type morphology. It has to be mentioned 
that this discrepancy could be caused by the remaining activity of the hypomorphic let-7(n2853) 
molecules, which might allow some basic LIN-29 activity. Or, let-7 might indeed control vulval 
development through a tissue-specific factor downstream of LIN-41. If that is the case, then the other let-
7 targets might potentially affect this enigmatic factor. Taken together, a final explanation for the 
suppressive effect of the published let-7 targets remains to be discovered. 
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miRNAs represent important regulators of the cell cycle 
 
As opposed to knockout studies indicating that the majority of miRNAs are not of major importance during 
normal development of multicellular organisms in ideal environments, reports of miRNAs that have crucial 
functions if normal cell homeostasis is perturbed seem to accumulate exponentially. Indeed, it has 
become increasingly clear that miRNA loss-of-function can be detrimental for development if animals are 
subjected to stress (Leung and Sharp 2010). Moreover, countless examples for aberrant miRNA expression 
in pathological conditions have been found, which has resulted in a model according to which many 
miRNAs function to allow dynamic responses to pathological or physiological stress situations (Mendell 
and Olson 2012). The identification of deletions of the miR-15a/16-1 cluster in chronic lymphocytic 
leukemia (CLL) established cancer as the first disorder connected to miRNA misregulation (Calin et al. 
2002). Likewise, since its initial discovery as a tumor suppressor in the lung, let-7 has been linked to 
multiple types of cancers. Interestingly, the major characteristic of cancer, namely overproliferation of a 
specific cell type due to ectopic stimulation of the cell cycle, resembles the hypodermis phenotypes 
observed in lin-4 and let-7 mutants in C. elegans. Accordingly, interactions between the heterochronic 
pathway and cell cycle components have indeed been verified for the early timer consisting of lin-4 and 
its target lin-14. LIN-14 directly or indirectly activates transcription of the cyclin-dependent kinase 
inhibitor cki-1, which results in a cell cycle pause prior to S phase in VPCs (Hong et al. 1998). My work 
presented here strongly indicates that such a miRNA-mediated regulation of cell cycle factors also occurs 
in the case of C. elegans let-7.  The genes identified in the genome-wide suppressor screen comprise 
numerous factors required for cell cycle and mitosis, such as the genes cyb-3 (Cyclin B) and plk-1 (Polo-
like kinase 1), as well as structural components required for mitosis, which suggests an important role for 
let-7 in repressing the cell cycle of the seam cells. Moreover, in the case of the cell cycle promoting factor 
cdk-1, we can show direct control by let-7 through the transcription factor LIN-29. Accordingly, a large 
number of cell cycle factors have been found to be downregulated upon let-7 overexpression in human 
lung cancer cells, among them the G1 phase promoting kinase CDK6 as well as CDC25A, an activating 
phosphatase targeting CDKs (Johnson et al. 2007). My genome-wide RNAi screen has also identified a 
number of cell cycle factors that affect let-7 activity. While the mechanism for this phenomenon remains 
to be identified, examples for a direct crosstalk with the cell cycle have been discovered for other miRNAs. 
The miR-16 family, which was found to be frequently mutated in human B cell chronic lymphocytic 
leukemias (B-CLL), is a prominent example for miRNA mediated regulation of cell cycle progression by 
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targeting factors like CDK6, CARD10, and CDC27 (Linsley et al. 2007, Liu et al. 2008, Calin et al. 2002, Klein 
et al. 2010, Bandi et al. 2009). Moreover, transcription of these miRNAs as well as rapid turnover are co-
regulated with cell cycle progression, ensuring rapid repression of  the inhibitory signal upon mitotic 
stimulation (Rissland et al. 2011). The fact that we have identified cell cycle factors to affect let-7 function 
in C. elegans could point to a similar mechanism as in the case of miR-16. Accumulation of let-7 can be 
detected from L3 stage onwards, a time when seam cells still have to undergo one more round of division. 
One could envision a situation in which cell cycle factors repress let-7 activity in order to ensure 
completion of the last seam cell division, after which continuing accumulation of let-7 represses the cell 
cycle and induces differentiation. Analysis by northern blot did not indicate substantial increase in mature 
let-7 levels upon RNAi of the candidate factors. However, it remains possible that some suppressors act 
for example on RISC activity or support the transcription of let-7 targets. 
Notably, let-7 is not the only miRNA for which cross-regulation with cell cycle components has been 
reported. A striking example is the interplay between p53 and miRNAs of the miR-34 family. The p53 
transcription factor is a, maybe the, key mediator of a signaling pathway that induces checkpoint 
activation and cell cycle arrest upon DNA damage or other signs of cellular abnormalities, which, if not 
resolved during the cell cycle halt, induces apoptosis . In 2007, several groups found direct transcriptional 
activation of the mir-34 miRNAs by p53 to be crucial for cell cycle arrest and apoptosis (Bommer et al. 
2007, Chang et al. 2007, He et al. 2007, Raver-Shapira et al. 2007, Tarasov et al. 2007). Conversely, the 
transcription factor Myc, which has emerged as a major proto-oncogene due to its strong capacity to 
induce cell growth and proliferation, was found to activate the prominent miR-17-92 cluster, a locus that 
has been identified to act oncogenic itself (Mendell 2008, He et al. 2005). Two of the miRNAs in this 
cluster, namely miR-17-5p and miR-20a, are capable of suppressing the cMyc target E2F1, a transcription 
factor that acts stimulating on cell cycle progression. However, E2F proteins have been proposed to induce 
apoptosis if too active (Ziebold et al. 2001). One model for the oncogenic capacity of the locus might 
therefore be that Myc activates transcription of E2F proteins, but in parallel counteracts apoptosis 
through the negative feedback loop established by the miR-17-92 cluster, resulting in full proliferative 
capacity of tumors (O'Donnell et al. 2005). An interesting notion in this context is the fact that regulation 
of let-7 itself is tightly linked the cell cycle through transcriptional activation of the pluripotency factor 
LIN28 by Myc. LIN-28 was found to inhibit let-7 processing at the level of Drosha in the nucleus, thereby 
blocking maturation. let-7 in contrast can target and repress the lin-28 mRNA through LCSs in the 3’UTR. 
This system generates a negative feedback loop that allows repression of let-7 activity in proliferating ES 
cells and rapid downregulation of LIN-28 when differentiation is induced, while excessive activation of 
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Myc in cancer can shift this balance towards proliferation. A second prominent oncogene that was 
identified as a conserved let-7 target is the small GTPase Ras, which acts as a major signal transmitter for 
proliferative stimulation (Esquela-Kerscher et al. 2008, Johnson et al. 2005). While we do not find a 
function for the C. elegans homologue let-60 in vulval development, our data does not argue with its 
regulation by let-7 in the hypodermis. This could indicate that ras is a tissue-specific let-7 target in C. 
elegans. Alternatively, given the conservation of ras as a let-7 target and its implications in cancer, this 
regulation could be important for the organism in situations that are, in the case of C. elegans, not 
encountered under lab conditions, or, in the case of cancer, represent a state of cellular stress. 
These examples and my findings show that let-7 and other miRNAs are indeed important players of the 
cell cycle, be it as active switches in development or as fine-tuners in the context of cell homeostasis. 
Notably, while many of the factors that actively regulate cell cycle progression have been found to interact 
with miRNAs, little is known about a potential contribution of structural factors to this system. With my 
genome-wide RNAi screen, I have discovered that many of the genes that act in the let-7 pathway as well 
as several factors that affect let-7 function comprise structural components required for chromosome 
integrity and cell division, such as the subunits of the condensin II complex. Therefore it might be worth 
to investigate the potential connections between let-7 and these factors in more detail. A possible 
experiment to address this could be to study RNA expression in let-7 mutants and wild-type worms both 
in presence and absence of such components. This experiment would have to be performed in a germline-
less background of in a tissue-specific manner to exclude effects of meiosis. Prior to cost-intensive RNA 
sequencing experiments, the effect of individual suppressors on let-7 activity could be analyzed 
quantitatively by using the microscope-based miRNA target reporter system developed by M. Ecsedi. 
 
let-7 and lin-41- a special pair? 
 
One the one hand, many miRNAs seem not to have strong effects on target levels and present 
inconspicuous phenotypes if deleted. In contrast, a subset of miRNAs do lead to significant degradation 
of target mRNAs, and their knockouts result in serious perturbations of development. Probably one of the 
most remarkable examples for this second class is let-7, mutations of which lead to severe developmental 
defects in C. elegans, and which is required for the differentiation of embryonic stem cells. Particularly 
the level of conservation not only in sequence, but also for its repressive function on lin-41 from simple 
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multicellular organisms all the way up to humans is astonishing. Therefore, one wonders what makes this 
function of let-7 so special. Or, to put it in a different way; what makes LIN-41 such an extraordinary target 
that its repression by let-7 was maintained through evolution of the animal kingdom? 
The answer to this question is obstructed by our little knowledge on the functions of LIN-41, and even 
more importantly, its mode of action. Research on let-7 in vertebrates has largely focused on its interplay 
with a second major let-7 target, namely LIN-28. But while this bistable switch explains how let-7 activity 
is regulated, it never fully sufficed to explain how let-7 was activating differentiation. Work from 
Worringer and colleagues has now nicely illustrated that a critical let-7 target that orchestrates 
proliferation and blocks differentiation is TRIM71/LIN-41, which underlines its function as a major effector 
of the LIN-28/let-7 “switch” (Worringer et al. 2014). Yet, LIN-41 has not fully stepped out of the shadows, 
because reports on its mode of action are inconsistent and many questions remain to be answered. 
LIN-41 was originally proposed to repress lin-29 by an unknown posttranscriptional mechanism, most 
likely at the mRNA level (Slack et al. 2000). However, the first molecular role of LIN-41 was linked to an E3 
ubiquitin ligase function. Rybak and coworkers were able to show mLin41-dependent  polyubiquitylation 
of the Argonaute protein Ago2 in mouse ES cells, leading to proteasomal degradation and an overall 
reduction of Ago2 (Rybak et al. 2009). The activity was associated with the RING and B-box domains but 
did not require the filamin or NHL domains. The observation that mLin41 colocalized with miRNA pathway 
members and caused degradation of Ago2 suggested a negative feedback loop to the miRNA machinery 
that targets mLin41 through let-7. On the other hand, the ESC cell cycle regulating (ESCC) miRNA families 
that oppose let-7 function play an important role in ES cell proliferation, indicating that a global inhibition 
of miRNA function might not make sense in the context of ESCs. Indeed, a second study has identified a 
role for mLin41 in promoting the response to EGF (Chen et al. 2012). In this context, mLin-41 was found 
to bind SHCBP1, a mediator of FGF signaling that represses differentiation. Similar to the effect on Ago2, 
mLin41-dependent ubiquitylation of SHCBP1 was detected, however, Lin41 binding was shown to lead to 
stabilization, not degradation of SHCBP1. Notably, mLin41 was not shown to affect Ago2 levels in this 
study. In parallel, evidence for LIN-41 acting as a repressor of mRNA translation has accumulated. Two 
studies independently reported repression of a large number of mRNAs by mLin41 in mouse ES cells, a 
function that was mediated through the 3’UTR of the targets (Chang et al. 2012, Loedige et al. 2013). Here, 
filamin and NHL domains were crucial for repression, while the RING domain that is mediating E3 ubiquitin 
ligase activity was not required. Interestingly, both studies find cell cycle inhibitors among the Lin41 
targets, which goes in line with the apparent connection between let-7/lin-41 and the cell cycle in C. 
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elegans. Moreover, a recent study identifies EGR1 as a major target of LIN41 at the mRNA level (Worringer 
et al. 2014). The transcription factor EGR1 is an important activator of genes expressed in differentiated 
fibroblasts that needs to be repressed during iPS cell induction (Fragola et al. 2013). Moreover, it contains 
a conserved LIN-29 domain and interacts with the cofactors NAB1 and NAB2, which are homologues of 
the LIN-29 cofactor MAB-10 in C. elegans (Harris and Horvitz 2011). This shows that not only the regulation 
of LIN-41 by let-7 but also important downstream factors are conserved from worm to human. To make 
matters more complicated, further insight on LIN-41 came from a recent study in C. elegans that found 
LIN-41 to be required in the germ-line (Tocchini et al. 2014). Here, LIN-41 plays an important role in 
suppressing the premature onset of developmental plasticity characteristic for early embryonic 
development. While the authors can exclude a function for the RING domain, they also find that key RNA 
binding residues in the NHL domain are dispensable for the germ-line specific function of LIN-41, but not 
for somatic phenotypes. Notably, LIN-41 has been implicated in establishment of muscle attachment to 
the body wall of Drosophila melanogaster (Loer et al. 2008). In this context, function of LIN-41 depends 
on physical interaction with integrins and other proteins of the cytoskeleton, and not on translational 
repression. The hypothesis of a structural role for LIN-41 in formation of cell-cell contacts within the vulva 
or with the vulval musculature would be an attractive alternative to a function in gene-repression, 
especially since this would explain the different phenotypes of let-7 animals in the vulva versus the 
hypodermis of C. elegans. Therefore, it will be exciting to determine the downstream factor of LIN-41 in 
the context of vulval bursting. 
Taken together, LIN-41 seems to be involved in an astonishing variety of different processes that control 
proliferation and differentiation. Maybe this kaleidoscope of functions is what makes LIN-41 so special 
and the requirement for regulation by let-7 so important. Future studies on individual LIN-41 functions 
and its interactions with yet undiscovered binding partners will help to expand our understanding of the 
let-7 network, a regulatory system that is one-of-a-kind in its ability to affect proliferation and 
differentiation both in development and disease. 
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